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Abstract
Lactim  ethers represent a labile and extremely applicable substrate for the formation of 
a wide variety of heterocyclic compounds. This thesis is dedicated to the development 
of methodologies relating to the alkylation, transesterification and isotopic labelling of 
the lactim ether functionality.
The first chapter of this thesis discusses the background reactions that lactim ethers 
readily undergo, and their applicability in the field of heterocyclic chemistry, and 
therefore also in the arenas of drug discovery and natural product synthesis.
The second chapter reports on the development of lactim ether alkylation strategies for 
the synthesis of a-alkyl lactim ethers, which are shown to proceed in high and reliable 
yields for a wide range of electrophiles. The applicability of this work is shown through 
the use of the newly form ed a-alkyl lactim ethers to produce a series of a-alkyl lactams 
and co-amino esters.
The third chapter of this thesis concentrates on the development of a chiral alkylation 
strategy that proceeds in an analogous way to the alkylation systems reported in the 
second chapter.
The fourth chapter of this thesis describes work extending Schollkopf’s 6/s-lactim 
ethers methodology to include the regioselective isotopic labelling of the fo's-lactim 
ether in order that it may be used to produce enantiopure isotopically labelled 
substituted phenylalanines. Also described in this chapter is research detailing the 
production of orthogonally protected O-methyl O-benzyl Schollkopf s bis-lactim ethers 
that once hydrolysed would allow facile separation of the chiral auxiliary fragment 
form the newly formed a-alkyl amino ester.
Chapter 1 1 Introduction
Chapter 1 
Introduction
Chapter 1 2 Introduction
Chapter 1
1.1. Introduction
This research thesis describes the use of lactim ether substrates in synthesis, 
concentrating on the development of efficient strategies for the alkylation of the aza- 
enolates of lactim ethers and its application to the asymmetric synthesis of isotopically 
labelled a-am ino esters. Consequently, the following chapter discusses the role of 
heterocycles in organic chemistry, and provides as overview of the range of methods 
employed for the synthesis of lactim ethers, and their use as building blocks for 
synthesis.
1.2. Heterocycles in Organic Chemistry
Heterocycles represent a widely used class of compounds in Nature and are frequently 
utilised as building blocks in synthetic chemistry, with over half the compounds listed 
in Chemical Abstracts being derived from heterocyclic compounds.
Heterocyclic compounds are essential to life, playing vital roles in metabolism in all 
living cells, for example the pyrimidine and purine bases of DNA, the essential amino 
acids proline, histadine and tryptophan, and sugars and oligosaccharides. (Figure 1.2.1.)
o
Thymine Cytosine Adenine Guanine
O O
H H
Proline Histidine Tryptophan D-Glucose
F igure  1.2.1. Heterocycles that play a key role in living systems.
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To become effective pharmacologically active species compounds must be readily 
absorbed by the host organism, and therefore must be soluble in aqueous media. The 
presence of heteroatoms helps facilitate solvation of organic compounds in aqueous 
media, with nitrogen being the most commonly used atom for the construction of 
heterocyclic compounds due to its basic nature. W hen treated with acid, many 
heterocycles containing nitrogen atoms form their corresponding salts, resulting in 
reduction in the com pound’s lipophilicity, thus increasing its solubility in aqueous 
















Organic soluble Aqueous soluble
Figure 1.2.2. Protonation of emetine to its diammonium salt.
As a result nitrogenous heterocycles often demonstrate excellent pharmacological 
activity, for example, penicillins and cephalosporins are superb antibacterial agents, 





C 02H O 
Cephalosporin C Morphine
Figure 1.2.3. Structures of penicillin G, cephalosporin C and morphine.
Compounds demonstrating biological activity often undergo rigorous structure activity 
optimisation studies before they are deployed as pharmaceuticals. Thus, many features 
o f a lead compound are varied during this optimisation stage to increase levels of 
biological activity. M ost heterocyclic molecules are prepared by multicomponent
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syntheses that result in the incorporation of a plethora of different functional groups, 
with rigid heterocyclic molecules being ideally suited as building blocks for generating 
the desired levels of diversity within a library of pharmacological compounds.
Nitrogen containing heterocycles represent one the most commonly used 
pharmacophores in drug discovery. For example, pyridines are aromatic heterocycles 
present in many active compounds such as nicotine, which is as an anthelmintic and an 
agricultural insecticide, whilst vitamin B6 contains a pyridine fragment that plays an 
important role in metabolism, and the cinchona alkaloids, such as cinchonine which 
have been used as anti malarial drugs and as catalytic chiral ligands for asymmetric 
synthesis. (Figure 1.2.4.)
Figure 1.2.4. Structures of nicotine, vitamin B6 and cinchonine.
Piperidines also represent an important structural motif in both natural compounds and 
synthetic drugs that display a wide range of biological activities. For example, naturally 
occurring alkaloids such as anabasine act as insecticides, whilst synthetic species 
(lS,2S)-2-methylpiperidinyl-3-cyclohexen-l-carboxamide acts as a potent insect 
repellent. As a result many stereoselective syntheses have been developed for the 
preparation of chiral polysubstituted piperidines. (Figure 1.2.5.)
Nicotine Vitamin B6 Cinchonine
Anabasine (1 S,2S)-2-methylpiperidinyl- 
3-cyclohexen-1 -carboxamide
Figure 1.2.5. Structure of anabasine and (l,S,25)-2-methylpiperidinyl-3-cyclohexen-l- 
carboxamide.
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Lactim ethers represent a class of compound that are well suited to the synthesis of 
highly functionalised nitrogen containing heterocycles, since they possess both 
electrophilic and nucleophilic character, which may act individually or in tandem to 
great effect. (Scheme 1.2.1.)
Schem e 1.2.1. Representative range of reactions using a lactim ether building block.
This thesis is concerned with the development of aza-enolate alkylation methodology 
using lactim ether substrates and as a consequence a comprehensive review of the 
chemistry o f this class of compound now follows.
1.3. Nomenclature of imino ethers and lactim ethers
Neilson provided an apt description of imino ethers in 1975 when he stated that ‘imino 
ethers are esters of the hypothetical imidic acids’,1 as shown for the Pinner synthesis of 







Schem e 1.3.1. Neilson’s description of an imino ether 1.
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W ith respect to Neilson’s description there exists a huge range of potential isomeric 
forms of imino and lactim ethers that may be accessed through formation of cyclic 
structures, or incorporation of the imino ether functionality within a ring. (Figure 1.3.1.)
lactim ether imino ether dihydrooxazine imino cylic ether
F igure  1.3.1. Isomers of imino and lactim ethers.
Naturally as the structures of the resultant heterocycles differ so do their properties, and 
as a result a vast amount of literature precedent exists that deals solely with the 
preparation of lactim ethers and imino ethers.
1.4. Methods commonly employed for the synthesis of imino 
ethers and lactim ethers
Imino and lactim ethers have been prepared by a variety of synthetic protocols with 
initial reports having appeared over a century ago. A review of the most commonly 
employed methods for their synthesis now follows.
1.4.1. Pinner synthesis
The Pinner synthesis is the most obvious and direct method for the formation of imino 
ethers. The protocol involves the action of a strong mineral acid upon a nitrile to 
activate it towards nucleophilic attack by an alcohol on heating. Beckurts and Otto first 
attempted this reaction in 1876,2 however the structure of the resultant product was not 
determined until the pioneering work of Pinner in 1892,3 who performed an in depth 
investigation of this methodology. (Scheme 1.4.1.)




NH.„AR" 'O R  
1
Schem e 1.4.1. Pinner synthesis of a generic imino ether 1.
W hilst the Pinner synthesis is still widely employed for the synthesis of imino ethers it 
is well known that it suffers from a range of competing side reactions. The reaction 
must be performed under anhydrous conditions as imino ethers readily undergo 
hydrolysis under aqueous acidic conditions. Other noted side reactions include the 
Chapman rearrangement, involving thermal degradation of the imino ether to afford N- 
alkyl amides, and triortho ester formation as a result of excess alcohol being present. 
(Scheme 1.4.2.)
NH u  _© O NH O NH ^ O R
X  3 , X  X  A . X  X  R0Hi HC|. X or
R"''X>R R" XD R R " 'X )R R-'^NHR R ' " X ) R  R' ' 'T)R
Schem e 1.4.2. Side reactions of the Pinner synthesis.
Other limitations of the reaction include the preclusion of using tertiary alcohols as 
nucleophiles because the imino ether product and the parent alcohol tend to undergo 
dehydration. Furthermore, the Pinner reaction often affords poor yields when the nitrile 
is sterically hindered, or when it contains a strong electron withdrawing substituent 
such as trichloroacetonitrile or a-nitroacetonitrile.4 In these cases rapid decomposition 
of the imino ethers occurs to afford the corresponding amide via attack of halide anion 
at the alkoxy substituent. (Scheme 1.4.3.)
Schem e 1.4.3. Pinner synthesis using an electron deficient nitrile and its subsequent 
decomposition to an amide.
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1.4.2. Base catalysed reactions of nitriles
W hilst the Pinner synthesis represents a facile pathway to imino ethers under acidic 
conditions any nitriles that contain basic substituents will become protonated and as a 
consequence tedious protecting group chemistry is often required for reaction to occur. 
In 1961 Schaefer and Peters confirmed that there existed a complementary base 
catalysed pathway employing electron deficient nitriles and the corresponding 
alkoxide.5 This method proceeds well for nitriles containing electron withdrawing 
groups, with a-chloroacetonitrile affording good yields of the desired a-chloro imino 
ether 2. (Scheme 1.4.4.)
RONa NH
c ih 2c — E E N -------------------► II
Yield = 93% CIH2C ^ C D R
2
Schem e 1.4.4. Base catalysed formation of an a-chloro imino ether 2.
The most widely used application of this reaction is for the formation of alkyl 
trichloroacetimidates, since these compounds are widely utilised as mild and selective 
O-alkylating agents, with the most commonly used examples being methyl and benzyl 
trichloroacetimidate 3 and 4 .6 (Scheme 1.4.5.)
TMSOTf
Schem e 1.4.5. Formation of benzyl trichloroacetimidate 4 and its use for the synthesis 
of benzyl valerolactim ether 5.
To date, little work has been described on developing a neutral analogue of the Pinner 
synthesis, however Robinson et al. did report that heating benzonitrile and ethylene 
glycol in a sealed tube for several days gave the corresponding fo's-imino ether 6 , 
whereas heating at reflux gave an ester derived from hydrolysis of a mono imino ether 
intermediate 7 .7 (Scheme 1.4.6.)
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Scheme 1.4.6. Robinson’s neutral Pinner synthesis involving reaction of benzonitile 
with ethylene glycol under thermal conditions.
1.4.3. Formation of lactim ethers through addition of alcohols to 
iminoyl halides
Several groups have shown that cyclic amides can be transformed into imino ethers via
siniminoyl halide intermediates. ' Reaction of an amide with halogenating agents such as 
PCI5 or phosgene affords the corresponding iminoyl halide, before addition of an 
alcohol to gives the desired imino ether. Koelsch et al. demonstrated use of this 
pathway in 1960 for the formation of bicyclic lactim  ether 8 from 4-am ino-1- 
phenylcyclohexanecarboxylic acid, 9, during research aimed at the production of a 
series of morphine analogues.11 (Scheme 1.4.7.)
Scheme 1.4.7. Iminoyl halide formation and subsequent reaction with ethanol to afford 
a bicyclic lactim ether 8 .
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Isolation and characterisation of the intermediary iminoyl halide are not normally 
carried out due to their instability. For example, in a study by Jurczak et al. in 1982, a 
range of caprolactims was synthesised via iminoyl halide intermediates that had been 
generated in situ.12 They treated caprolactam 10 with phosgene in chloroform, followed 




R = Me, lPr, cHex, Bn or Ph
Scheme 1.4.8. Formation of lactim ethers through intermediary iminoyl halides.
It was noted that the procedure failed for tertiary alcohols and gave very poor yields for 
phenol, presumably as a result of the harsh acidic conditions employed in the reaction.
Some of the most compelling evidence for the formation of the intermediary iminoyl
halide species came from the work of Glushkov who reported on the action of tolyl
1 ^sulfonyl chloride on caprolactam 10 for the formation of amidine 12. This work 
corrected a previous report by Short et al. in 1948 who had claimed to produce amidine 
12 via an 0-tolylsulfonyl lactim ether intermediate 13.14 Glushkov however, showed 
that pyridinium benzene sulfonate could be isolated in high yield from the reaction 
mixture implying formation of the iminoyl halide 14. (Scheme 1.4.9.)
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Schem e 1.4.9. Synthesis of amidine 12 via treatment of caprolactim 10 with 
tolylsulfonyl chloride followed by addition of an amine.
1.4.4. Preparation of lactim ethers through the use of diazomethane 
and alkyl sulfates
Until recent years the most widely reported method for the preparation of lactim ethers 
was through the employment of O-alkylating agents such as diazoalkanes and dialkyl 
sulfates upon the corresponding lactam.
In 1961 Ralls first discovered that lactams could be O-alkylated via treatment with 
diazomethane (or diazoethane) during work directed towards the synthesis of 
carboxylic acids found in vegetable flavour.15 Ralls was attempting to esterify the acid 
functionality of 14 using diazo reagents so that they could be analysed by gas 
chromatography. However, in the case of 5-pyrrolidone-2-carboxylic acid 14 an 
anomalous second compound was observed, later revealed to be the N-alkyl lactam 15. 
(Scheme 1.4.10.)
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H J t ®  H X ®  ^
m Me N.- m Me N.-.. m
________ ~N ( EtOOC— y  \ ^ 0 _________ N < E tO a C ^ /^ N ^ - C
\ ___ / ____________________________ \ ___/  Yield = 3% \ ___ /
14 15
Schem e 1.4.10. Esterification and Af-alkylation of 5-pyrrolidone-2-carboxylic acid 14 
using diazoalkanes.
During further research Ralls demonstrated that the Af-alkyl lactam had probably been 
formed via Chapman rearrangement of the corresponding lactim ether since performing 
related reactions in a mixed ethereal alcoholic solvent system afforded a 12% yield of 
valerolactim ether and 9% yield for caprolactim ether. (Scheme 1.4.11.)
c r
n = 1 or 2
Me N*
N, EtgO. nPrOH
Yield = 12% (n = 1) 
Yield = 9% (n = 2)
OMe
Schem e 1.4.11. Lactim ether formation through addition of diazoalkanes to a lactam.
The use of dialkyl sulfates is a much more powerful synthetic procedure. The reaction 
generally affords excellent yields of lactim ethers, however competing TV-alkylation 
products are often observed unless reaction conditions are carefully monitored. In 1948 
Cairns and Benson investigated the alkylation of lactams and found that slow addition 
of dialkyl sulfate reagents to lactams favoured O-alkylation, whilst an excess of dialkyl 
sulfate tended to give the iV,0-dialkylated imidic salt 17 that may be converted to the 
corresponding N-alkyl lactam 18 on treatment with base.16 (Scheme 1.4.12.)
Schem e 1.4.12. O-alkylation of caprolactam 10 using dialkyl sulfate and subsequent N- 
alkylation to afford lactam 18.
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1.4.5. Preparation of lactim ethers through the use of alkyl 
trichloroacetimidates
The use of alkyl trichloroacetimidates for the synthesis of lactim ethers remains an 
underemployed method that represents a synthetically versatile route to a large range of 
lactim ether substrates. As described, trichloroacetimidates are easily synthesised via 
the action of an alcohol on trichloroacetonitrile under mild basic conditions. Primary 
(and secondary) trichloroacetimidates react readily under Lewis acidic conditions with 
cyclic secondary amides to give lactim ethers in good yield. W hilst the most notable 
use of trichloroacetimidate methodology is for the mild O-benzylation of hydroxyl 
groups, it has also been used for O-alkylation of amides. (Scheme 1.4.13.)
H NH
a 0  A  . . . . . .  ^ N . ,ORRO CCU, Lewis Acid f
 - u
Schem e 1.4.13. Formation of valerolactim ether using trichloroacetimidate 
methodology.
This approach was employed in 1989 by Honig et al. during the selective benzylation 
of a series of morpholinones for use as building blocks for the synthesis of pesticides.6 
They treated the lactam core of the hydroxy alkyl morpholinone 19 with benzyl 
trichloroacetimidate 4 employing a range of Lewis acids to afford the desired lactim 
ether structure 20 in poor to good yields (6-80%). (Scheme 1.4.14.)
NHJl
H BnO CCU H
HOC3H6„ g HOC3H6, N ^ ^ O B n  BnOC3H6/( BnOC3H6/, N ^ ^ O B n
™ S 0 T f 0 f B F3 ° Et2 '  + +O Me O Me O Me O Me
19 20 21 22
Schem e 1.4.14. Formation of the benzyl lactim ether 20 of morpholinone 19.
The author concluded that the use of BF3.0 Et2 or TM SOTf as Lewis acids gave the 
most reliable and robust yields of lactim ether 20, 70 and 80% yields respectively (entry
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3 and 4, Table 1.4.1.). Under these conditions the potential formation of the competing 
benzyl ether lactam 21 and benzyl ether benzyl lactim ethers 22 only occurred in small 
yields.
Entry Lewis acid % yield of 
lactim ether 20
% yield of 
benzyl ether 21
% yield of benzyl 
ether lactim ether 22
1 TFMSA 6 26 0
2 TFA 0 0 0
3 BF3.0Et2 70 10 20
4 TM SOTf 80 0 20
Table 1.4.1. Yields of lactim ether 20 under different Lewis acidic conditions.
Further to this in 1993 Schollkopf et al. showed that diketopiperazines could react with 
trichloroacetimidates to afford the corresponding dialkyl fo’s-lactim ethers.17 Schollkopf 
noted that yields for the O-alkylation stage of his diketopiperazine 23 were often poor, 
which he attributed to the poor solubility of trimethyloxonium tetrafluoroboronate 221 
and the parent diketopiperazine 23 in CH2CI2, with yields being highly dependent on 
the quality and consistency of the trimethyloxonium tetrafluoroboronate. As a result of 
these factors an alternative route to the synthesis of bis-lactim ether auxiliary 24 and 25 
employing alkyl trichloroacetimidate was reported. Schollkopf noted that while O- 
alkylation failed using methyl trichloroacetimidate, moderate to good yields of the bis- 
lactim ethers 24 and 25 were recorded for the ethyl and benzyl analogues (82 and 61% 
respectively). The group went on to lithiate the bis-benzyl auxiliary 25 and react it with 
benzyl bromide to produce enantiopure (/?)-phenylalanine. (Scheme 1.4.15.)





Yield = 53% overallBnO'
Scheme 1.4.15. O-benzylation of diketopiperazine 23 using benzyl trichloroacetimidate 
4.
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1.4.6. Preparation of lactim ethers using trialky loxonium
tetrafluoroboronates
Tri alky loxonium tetrafluoroboronates represent the most commonly used method for 
the synthesis of lactim and imino ethers over the last 25 years owing to the simplicity 
and reliability of these reactions. Despite their discovery dating back to the 1930’s,18’ 19 
this type of reagent was not widely employed until 1961 when Meerwein demonstrated 
that triethyloxonium tetrafluoroboronate could be used to convert DM F into its imino 
ether 26.20 (Scheme 1.4.16.)
o.ANHo Et3O.BF4, DCM Yield = 87%
OEtAH NH 
26
Scheme 1.4.16. Formation of imino ether 26 using M eerw ein’s salt.
The popularity of trialkyloxonium tetrafluoroboronate methodology for the synthesis of 
lactim ethers has increased in recent decades, and it now represents the most common 
method for the preparation of lactim ethers. Trialkyloxonium tetrafluoroboronates are 
readily prepared, offering extremely high O-alkylation chemoselectivity for amides 
affording excellent yields of lactim ether product, having been widely used on 
substrates containing carbonyl, cyano and carbethoxy functionalities.13
In addition trialkyloxonium salts can be employed to selectively discriminate between 
amide groups in the same molecule. In 2002 W asserman published a synthesis of (±)- 
dihydroperiphylline in which the amide group within the nine membered ring was 
selectively O-alkylated in the presence of a competing tertiary a,p-unsaturated am ide.21 
(Scheme 1.4.17.)
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Major product Trace amounts
Schem e 1.4.17. Regioselective lactim ether formation.
Furthermore, trialkyloxonium tetrafluoroboronate offers greater reactivity than other 
available reagents, e.g. O-alkylation of some lactams such as morpholin-3-one 27 fail 
completely with dialkyl sulfates, while other ketonic substrates such as 3,3-diethyl-5- 




Schem e 1.4.18. Competing reaction pathway for alkylation of morpholin-3-one 27 and 
keto-lactam 28 using Et30 .BF4 and dimethyl sulfate.
1.5. The chemistry of imino ethers
Imino ethers are labile and act as versatile synthetic intermediates owing to the range of 
possible reaction pathways available to them. They can act as electrophiles towards an 
incoming nucleophile with net replacement of their alkyloxy or imino units. 
Conversely, they can employ their basic sp2 nitrogen atom as a nucleophile, whilst they 
may also be deprotonated at their a-position through the action of strong bases to afford 
aza-e,nolates that then react with electrophiles. They can be reduced using 
organometallic hydride reagents, whilst they may also be employed as alkylating
Chapter 1 17 Introduction
agents, where their amido character is regenerated through fission of their alkyl-oxygen 
bond.
1.5.1. Formation of amidines
One of the most useful and successful reactions of imino ethers is the replacement of 
the alkyloxy group with an amino group, yielding an amidine, which has been widely 
reported and proceeds readily with high yields.16,22'24 The reaction is chemoselective 
and may be performed in the presence of a large range of other functional groups such 
as esters, ketones and halogens owing to the lability of the imino ether and the 
subsequent stability of the amidine functionality.
Given the facile nature of this reaction it is not surprising that this reaction was the first 
transformation reported for lactim ethers in 1934 by Stolle et a l  who reported amidine 
formation during the synthesis of 30.25 Furthermore upon neutralisation of the system 
the authors also demonstrated the nucleophilic character of the amidic nitrogen atom by 
effecting a subsequent ring closure step, to afford bicyclodihydroimidazole 30. 
(Scheme 1.5.1.)
NaOEtHBrH2N
Schem e 1.5.1. Amidine formation followed by cyclisation to afford a dihydroimidazole 
30.
The potential of this synthetic methodology in medicinal chemistry was demonstrated 
in 1988 by Chapleo et a l  who reported the synthesis of a range of novel amidines 
derived from simple imino ethers and amino substituted 1,3,4-thiadiazoles for use as
Oftanticonvulsant agents. Previous work had shown that 2-aryl-5-hydrazino and 2-aryl-5- 
guanidino-1,3,4-thiadiazoles 31 and 32 showed good activity as potential
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anticonvulsants, however their use was associated with undesirable side effects. (Figure
1.5.1.)
31 32
F igure  1.5.1. Structures of 2-aryl-5-hydrazino and 2-aryl-5-guanidino-1,3,4- 
thiadiazoles 31 and 32.
Chapleo speculated that the hydrazine functionality might be replaced by amidino 
groups to afford target compounds with similar anticonvulsant properties. He targeted 
the synthesis of both possible regioisomeric forms, i.e. 33 and 34 linked through either 
the amidine nitrogen atoms, or 35 linked through its central carbon atom. (Figure
1.5.2.)
F igure  1.5.2. Generic isomers synthesised by Chapleo et a l
The author initially attempted the synthesis of the first two amidine compounds 33 and 
34 via reaction of a 2-aryl-5-aminothiadiazole 36 with the hydrochloride salt of the 










A r A X NX
34
Schem e 1.5.2. Chapleo’s proposed synthesis.
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However, the substitution products formed were actually those derived from a 
transimidation reaction, involving amino substitution of the imino group of 37 and not 
replacement of its ethoxy substituent. Fortunately, this intermediate proved to be an 
even more valuable synthetic intermediate, since a subsequent treatment of 38 with a 
secondary amine enabled access to the desired amidine 34. (Scheme 1.5.3.)
N—N 
A r^V ^N H 2





1Ar x s  N R
N—N OEt mur2r 3A X A , —
N -N  N
 „ n \  1
Yield = 14-69% A r  X s  N R 1 
34
Ar ' s  N R 
38
Schem e 1.5.3. Synthesis of amidino thiadiazoles.
In 2001 Ehrhardt et a l  prepared a series of 8 amidines via addition of amines to 
butyrolactim 39 and butyrothiolactim ethers 40 as analogues of clonidine,29 which is an 
antihypertensive drug known to act within the central nervous system. Ehrhardt’s hope 
was to develop new compounds with selectivity for Ii im idazolidinone receptors over 
adenoreceptors via the synthesis of a series of pyrrolinic isosteres of rilmenidine, a 
second generation analogue of clonidine. This was achieved via treatment of a series of 
butyrolactim 39 and thiobutyrolactim ethers 40 with dicyclopropanamine, to afford a 
small library of amidines for screening. (Scheme 1.5.4.)
n h 2 h c i .  n h 2.hci
SMe V ^ 7
Yield = 42-87% I A  I Yield = 39-56%
R R ZA R R
39 40
R = H, 3-Me, 4-Me, 5-Me R = c/s/frans-4,5-diMe, 5-Et, c/s-4,5-(CH2)4
NL .N
Schem e 1.5.4. Synthesis of a series of amidine derivatives of rilmenidine.
If excess amine is employed and the reaction mixture heated for prolonged reaction 
periods then the A /^V’-disubstituted amidine product is formed. Interestingly, given the 
different reaction conditions required for substitution of the alkyloxy substituents of
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imino ethers, this approach provides an excellent route to the synthesis of 
unsymmetrical Af,Af’-di substituted amidines. (Scheme 1.5.5.)
H2NV ^ i ^
NH M  NH S ’ s 'j
Schem e 1.5.5. Unsymmetrical amidine formation from an imino ether.
Indeed, this attractive approach has been employed for the synthesis of diverse 
amidines by Meresz and Foster-Vemer,30 who developed a synthetic route to 
unsymmetrical 3-alkyl-1,2,4,5-tetrazines 41 from intermediary bis-N-amino amidines
42. Therefore, reaction of an imino ether with hydrazine, followed by reaction with a 
second equivalent of amidine afforded bis-amidine 42 that was reacted with a further 
equivalent of hydrazine to afford an unsymmetrical tetrazine 41 in good yield. (Scheme 
1.5.6.)
X = H or Me
Schem e 1.5.6. Formation of an unsymmetrical 1,2,4,5-tetrazine 41 from the 
corresponding imino ether and hydrazine.
1.5.2. Formation of iV-substituted imino ethers
W hen imino ethers react with amines under acidic conditions the imino ether undergoes 
an imino substitution or transimidation reaction to afford an ^-substituted imino ether
43. (Scheme 1.5.7.)
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NHH Et0A ^ N H 2 HCI NH Et0^ N H 2.H a^ ^ 0 0 2 0
F r^ N '^ C O O E t R^ XJ R  R'^XDR
H
43
Schem e 1.5.7. Formation of iV-substituted imino ether 43.
Huffman and Schaefer were the first to report in 1963, that imino ethers react through 
their imidic centres with ensuing loss of their alkyloxy fragments to afford amidines 44, 
while their imino ether hydrochloride salts reacted with substitution of the imidic
31 32nitrogen atom via a transimidation pathway to afford //-substituted imino ethers 45. ’ 
(Scheme 1.5.8.)
C^N
j jH h 2n - c n  JJH n c - n h 2.h ci j j
Me N^ Me OEt Yield = 43-83% Me OEt
H
44 45
Schem e 1.5.8. Competing amidine formation versus transimidation.
Meyers et al. employed this type of reaction for the formation of substituted oxazole
28fragments during their stereoselective syntheses of griseoviridin and madumycin, two 
streptogramin antibiotics isolated from the soil microorganism Streptomyces 
graminofaciens.33 (Figure 1.5.3.)
N HN N HN
\  .'Me
Griseoviridin Madumycin
F igure  1.5.3. Structures of griseoviridin and madumycin.
They reacted methyl acetimidate hydrochloride 46 with glycine methyl ester to generate 
an imino ether 47, which they then deprotonated using potassium te/t-butoxide and 
quenched with formaldehyde to form Com forth’s intermediate 48,34 that cyclised on
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heating to afford oxazole 49. The Comforth intermediate 48 could also be treated with 
lBuLi to effect a second deprotonation at the methyl terminus, and this acyclic aza- 
enolate was then alkylated with (7?)-glyceraldehyde acetonide prior to formation of 
oxazole 50. (Scheme 1.5.9.)
O O OK
NH.HCI HoN OMe , J i  OMe (f  , ,  O —j\ll ^ v ^ 0M e Y KO Bu, H H T  | |  HCQ2H / \\
Me'^'^OM e Me/ ^ N ' ^ x C02Me Me/ ^ N / ^ C 0 2Me M e ' '^ N/ ^ C 0 2Me
46 47 48 49
fi ‘BuLi
k PV^H /OK
0H  0 - 7 \  X  J OMeI j J \  A 0J - BF3 I I
COjMe Yield = 38-56% C 0 2Me
50
Schem e 1.5.9. M eyers’ approach to formation of oxazoles 49 and 50.
1.5.3. Reaction with amino acids and their derivatives
Imino ethers react readily with amino acids and their derivatives via a number of 
pathways.35,36 The simplest reaction occurs between a lactim ether and the nitrogen 
atom of the amino acid, resulting in formation of a substituted amidino acid, however 
the resultant intermediates often undergo further cyclisation reactions to generate fused 
dihydropyrimidinones or imidazolinones. (Scheme 1.5.10.)
h2NvX
Schem e 1.5.10. Reaction of valerolactim ether with L-valine.
W hile the initial amidine formation step proceeds readily, due to the increased stability 
of the amidine moiety, the cyclisation step often requires harsh conditions. Korosi 
studied the mechanism of this reaction in 1964 and proposed that the initial step is
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proton transfer from the amino acid to the nitrogen atom of the lactim ether,37 which 
has the effect of increasing the electrophilic nature of the imidic carbon atom towards 
nucleophilic attack by the nitrogen atom of the amino acid. Amino esters react 
analogously to amino acids with lactim and imino ethers, however they do so under 
m ilder conditions.38
Lactim  ethers react with most classes of amino acid, with the use of p, y, 8 and e amino 
acids having been reported, p-amino acid derivatives have also been reported to 
cyclise, but only where the intermediary amidino acid adopts a conformation that 
facilitates the cyclisation step. For example, both anthranilic and o-aminophenylacetic 
acid derivatives readily cyclise on account of the fact that the amine group is directed 
by virtue of the conformation imposed by the aromatic ring. (Scheme 1.5.11.)
NH




R1 = H, Me, Et, nPr or Ph 
R2 = Me or Et
NH




Schem e 1.5.11. Reaction of an imino ether with anthranilic acid or o- 
aminophenylacetic acid.
Lehr et al. proposed a protocol in 1953 in which imino ethers could be used to produce 
a-am ino acids derivatives.39 They noted that when imino ethers were allowed to react 
with an amino ester in a ketonic solvent, an ylidene derivative 51 was obtained. 
Hydrogenation of the imidazolone product using a platinum catalyst, followed by 
alkaline hydrolysis with barium hydroxide yielded a substituted glycine derivative 52, 






R1 = Me, Et or nBu 





i) Hjx/Pt, ii) Ba(OH)2 H2N
Schem e 1.5.12. Imino ethers for the synthesis of a-am ino acids 52.
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1.5.4. Addition of stabilised enolates to lactim ethers
The lability of the imino ether functionality allows it to react with many potential 
nucleophiles; with many useful examples having been reported using stabilised enolate 
equivalents. For example, dimethyl malonate attacks valerolactim ether 15 with 
displacement of the alkyloxy group resulting in formation of a stabilised enamine 
adduct 53 in quantitative conversion and high selectivity. This reaction is a powerful 







Schem e 1.5.13. Reaction of valerolactim ether 15 with diethyl malonate.
The enamine fragment of 53 may react further with other reactants, thus affording a 
facile route to a large range of heterocyclic compounds. In 1960 Glushkov 
demonstrated the potential of this approach via the reaction of caprolactim ether 16 
with 2-phenyloxazolin-5-one 54 ,13 which afforded an enamine product 55, that cyclised 












Schem e 1.5.14. Reaction of phenyloxazolin-5-one 54 with caprolactim ether 16.
In 2000 Mete et al. showed that lactim ethers also reacted with nitromethane during 
their work on the formation of diazocompounds.40 They reported that heating methyl 
valerolactim ether 15 and nitromethane at 100 °C for 18 hours with removal of 
methanol resulted in the desired 2-nitromethylenepiperidine 57 in moderate yield. The
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group then formed the diazo compound 58 via 6/s-bromination with NBS and imine 
formation with hydrazine, followed by diazo-formation via oxidation with mercuric 
oxide. (Scheme 1.5.15.)
MeN02
Schem e 1.5.15. Formation of a diazo piperidine 58 via the reaction of nitromethane 
with valerolactim ether 15.
They found that the resultant 3-diazo-2-nitromethylene-piperidine 58 underwent slow 
rearrangement to its pyrazolo-tetrahydropyridine derivative 59, which in turn was found 
to be in equilibrium with two different tautomeric forms 60 and 61. (Scheme 1.5.16.)
58 59 60 61
Schem e 1.5.16. Cyclisation and rearrangement of 3-diazo-2-nitromethylene-piperidine 
58.
1.5.5. Alkyloxy substitution
It is well known that lactim  ethers readily undergo alkyloxy substitution reactions with 
alcohols enabling facile access to a wide range of lactim ethers.41 It has been reported 
that simple heating with a higher boiling alcohol results in alkyloxy substitution by 
removal of the lower boiling alcohol via distillation.42, 43 It is worthy of note that the 
most reliable routes to imino ethers using this approach employ imino ether substrates
-30
derived from low molecular weight alcohols such as methanol and ethanol.
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In 1923 Kaufmann and Adams reported that thioimino ethers of resorcinol 62 
underwent a transesterification type reaction to afford aryl oxy-imino ethers 63 via 
heating to reflux with an alcohol.43 (Scheme 1.5.17.)
Schem e 1.5.17. Substitution of a thioimino ether derivative of resorcinol 62 to afford 
an imino ether 63.
It was reported by Roberts et al. in 1955 that the presence of acid has a positive effect 
on the yield of this type of transesterification reaction 42 They were investigating direct 
reaction of aniline with a range of alkyl orthoformates in an effort to prepare the 
corresponding TV-phenyl formimidate ethers 64. However, it was found that an indirect 
approach involving formation of the imino ether 65 using methyl or ethyl orthoformate, 
followed by transesterification with an alcohol led to higher yields of this class of 
compound. (Scheme 1.5.18.)
NH2.HCI
NH2 n h 2
HCtOR^a r p ^ i  HC(OR2)3 N v  R1OH, ^  N
Yield = 51-89% h ^ q r 1 H ' ' X ) R 2 Yield = 51-94% H^ X ) R 1
64 65 64
R1 = ‘Pr. nBu, ‘Bu, sBu or "Hex R2 = Me or Et
Schem e 1.5.18. Roberts’ formation of A^-phenyl formimidate ethers 65 followed by 
transesterification under acidic conditions.
The group developed a second synthetic route in order to combat the problems 
associated with preparing imino ethers containing alkyloxy fragments prone to 
dehydration. They reported that generation of sodium alkoxides of hindered alcohols 
was successful in promoting nucleophilic attack at the imidic centre of imino ethers. 
(Scheme 1.5.19.)






R1 = Me or Et
R2 = 'Bu, ‘Amyl or cyHex
Schem e 1.5.19. Base catalysed transimidation of Af-phenyl formimidate ethers.
Benko and Pallos published work 16 years later detailing further research on 
transesterification of methyl and ethyl N -pyridyl formimidate ethers 66.41, 44 They 
reported that the reaction was best carried out using sodium alkoxides, with poorer 
yields being reported using acid catalysts 41 (Scheme 1.5.20.)
R1 R1
N" Na(s), R2OH IjT
HA 0 Et Yield = 38-92% h A q r 2  
66
R2 = Me, Et, nBu, Hex, Hept, Oct, Dec, Dodec, Cet, ^Hex, Bn or p-PhEt
Schem e 1.5.20. Benko and Pallos’ base catalysed transesterification reactions of A^-aryl 
formimidate ethers 66 .
In 1994 Brace et a l  carried out alkyloxy substitution reactions on a range of 5, 6 and 7 
membered lactim ethers using polyfluorinated alcohols as nucleophiles in moderate to 
good yield .45 (Scheme 1.5.21.)
/ NV - O M e  H O ^ v ' C6F' 3
Yield = 68%
Yield = 70%, n = 2 
n =  1 ,2  or 3 Yield = 72%, n = 3
a t q :
CrF,
Schem e 1.5.21. B race’s synthesis of polyfluorinated lactim ethers.
Yang et al. em ployed an intramolecular lactim ether bond forming reaction in 1994 
during their synthesis of azithromycin, in the first reported synthesis of the azalide
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antibiotics.46 Azithromycin differs from erythromycin A by the incorporation of an 
extra Af-methyl substituent at the 9a position of the lactone, increasing the ring size 
from a fourteen to a fifteen membered macrocycle. This subtle variation increased 












F igure  1.5.4. Structures of azithromycin and erythromycin A.
A 6,9-imino ether intermediate 67 was generated by Beckmann rearrangement of 9(E)- 
oxime erythromycin 68 at 0 °C in aqueous acetone, employing toluenesulfonyl chloride 
to activate the oxime oxygen to migration, with intramolecular quenching o f the 
intermediate nitrilium cation 69 by an adjacent hydroxyl group. Subsequent 
hydrogenation of 67 at high pressure followed by A-methylation furnished the desired 
azithromycin. (Scheme 1.5.22.)











































Scheme 1.5.22. Y ang’s synthesis of azithromycin.
Yang et al. isolated a second 9,11-stable imino ether intermediate 70 at lower 
temperature (-45 °C) formed from intramolecular trapping of the nitrilium cation 69 
with another hydroxyl group. It was also reported that the 6,9 imino ether 67 readily 
isomerised in a range of organic solvents via a transesterification mechanism to afford 
the 9,11 imino ether 70. (Figure 1.5.5.)














F igu re  1.5.5. Structure of the 6,9-imino ether 67 and 9,11-imino ether 70 interconvert 
readily in organic solvents.
1.5.6. Hydrolysis of imino ethers and lactim ethers
Imino ethers are readily hydrolysed in the presence of catalytic amounts of acid to 
provide the corresponding amine (often as the ammonium salt) and ester in good 
yield.24, 47'50 This type of hydrolysis reaction has been widely studied since it is 





RO( T f l1
OH
 ^ J-ls* 3 + 2r - n h 2 h c i
R OR
Schem e 1.5.23. Acid catalysed hydrolysis of an im ino ether.
M eerwein et al. reported on imino ether hydrolysis in 1961 during their research into 
the development of trialkyloxonium tetrafluoroboronates for amide O-alkylation 
reactions.20 They successfully reacted DMF with triethyloxonium tetrafluoroboronate to 
generate the corresponding imino ether tetrafluoroboronate salt 71, which they then 
treated with sodium ethoxide to afford a dimethylaminoformamide diethyl acetal 72. 
Both these compounds were then hydrolysed to afford ethyl formate and dimethyl 
ammonium chloride via treatment with HCI and water. (Scheme 1.5.24.)
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OEt
N I HCI,
Me2N H H BF4
M e^^O ^O  + NHMe2 HC)
Me
71
NaOEt Mo Et° \ >/ 0 E t i) HCI(g), ii) HzO
"* 6" n HI
Me
72
Schem e 1.5.24. M eerwein’s original hydrolysis studies on imino ethers.
Lactim ethers also decompose under mild acidic aqueous conditions, to yield their 
corresponding co-amino esters, as their hydrochloride salts, which on neutralisation 
afforded the corresponding lactam. (Scheme 1.5.25.) This was demonstrated by Kende 
et al. during their synthesis of (±)-alantrypinone, a novel penicillium alkaloid.51








Schem e 1.5.25. Acid catalysed hydrolysis of a lactim ether 73 followed by 
intramolecular cyclisation to afford (±)-alantrypinone.
Korosi showed that treatment of caprolactim ether 16 with water and heating resulted in 
formation of the corresponding amino ester 74 ,37 although in the same report he showed 
that extended heating resulted in polymerisation. Korosi suggested a mechanism for the 
formation of the polymeric material that proceeded via an amidine intermediate 75. 
(Scheme 1.5.26.)











Schem e 1.5.26. Korosi hydrolysis and polymerisation of caprolactim ether 16.
Imino ethers have also been shown to undergo hydrolysis under basic conditions to 
afford their corresponding amides. Under these conditions the leaving properties of the 
amine are reduced, thus allowing the ester group to become the leaving group, 
affording the corresponding amide and alcohol.47,49,50,52-54 (Scheme 1.5.27.)
( J i
n ' r  ©.OH, H20
R OR
HN
'R ^ k r f
OH
1 ^ R 2 + RL OH
R N 
H
Schem e 1.5.27. Hydrolysis of an imino ether under basic conditions.
In 1973 Schmir et al. reported an in depth kinetic study of the hydrolysis of a range of 
N-aryl imino ethers 76 under basic conditions.48 They reported that as the pH of the 
buffer solution rose then the yield of the amide product increased, with the amide 
product being afforded in quantitative yields at pH > 10. (Scheme 1.5.28.)
- r X
N H20 , phosphate buffer >pH 8 o
II  ► JJ -X + EtOH
R OEt fT V
H76
X = p-OMe, H, p-CI, m-N02, p-N02 or 2,4-(N02)2 
R = H or Me
Schem e 1.5.28. Basic hydrolysis of iV-aryl imino ethers 76.
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Employment of H 2S as a nucleophile gives rise to the formation of thioesters, although 
this reaction does not proceed as readily as the corresponding hydrolysis reaction with 
water. The most commonly observed side product in these reactions is formation of the 
corresponding thioamide 77 as a result of a reaction involving secondary attack of the 
amine 78 on the thioester 79. (Scheme 1.5.29.)
N " R3 s  s
1 2 HaS > 1 2 + H2N—R3  ► , J-L 3 + 2ROH
R OR R OR 2 R NHR3
79 78 77
Schem e 1.5.29. Formation of thioester 79 from an imino ether.
During the late eighties there was a tremendous growth of interest in the preparation of 
thiopeptides with particular attention being placed on the selective formation of 
thioamide groups within a peptide backbone.55, 56 In this regard, W illiams et al. 
synthesised an array of methyl, ethyl and benzyl thioesters from imino ethers in 1988, 
and employed them to thioacylate amino acids, peptides esters or amide derivatives.57 
(Scheme 1.5.30.)
^ n^ A oh
2r c A n ^ r !  - ----- ► ' r c A n ^ r2 ------- N h ' -H fl Yield = 47-90% R0 W f] Yield = 40-90% R0 f| fj i 0H
NH S S
R1 = Bn or 9-fluorenylmethyl 
R2 = Me, CH2N 02 or Bn
Ph
Schem e 1.5.30. Selective thiopeptide formation using Z- and Fmoc-glycine derived 
imino ethers.
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Entry Thioester formed % yield Thiopeptide formed % yield
T able 1.5.1.
1.5.7. Tautomerisation
Carbonyls possessing an a-proton can readily undergo tautomerisation to their enolic 
form and imino ethers also undergo such tautomerisation, particularly in the presence of 
functionality that can result in stabilisation of the enamine tautomer via conjugation. In 
1964 Harley-M ason and Leeney demonstrated that certain imino ethers exist in 
equilibrium with their enamine tautomer.58 They treated a range of oxindole derivatives 
with M eerwein’s reagent to give the expected lactim ether product 80 which on heating 
to its sublimation point afforded the enamine tautomer 81, which was found to be stable 
as a result of conjugation with the neighbouring aromatic ring. Reversion to its imino 
ether form 80 was achieved by heating the enamine tautomer above its new melting 
point. (Scheme 1.5.31.)







Scheme 1.5.31. Tautomerisation between the imino ether 80 and enamine 81 forms of 
an oxindole.
Kato et al. showed in 1975 that lactim ethers could dimerise via reaction through their 
enamine tautomer, with the enamine carbon atom acting as a nucleophile.59 The 
reaction proceeds with subsequent loss of methanol to afford the dimer 82. They then 
reacted the dimer with two equivalents of diketene to afford a highly functionalised 










Scheme 1.5.32. Tautomerisation of valerolactim ether 15 and ensuing dimerisation.
1.5.8. Triortho ester formation
Imino ethers can react with alcohols at room temperature under strongly acidic 
conditions to afford simple or mixed ortho esters.60, 61 This reaction was first noticed 
from observations on the Pinner synthesis where forcing conditions result in attack of 
excess alcohol on the imino ether hydrochloride intermediate 37, with subsequent 
release of the nitrogen atom as its ammonium salt.1 (Scheme 1.5.33.)
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Schem e 1.5.33. Pinner synthesis of ortho esters.
This transformation occurs as a side reaction of the Pinner synthesis and was originally 
characterised by poor yields and slow reaction rates, however work performed during 
the late 1940’s and 1950’s by McElvain and co-workers succeeded in optimising it as a 
viable approach for the synthesis of trialkyl ortho esters. They discovered that refluxing
fsyimino ether salts in the presence of a large excess of alcohol, or stirring with alcohol
yro /Tf
in petrol at room temperature " gave improved yields of the desired ortho ester. 
(Scheme 1.5.34.)
NH.HCI 9 OR 2
A  1 —  A 0R + NH<CIR OR R ^ O R
Schem e 1.5.34. Generic overview for the formation of triortho esters.
There are several competing side reactions that must be considered if good yields of 
ortho esters are to be achieved; i) heating allows imino ethers to undergo the Chapman 
rearrangement to their corresponding to their TV-alkyl amides, thus any reaction 
involving high temperatures must be carefully monitored; ii) the reaction mixture must 
be free from excess acid, as the formed triortho ester can easily degrade to its 
corresponding ester, alcohol and alkyl halide; iii) the reaction mixture must be 
performed under anhydrous conditions as the triortho ester can undergo rapid 
hydrolysis to the ester and alcohol.
During the late 1980’s and early 1990’s Kelley et al. synthesised 78U79, a purine based 
anticonvulsant drug.66 It was noted however that compounds containing this purine 
rings system exhibited a propensity to cause emesis, and as a consequence structure
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activity optimisation studies carried out in order to eliminate these side effects. In 1995 
Kelley et al. prepared a series of triortho esters from the intermediary imino ether salts 
84 during their synthesis of eleven pyrazines as test compounds for anticonvulsant
fnactivity, with the l,2,4-triazolo[4,3-a]pyrazine ring system of 85 serving as 
bioisosteres of the purine fragment of 78U79. (Figure 1.5.35.)
85
78U79 Ri = NHMe or NH2
R = NHMe or NH2 R 2 = H> 2_f, 3-F, 4-F, 2,5-F2 or 2,6-F2
F igure 1.5.35. 78U79 and the generic pyrazines 85 used by Kelley.
The author’s work centred on developing a simple four stage synthetic protocol starting 
from the corresponding phenyl acetonitriles, that were converted to their triethyl ortho 
esters 86 in high overall yields, via treatment of an intermediate imino ether 
hydrochloride salt 84 with a large excess of ethanol. Subsequent treatment of these 
ortho esters with hydrazines afforded the triazolopyrazine cores 85, a number of which 
displayed high anticonvulsant activity, without the side effects of the purine analogue. 
(Scheme 1.5.36.)
EtOH, MeNH2 or MeOH, NH3
85
R1 = H, 2-F, 3-F, 4-F, 2,5-F or 2,6-F 
R2 = NH2 or NHMe
Schem e 1.5.36. Use of triortho esters 86 in the synthesis of a range of pyrazines 85.
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1.5.9. Reaction with organometallic reagents
Imino ethers have often been shown to undergo nucleophilic attack by organometallic 
reagents such as Grignard reagents and alkyl lithiums.23, 68'70 The reaction proceeds 
with substitution of the alkyloxy group for an alkyl group of the organometallic reagent 
used, affording the corresponding imine, with excess nucleophile often resulting in the 
formation of a tertiary amine. This nucleophilic addition reaction was first 
demonstrated as early as 1941 when Smith and Nichols reacted a series of aryl 
Grignard reagents with ethyl N-phenyl formimidate 87 to generate the corresponding
H1imines 88 , which were then hydrolysed to the resultant aryl aldehydes 89. (Scheme 
1.5.37.)
ArMgBr
Schem e 1.5.37. Reaction of an imino ether 87 with aryl Grignard reagents and 
subsequent hydrolysis.
In 1959 Lukes and Cervinka showed that lactim ethers are also susceptible to 
nucleophilic attack when they reacted pent-4-enyl magnesium bromide with 
valerolactim ether 15, to form a pentenyl-tetrahydropyridine 90 in moderate yield. 
The product was subsequently elaborated to afford the desired 4- 
hydroxymethylquinolizidone 91, as well as l-az<2bicyclo-[0 ,4 ,5]-undecan-3-ol 92. 
(Scheme 1.5.38.)




Schem e 1.5.38. Cervinka and Lukes synthesis of 4-hydroxymethylquinolizidone 91 
from valerolactim ether 15.
Further work carried out by Booth, Johnson and Johnson three years later demonstrated 
that reaction of butyrolactim ether 39 with the Grignard reagents of 2,3,4- 
trimethylpyrrole and 3,4-dimethyl pyrrole resulted in 2,2’-pyrrylpyrrolines 92,69 
however the yields obtained were generally low. (Scheme 1.5.39.)
BrMg' R
Yield = 8-28%
92R = H or Me
Schem e 1.5.39. Reaction of butyrolactim ether 39 with pyrrole derived Grignard 
reagents.
This work was followed by more general work on the reaction of Grignard reagents
/TO
with lactim ethers by Dudek and Li-Kuan. Their work centred on the synthesis of 
cyclic 2-alkyl imines from caprolactim ether 16 via reaction with alkyl magnesium 
bromides affording a series of imines 93 in 8 to 44% yield. The pair then hydrolysed 
these cyclic imines to produce a range of co-amino carbonyl compounds 94. (Scheme 
1.5.40.)
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RMgBr
R = Me, Et, nPr, nBu, Ph or Bn
Schem e 1.5.40. Reaction of caprolactim ether with Grignard reagents to afford an co­
amino ketone 94.
Smith et al. performed the widest and most comprehensive study on the reaction of the 
organolithiums with lactim ethers in 1984.73 They studied reaction of a large range of 
organolithium reagents with butyro, valero and caprolactim ethers, concentrating on 
formation of the corresponding imines and amines as building blocks for indolizidines 
and quinolizidines. They noted that while addition of organolithium reagents to lactim 
ethers gave moderate to good yields of imines using butyrolactim ether (60 to 85% 
unpurified), yields of imine dropped off dramatically for valero and caprolactim ethers 
(0 to 50%). (Scheme 1.5.41.)
^ v V ^ O M e  RLi, Et2Q, -20°C
\  y  Yield = 4-85%, n = 1
'  ' n Yield = 0-47%, n = 2
Yield = 8-67%, n = 3
RLi, Et2Q, -20°C
\  Yield = 0-35%, n = 1 \  ,A R
" Yield = 0-25%, n = 2 In
Yield = 0-33%, n = 3
5 eq. RLi
n = 1, 2 or 3 Yield = 49-75%, n = 1
R = Me, nPr, nBu, 'Bu or Ph Yield = 0-67%, n = 2
Yield = 0-68%, n = 3
Schem e 1.5.41. Reaction of organolithiums with lactim ethers.
The main problem the authors encountered was further reaction of the imine 
intermediate to afford 2 ,2-dialkyl amines, which was ascribed to the well known ability 
of imines to react with alkyl lithiums. For example, in the case of allyl magnesium 
iodide, butyrolactim ether afforded 2 ,2-allylpyrrolidine as the only isolatable product. 
The authors reported that controlled addition of a single equivalent of alkyl lithium to 
lactim ethers failed to afford a reliable route to 2-alkyl imines, with the reaction usually 
returning unreacted lactim ether 39 (typically 40 to 100%), 0-30% yield of imine 96, 
with the remainder being 2,2-dialkyl amine 97. The only notable exception was for the 
use of PhLi which afforded the corresponding imine in 85% yield. (Scheme 1.5.42.)
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,N^  ^ y » O M e  RLi /  < v ^ -R  /  < v^-R
\ -----/  Yield = 4-85% \ -----/  + \ -----/
39 96 97
R = Me, nPr, nBu, lBu or Ph
Schem e 1.5.42. Reaction of organolithiums with lactim ethers to form imines.
Entry Alkyl Lithium % recovered starting % yield of % yield of 2,2-
________________________ butyrolactim ether 39 butyroimine 96 dialkyl amine 97
1 MeLi 59 4 0
2 nPrLi 52 11 35
3 nBuLi 38 34 24
4 lBuLi 51 49 0
5 PhLi 5 85 0
All yields unpurified.
T able 1.5.2.
It was noted that employment of five equivalents of organolithium afforded reliable 60- 
75% yields of the desired 2,2-dialkyl amines 97, except in the case of the sterically 
demanding lBuLi, which gave the corresponding di-lbutyl amine 98 in only 45% yield. 
(Scheme 1.5.43.)
/ V ^ O M e  5 eq. RLi, Et2Q
\ ___ /  Yield = 67-75% \ ___ /  R
39 97
R = nPr, nBu, lBu or Ph
Schem e 1.5.43. Synthesis of 2,2-dialkylamines 97 from butyrolactim ether 39.
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Entry Alkyl lithium % recovered starting 
butryolactim ether 39
% yield of 
butyroimine 96
% yield of 2 ,2- 
dialkyl amine 97
1 nPrLi >5 >5 67
2 nBuLi >5 >5 75
3 ‘BuLi >5 13 49
4 PhLi >5 >5 74
All yields unpurified.
T ab le  1.5.3.
The group reported that starting material in these reactions was the result of ‘a minor 
reaction’ where the starting lactim ether was deprotonated by the organolithium to 
afford an aza-enolate intermediate. They attempted to prove this mechanism by 
quenching the reaction mixture with methyl iodide and found that small amounts of a- 
methyl butyrolactim  ether 99 could be formed. Furthermore, they noted that as the 
basicity of the organolithium species decreased the amounts of a-alkylated material 
recovered became smaller, implying that the organolithium species was acting as the 
source of base and not the lithium 2,2-dialkyl amide species 100 generated in situ. The 
potential o f this type of aza-enolate alkylation strategy for the synthesis of a-alkyl 
lactim ethers will be discussed in more detail as part of the research program described 
in Chapter 2 of this thesis. (Scheme 1.5.44.)
LiI
100
Schem e 1.5.44. Alkylation of the aza-enolate of lactim ethers using the initial 
organolithium as a base.
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In 1986 Ryckman and Stevens reported a total synthesis of (±)-Porantherine, a major 
alkaloid isolated from the alkaloid rich plant Poranthera corymbosa,74 that is 
responsible for many livestock poisonings in New South Wales and Queensland. They 
planned a retrosynthetic approach that required access to a key frfs-acetal amine 101, 
and performed test reactions on valerolactim ether 15 using butyl and 4-pentenyl 
lithium as nucleophiles to afford their corresponding 2,2-disubstituted piperidines in 72 
and 85% yield. It was then found that reaction of five equivalents of valerolactim ether 
15 with one equivalent of lithium ketal species 102 resulted in the desired diketoamine 







O | J O 
103
Schem e 1.5.45. Nucleophilic attack of a bis-acetal lithium reagent 102 on valerolactim 
ether 15.
1.5.10. Oxidation and reduction
A relatively small number of reports on the oxidation of imino ethers have been 
reported to date. The most in depth oxidation study was performed by Aue et al. in 
1973 and 1974, ’ who treated a series of A-substituted imino ethers and lactim ethers 
with mCPBA to generate a series of oxaziranes, as potentially valuable synthetic 
intermediates. For the case of methyl / / - ‘butyl formimidate 104 the expected oxazirane 
105 was formed, which on treatment with aqueous acid yielded ‘butyl hydroxylamine 
and methyl formate. This approach represents a useful synthetic protocol for the 
synthesis of substituted hydroxylamines from formamide. (Scheme 1.5.46.)
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mCPBA
104 105
Schem e 1.5.46. Oxidation of an imino ether 104 to afford an oxazirane 105 and 
subsequent acid hydrolysis.
In the case of butyrolactim ether 39 the expected oxazirane 106 was obtained in 60% 
yield, however it was noted that it readily decomposed thermally in the presence of acid 









Schem e 1.5.47. Oxidation of butyrolactim ether 39 with raCPB A.
The author also studied the oxidation of a betalactim ether 108 and found NMR 
evidence at low temperature for the formation of l-<zza-5-oxabicyclo[2.1.0]pentane 109 
which decomposed to the nitroso ester 110. (Scheme 1.5.48.)




«0<AN ^  OMe yield = 50% 
110
OMe
Scheme 1.5.48. Oxidation of a betalactim ether 108 to afford the nitroso ester 110.
Alternatively, oxidation of tetramethyl betalactim ether 111 with mCPBA resulted in 
the formation of the alternative oxazole product 112. It was proposed that this reaction 
proceeded via an oxazirinane intermediate 113 that subsequently rearranged to the 






________   o '^ O M e
Yield = 73%
112
Scheme 1.5.49. Oxidation of tetramethyl betalactim ether 111 using mCPBA.
Reduction o f lactim ethers on the other hand has been far more widely studied, with 
Henle being the first to report the reduction of simple imino ether salts in 1905.77 His 
protocol involved treatment of imino ether hydrochloride salts with 3% sodium 
amalgam and dilute mineral acid to directly afford an aldehyde after two hours, with a 
yield o f 24% being reported for the methyl benzimidate salt. However, given the 
aqueous acidic conditions used it is entirely possible that the imino ether was 
hydrolysed in situ to its ester, which in turn was reduced to an aldehyde in low yield by 
the sodium mercury amalgam. (Scheme 1.5.50.)




Na/Hg, H2S0 4 (aq)
Yield = 24% R H
i l  + NH4CI 
R OEt
3% Na/Hg
R = Me, Ph, p-tolyl or Bn,
Schem e 1.5.50. Reduction of imino ethers using sodium mercury amalgam.
In 1968 Borch reduced a wide range of amides and lactams by converting them to their 
corresponding imino and lactim ethers which could then be reduced to their amines via 
treatment with sodium borohydride,78 with the reduction step occurring in high yield for 
a range of cyclic and acyclic imino ethers (81 to 94%). Borch speculated on a 
mechanism involving initial attack of the borohydride anion at the imidic centre 
affording a tetrahedral intermediate that decomposes via expulsion of the alkyloxy 
fragment to afford an imine, which is then further reduced under well established 
precedent. (Scheme 1.5.51.)
2 _ _ 3Rx®x-R N




R1 = nBu, 'Bu, Ph or p-N 02Ph 
R2 = H or Et 
R3 = Et
R1 and R3 = (CH2)5
2 r s  . r 3N
1 R"^}Et
2 _  _  3RV®XRN
1 R ^ H  BF?
Schem e 1.5.51. Borohydride reduction of an imino ether generated in situ from their 
corresponding amides.
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Entry Amide Amine % yield
1 0
O ^ nhb Q T nhe'
92
2 0
O r * - *























Borch also reported that reduction of primary imino ethers with sodium borohydride in 
ethanol did not result in primary amines, but instead gave nitriles as the major 
product.78 Optimisation of this elimination reaction lead to the discovery that sodium 
ethoxide was an effective base for converting this class of imino ether into nitriles in 
good yield (86% to quantitative yield). (Scheme 1.5.52.)
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n h  r f
II NaBH4 or NaOEt, EtOH | | ^  .
1 A  2 ---------------------  ^ 1 2  ► R—=N
R OR Yield = 86-100% R Q ) R
R1 = Me, Et, nPr, nBu or Ph 
R2 = Me or Et
Schem e 1.5.52. Reduction of a primary imino ether to the corresponding cyanide.
Later in 1969 Borch devised a protocol that enabled nitriles to be reduced by sodium 
borohydride to their corresponding amines in high yields via formation of an
7 0intermediate imino ether, as an alternative to using harsh reducing agents such as 
LiAlHU. (Scheme 1.5.53.)
^Et
i) E t03 BF4, ii) EtOH n NaBH4
RON - — : ---------- L .  R/ \ M- E t
R OEt R N
R = Me, Et, nPr, nBu or Ph
Schem e 1.5.53. Sodium borohydride reduction of nitriles and amides via the imino 
ether intermediate.
Reduction strategies have often been combined with az<z-enolate alkylation reactions to 
afford powerful synthetic protocols. For example, Meyers et al. treated dihydrooxazines 
114 (isomeric forms of lactim ethers) with BuLi and alkylated the resultant aza-enolate
on
with a range of electrophiles. Reduction of the resultant species with sodium 
borohydride gave access to a-substituted aldehydes, whilst reduction using sodium 
borodeuteride allowed access to the corresponding isotopically labelled analogues 115. 
(Scheme 1.5.54.)
BuLi, R‘X NaBD4 HO OH
Yield = 50-70°/< Yield = 90-100%
R1 = H or Ph
R2 = Me, nPr, nBu, Ally), *Pr or Bn
115
Schem e 1.5.54. Azcz-enolate alkylation and reduction of an oxazine 114 to afford 
isotopically labelled a-alkyl aldehydes 115.
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Alkylation of aza-enolates of these oxazine systems with aldehydes affords alcohols 
116, which in turn could be reduced to their corresponding aldol products 117, which 
on treatment with oxalic acid resulted in elimination/hydrolysis to afford a,P- 
unsaturated aldehydes 118. (Scheme 1.5.55.)
NaBD,
R Yield = 88-100%R Yield = 87-100%
R2 = H, Me, Et or Ph
R3 = Me, Et, nBu, nHept, Ph, p-tolyl, p-anisyl, 2-naphthyl
Schem e 1.5.55. Reaction of the aza-enolate of a dihydrooxazine 114 with an aldehyde 
to afford the isotopically labelled a,P-unsaturated aldehyde 118.
Meyers et al. also noted that a,p-unsaturated aldehydes could be used as electrophiles 
in this type of aldol reaction, thus affording a two carbon stereoselective chain 








Schem e 1.5.56. Stereoselective two carbon chain homologation of cinnamaldehyde 
120.
It was also reported that the oxizanes 114 could be dialkylated using bis-halo- 
electrophiles thus, enabling the efficient preparation of cyclic carboxaldehydes 121.82 
In the case of 1,3-dibromopropane it was found that its o-brom o intermediate 122 was
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trapped by the nitrogen atom of the oxazinane. 1,2-dibromoethane acted as a bromine 
source and not as an alkylating agent, resulting in aza-enolate halogenation, which 
ultimately resulted in a dimeric product 123. (Scheme 1.5.57.)
Schem e 1.5.57. Alkylation of dihydroxazines with electrophiles containing a second 
electrophilic centre.
It has also been shown that lactim ethers are readily reduced using Raney nickel, 
ruthenium oxide and barium-copper chromite catalysts affording the corresponding 
cyclic imines in good yields. ’ However, the use of a platinum catalyst has been 
shown to afford the corresponding amidine with piperidine and pyrrolidine derivatives 
being readily prepared via these approaches.23 (Scheme 1.5.58.)
Schem e 1.5.58. Catalytic reduction of caprolactim ether 16.
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1.5.11. Pericyclic reactions of lactim ethers
There have been a number of reports on pericyclic reactions of lactim ethers. In 1992 
Sano et a l observed an unexpected aza-Cope [3,3]-sigmatropic rearrangement of 
lactim ether 124 under conditions initially designed to favour photocycloaddition 
products.83 (Scheme 1.5.59.)
Schem e 1.5.59. Unexpected aza-C ope reaction of a diastereomeric imino ether 124.
Yamazaki et a l  have also shown that [2+2] cycloadditions could be performed on a 
related thiolactim ether substrate 40.84, 85 On N-methylation, the thiolactim ether 
underwent isomerisation to the enamine 125 that then underwent cycloaddition with 
dimethyl acetylenedicarboxylate (DMAD) to ultimately afford substituted cyclic 
dieneamines 126. Although the initial cyclobutyl product 127 was never isolated, the 















n= 1 ,2 or 3
Schem e 1.5.60. [2+2] cycloaddition reaction of N-thiolactim ethers 40 and DMAD, 
followed by an electrocyclic ring opening.
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Lerestif et al. demonstrated that reaction of dimethyl amino malonate with ethyl 
acetimidate hydrochloride 128 resulted in formation of a dipolarophile 129, ideally
o/r
suited for 1,3-dipolar cycloaddition reactions. They reacted the dipolarophile 129 
derived from dimethyl a-aminomalonate with a range of aldehydes thus generating the 
corresponding 2-oxazolines 130 in good yield. (Scheme 1.5.61.)
OMe
mH H C I __________ n h 2 M e Vv^ . N N . C 0 2M e  _ = _  M e ^ . N ^ . C O g M e
M A - O E t  Yield = 81% r  I X I®





OEt C 02Me 
129
R = Ph, Furyl, 'Pr, 2-OH-Ph, 2-pyridyl, PhC(H)=CH
H
Me. n C 0 2Me







Schem e 1.5.61. L erestif s 1,3-dipolar cycloaddition reaction of imino ether derived 
dipolaraphiles with aldehydes.
It was found that subsequent treatment of the resultant 2-oxazolines 130 with piperidine 
followed by heating to reflux in acetonitrile resulted in Krapcho decarboxylation to 
afford a tam s-substituted oxazoline 131 in good yield. (Scheme 1.5.62.)
X . y V 0 0 ’0 ' '  Piperidine
O — (^C02CH3 ---------- - O—S H
Ph ph
130 131
Schem e 1.5.62. Krapcho decarboxylation of L erestif s oxazoline 130.
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1.5.12. The use of lactim ethers for the synthesis of heterocyclic 
compounds
One of the most chemically and biologically important areas of modem organic 
chemistry is the development of the methodology for the synthesis of heterocycles. 
Imino and lactim ethers are ideal building blocks for the synthesis of a wide range of 
structurally complex heterocycles, owing to the electrophilicity of their alkyloxy units 
and the nucleophilicity of their imidic nitrogen atoms. One of the most commonly 
employed routes is to react a lactim ether with a substrate that contains complimentary 
electrophilic and nucleophilic centres, thus enabling intramolecular coupling and 
intramolecular ring cyclisation reactions to be carried out in a single step.39 87,88 This 
approach is demonstrated for reaction of valerolactim ether 15 with a-am ino ester 132, 
and azides which afforded excellent yields of the desired bicyclic heterocycles 133 and 
134. (Scheme 1.5.63.)
HaN^ COzEt Ph Ph










Schem e 1.5.63. One step heterocyclic formation reactions using valerolactim ether 15.
In 1975 W am hoff et a l  showcased the fact that the electrophilic nature of the sp2
carbon atom of lactim ethers could be combined with the nucleophilicity of the sp2
80nitrogen atom to afford families of heterocyclic compounds. Treatment of P-amino 
esters 135 with a series of lactim ethers resulted in the rapid generation of complex 
multicyclic compounds 136 in good yield. (Scheme 1.5.64)
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Schem e 1.5.64. W am hoff’s synthesis of a tetracyclic structure 136 using lactim ethers.
In 1966 W inkelman and Hagedom treated ethyl A-benzylimine formimidate 137 with 
sodium azide and reported formation of phenyl-iV-(lH-tetrazol-l-yl)methanimine 138. 
87,88 It has been speculated that the process proceeds though an azido amidine structure 
139 that cyclises intramolecularly, however it is possible that the reaction may proceed 





Schem e 1.5.66. Tetrazole formation from reaction of azides with imino ethers.
Attack of amines, and especially hydrazines, upon imino ethers can be utilised to 
generate heterocycles intramolecularly provided there is a second electrophilic site 
available. In 1961 N aylor et a l  employed this approach in their synthesis of substituted 
imidazoles 140.90 Once the hydrazine had attacked the imino ether to form an 
intermediary hydrazine derived amidine 141, the molecule was able to cyclise via 
intramolecular attack of its secondary amine on the cyano group. (Scheme 1.5.67.)
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Schem e 1.5.67. N aylor’s synthesis of substituted imidazoles.
In 1961 Glushkov showed that reaction of caprolactim ether 16 with a-am ino-a-
cyanoacetamides 142 gave l,2-pentamethylene-4-carboxamido-5-aminoimidazoles 
11143. They reported that the lactim ether 16 initially reacted with the nucleophilic 
amine functionality, followed by intramolecular cyclisation of its amino functionality 
onto the cyano group to afford an endocyclic amino group. (Scheme 1.5.68.)
n h 2JL
.OMe NC CONH2 
142
16 143
c o n h 2 
h2n ' ' \ ' NH2
NH
X = N or O
Schem e 1.5.68. Reaction of caprolactim ether 16 with a-am ino a-cyanoacetamide 142.
Baccar and Mathis also employed this approach for their parallel 1,2,4-triazole 
synthesis where reaction of hydrazine with //-acyl imino ethers 144 initially resulted in 
amidine formation, followed by intramolecular attack by the hydrazine terminal 
nitrogen atom to afford highly functionalised 1,2,4-triazoles 145. 91 (Scheme 1.5.69.)
o oX X
N R h 2n - n h 2 N R2
1 A  ---------------- ** 1 x<NH2





Schem e 1.5.69. Baccar and M athis’s 1,2,4-triazole synthesis.
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Triazoles are present in many natural structures and medicinally active compounds 
since their high heteroatom content ensures solvation in aqueous media. For example, 
Arrowsmith et al. synthesised a sequence of triazole-dihydropyridines during their 
research into identifying selective coronary vasodilators.92 They introduced a 1,2,4- 
triazole fragment via reaction of primary amine 146 with an A-cyano-dithioimino ether 
147 to generate an A-cyanoamidino thioimino ether 148. This thioamidino structure 
was then allowed to react with hydrazine which displaced the alkylthio fragment and 









R = 2 -Cl, 2,3-CI, 3-CI, 2-chloropyrindin-3-yl, 2-CI, 3-CF3,
HN
MeS'






Schem e 1.5.70. Triazole 149 formation from the A-cyano-dithioimino ether 147.
Other three component coupling strategies have also been developed for heterocyclic 
syntheses involving reaction of an imino ether with a nucleophile, followed by addition 
of a second reagent to induce ring closure, as shown for the formation of imidazoles 
150 and tetrazoles 151. (Scheme 1.5.71.)
NH.HCI h2N ^ n N ^  
1R " \ ) R  1R OR
n- ^ ^ nh2
, J KR R" 
150
N H  U  M M U  N H|| h2n~n h2
R^X)R R" 'N
H
II h n o 2 R - v f  vnA „ . nh2    \\ /r
N—N 
151
Schem e 1.5.71. Imidazole 150 and tetrazole 151 formations using imino ethers.
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In 2002 Herr et al. published work detailing production of a late stage intermediate of 
chiral xanthine CVT-124,93 which is a potent and selective adenosine A l receptor 
antagonist that is currently undergoing phase II clinical trials.94 (Figure 1.5.6.)
CVT-124
F igu re  1.5.6. CVT-124.
They took a racemic mixture of 5-norbomene-2-carbonitrile 152 and carried out a 
Pinner reaction with methanol and HC1 to furnish a racemic imino ether hydrochloride 
153. This mixture was then allowed to react with cyanoglycine methyl ester 154 to 
generate intermediary imino ether 155, which was then treated with benzylamine to 
afford an amidine 156 that reacted intramolecularly to effect ring closure with 
formation of an exocyclic amine functionality 157. (Scheme 1.5.72.)
MeOH, HCI










Schem e 1.5.72. Synthesis of the norbomyl fragment of CVF-124.
The approach o f combining an imino ether with a reactant that contains both an 
electrophilic and nucleophilic centre was employed by Wassermann et al. as
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methodology for the total syntheses of the macrocyclic spermidine alkaloids (±)- 








Ph r x j T
(±)-anhydrocannibisativine
Pent
F igure 1.5.7. Structures of (±)-dihydroperiphylline, (±)-verbascenine and (±)- 
anhydrocannibisativine.
In this approach the author reacted p-lactams with butyrolactim ether 39 to generate a
01 Q7 QQ
p-lactam amidine intermediate 158, ’ ’ that underwent intramolecular rearrangement 
to afford an amido dihydropyrimidine ring structure 159 on heating to 130 °C. They 
then reduced the resultant bicyclic compound 159 with sodium cyanoborohydride to 
afford 4-oxo-hexahydropyrimidine intermediate 160 which underwent tautomerisation 
to an amido imino structure 161 that was further reduced to afford the desired 
macrocyclic product core 162. (Scheme 1.5.73.)
NaBH3CN
NaBH3CN
Schem e 1.5.73. Use of butyrolactim ether 39 for the synthesis of a series of 
macrocyclic spermine and spermidine alkaloids.
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In 1995 Fujii et al. employed the nucleophilic nature of the nitrogen atom of a lactim 
ether as a key step in their convergent chiral synthesis of (-)-Ophiorrhizine,99 an 
alkaloid isolated in 1992 from Ophiorrhiza bracteata100 that has been reported for the 
treatment of eczema and other skin disorders.101 They coupled a chiral lactim ether 
fragment 163 to an indole derivative 164 through its a-chloro ketone functionality, 















Schem e 1.5.74. A chiral lactim ether 164 being used in the synthesis of (-)- 
Ophiorrhizine.
Imino ethers have also been widely used as reagents to effect the ring closure of chiral 
2-amino alcohols, or 2-amino thiols under acidic conditions.1,13,102 This approach was 
employed by Gmeimer et al. for the synthesis of a series of conformationally restricted 
benzamide bioisosteres as highly selective dopamine D4 receptor inhibitors.103 The 
strategy employed for the formation of the dihydroimidazoles 165 and dihydrothiazoles 
166 was based on condensation of methyl benzimidate 167 with either (/?)-serine 
methyl ester hydrochloride or (2/?,35)-threonine methyl ester hydrochloride to afford 
the corresponding dihydrooxazole 168 or dihydrothiazole species 169, which were then 
further functionalised to afford dihydroimidazoles 165 and dihydrothiazoles 166. 
(Scheme 1.5.75.)
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X = 0 , 168 
X = S , 169
X = 0 , 165 
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Schem e 1.5.75. Synthesis of dihydrooxazoles and dihydrothiazoles from methyl 
benzimidate 167.
Nitrogen analogues were subsequently prepared via a ring opening amination step of 
the parent dihydrooxazole 165 using trimethylsilyl azide as a nucleophile to generate an 
azido amide compound 170, which was reduced using LiAlH4 to the corresponding 
diamine 171. This diamino species 171 was then treated with methyl benzylimidate 167 

























Schem e 1.5.76. Synthesis of the imidazole analogue 172.
Sulfur based nucleophiles may also be used for the synthesis of chiral heterocyclic 
products. In 1990 Pattenden et al. prepared a range of iV-protected imino esters 173 
from naturally occurring L-amino acids.104 They converted the intermediary amide 174 
into its corresponding imino ether 173 via treatment with triethyloxonium 
hexafluorophosphate, as triethyloxonium tetrafluoroboronate had resulted in extensive 
cleavage of the amine protecting groups. (Scheme 1.5.77.)
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R1 = H, Me or Bn 1 7 4  1 7 3
R2 = H, ‘Pr
R3 = Allyl, CH2CCI3 or lBu
Schem e 1.5.77. Formation of TV-protected imino ethers 173 from the corresponding 
amino acid.
The group then condensed a series of these imino ethers 173 with the amine and thiol 
group of (/?)-cysteine methyl ester to afford enantiomerically pure thiazolines 175, 
which were easily oxidised to their corresponding thiazoles 176. As expected, the 
stereochemical integrity at both stereogenic centres of the thiazoline intermediate 175 
was retained, although the thiazoline 176 stereocentre was lost during the subsequent 
aromatisation reaction. (Scheme 1.5.78.)
M e02C
M e02C-
Yield = 24-91% M e02C’
173 175 176
R1 = H, Me or Bn 
R2 = H or ‘Pr
R3 = Allyl, CH2CCI3i Bn or (Bu
Schem e 1.5.78. Synthesis of chiral thiazolines 175 and thiazoles 176.
Tetrazines are also readily formed through the use of imino ether intermediates. A 
powerful example of this type of approach was demonstrated by Boger et a l  for the 
preparation of a 3,6-£fs-(3,4-dimethoxybenzoyl)-l,2,4,5-tetrazine intermediate 177 
during his total synthesis of ningalin D and purpurone.105 Previous work had employed 
dimethyl dicarboxylate 178 for Diels-Alder reactions with a wide range of dienophiles 
for the formation of a new aromatic ring through loss of nitrogen. This approach was a 
very effective strategy for synthesising 1,2-diazines 179 as both electron rich and 
electron deficient dienophiles could be used for synthesis. These types of pyridazines 
are easily transformed into pyrroles 180 via ring contraction reactions facilitated by the 
action of zinc and acetic acid. (Scheme 1.5.79)
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Ningalin D, R = OH 
Purpurone, R = H
Schem e 1.5.79. Generic overview of the synthetic scheme employed by the Boger 
group.
The 1,2,4,5-tetrazine 177 was synthesised in a 5 step process in 28% overall yield from 
3,4-dimethoxy benzaldehyde 181. In the initial step the group treated arylaldehyde with 
TM SCN to yield the TMS protected cyanohydrin 182, which was subsequently reacted 
with ethanol in a Pinner synthesis to generate the desired imino ether hydrochloride salt 
183. Treatment of the imino ether 183 with hydrazine under acidic conditions resulted 
in transimidation to afford the W-amino imino ether 184. Dimerisation of 184 to afford 
dihydrotetrazine 185, followed by oxidative aromatisation with FeCb and facile Dess- 
M artin oxidation of the benzylic alcohols gave a key synthetic intermediate 177 for the 
synthesis of ningalin D and purpurone. (Scheme 1.5.80.)


























Schem e 1.5.80. B oger’s tetrazine 177 synthesis.
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1.6. Conclusion
This introduction section has demonstrated that imino ether and lactim ethers are 
versatile synthetic intermediates for the preparation of a wide range of heterocycles of 
use for drug discovery and for natural product synthesis.
The rem ainder of this thesis describes the development of synthetic methodology 
directed towards the use of the lactim ether moiety for synthesis. Specific interest has 
been focussed on three areas;
•  Developm ent of methodology for the alkylation of aza-enolates of the lactim 
ether functionality, followed by subsequent hydrolysis to afford a-alkyl co­
amino esters or a-alkyl lactams
• Developm ent of alkyloxy substitution strategies of lactim ethers and its 
application for the development of asymmetric azcz-enolate alkylation reactions 
using chiral auxiliary and chiral ligand strategies
• Developm ent of synthetic strategies for the isotopic labelling of fo's-lactim 
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Chapter 2. Alkylation of the aza-enolate of lactim ethers for 
the synthesis of a-alkyl co-amino esters and a-alkyl lactams
2.1. a-Alkyl amino esters and lactams
This chapter describes the development of synthetic methodology for the synthesis of 
a-alkyl lactams and a-alkyl co-amino esters through alkylation of czzcz-enolates of lactim 
ethers. It has been shown that lactim ethers can be deprotonated to afford their aza- 
enolates, which then undergo alkylation in the presence of an electrophile to generate 
their corresponding a-alkyl lactim ethers. It has also been demonstrated that hydrolysis 
of the a-alkyl lactim ethers affords the a-alkyl amino esters, which could be readily 
cyclised to afford their corresponding a-alkyl lactams. (Scheme 2.1.1.)
Alkylation Hydrolysis Cyclisation
Schem e 2.1.1. Overview of the proposed strategy for the formation of a-alkyl co-amino 
esters and a-alkyl lactams.
Consequently, a brief discussion of the current uses and methodologies used to prepare 
a-alkyl co-amino esters and a-alkyl lactams now follows.
2.1.1. Current uses of a-alkyl lactams and co-amino esters
a-alkyl lactams exhibit a wide and varied range of biological activities as demonstrated 
by their presence as fragments in natural products and medicinally active compounds. 
This biological activity predisposes them as pharmocophores for the preparation of a 
wide range of drug like molecules including AG7088 a human rhinovirus protease 
inhibitor,106 and 186 which is an inhibitor for human cancer cell-lines that contains a 
derivatised caprolactam fragment.107 (Figure 2.1.1.)





F igure 2.1.1. AG7088 a human rhinovirus 3C protease inhibitor containing an a-alkyl 
butyrolactam and 186 an RGD peptidomimetic that selectively binds to human cancer 
cells reducing tum our growth.
Given the recent success of a-alkyl a-am ino acids, a-alkyl p-amino acids and butyro- 
amino acids in inducing secondary structure into short peptide fragments, a-alkyl co­
amino acids represent potentially attractive monomers for probing the conformation of 
derived peptidic isosteres.108 They also represent a valuable class of synthetic 
compounds in their own right demonstrating a range of properties that make them 
desirable synthetic targets or intermediates. For example, 187 is a substrate analogue 
that acts as an inhibitor of chymotrypsin,109 whilst dibutyro-peptide 188 was reported 
by Seebach to be a potent human somatostatin m im ic.110 (Figure 2.1.2.)
F igure 2.1.2. Chymotrypsin substrate analogue 187 that exhibits enzyme inhibition 
through acylation of key serine residues and human somatostatin mimic dibutyro- 
peptide 188.
188
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2.1.2. Current synthetic protocols for the production of a-alkyl 
lactams and co-amino esters
a-alkyl lactams have been prepared via many routes, However, the two main 
approaches currently employed involve direct alkylation of the enolate of a lactam, or 
alkylation of the enolate of a ‘proam idic’ compound such as an ester, which at a later 
stage undergoes ring closure to afford the a-alkyl lactam ring. (Scheme 2.1.2.)
p pi i
Alkylation Deprotection
P = Protecting group
Addition Cyclisation
Schem e 2.1.2. Preparation of a-alkyl lactams through direct alkylation of a lactams and 
through cyclisation of an a-alkyl amino ester.
The first method is the most widely used, and many groups have reported the formation 
of a-alkyl and a,a-dialkyl lactams through its use. In this approach the nitrogen atom of 
the amidic bond often requires protection in order to avoid competing side reactions 
involving reaction of the nitrogen atom of the resultant metal amide with the desired 
electrophile. This method therefore requires a prior //-protection step and a subsequent 
deprotection step to remove the //-protecting group.
This methodology has been regularly employed owing to its wide applicability; for 
example Covey et al. alkylated a-alkyl valerolactams 189 and a-ethyl caprolactam 190 
to prepare the corresponding a,a-dialkyl lactams 191 and 192 for use in anticonvulsant 
studies.111 The group produced a,a-dialkyl valerolactams 191 through alkylation of the 
enolate o f the N-benzyl mono-alkylated lactams 193, before removing the N-benzyl 
protecting group using dissolving metal conditions. (Scheme 2.1.3.)
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Schem e 2.1.3. Preparation of a,a-dialkyl valerolactam 191 from the parent lactam 189 
through a benzyl A-protection pathway.
For the synthesis of a,a-dialkyl caprolactams 192 the authors switched to using a TMS 
group for AAprotection of the lactam, thus demonstrating the stepwise production of two 
a,a-dialkyl caprolactam s.111 The group described that addition and removal of the TMS 
protecting group was more facile than for the benzylic analogue, involving in situ 
formations of AATMS lactams, followed by aqueous desilylation during work up. 
(Scheme 2.1.4.)
O i) Et3N, TMSCI 
ii) LDA, RX
" E t  Yield = 67-69%
O i) Et3N, TMSCI 
ii) LDA, Etl
Schem e 2.1.4. Preparation of a,a-dialkyl caprolactam 192 from caprolactam 10 through 
a sequential in situ N -TMS protection/enolate alkylation/deprotection approach.
A number of approaches involving prior formation of the skeleton for the desired
lactam prior to cyclisation have been described. For example, in 2004 Chavan et al.
employed a [3,3]-sigmatropic rearrangement of 194 to generate an a-alkyl lactam 195
as a building block for total synthesis of nothapodytine B, (±)-mappicine and
110camptothecin, as topoisomerase inhibitors for antitumour research. (Figure 2.1.3.)





Figure 2.1.3. Structures of nothapodytine B, mappicine and camptothecin.
In this approach the pyridinone cores of 196 were produced via deprotection and 
cyclisation of the corresponding ‘open chain’ iV-CBZ-protected a-methyl 5-amino ester 
195. The key intermediate 195 was formed by [3,3] sigmatropic rearrangement of 194, 
formed in situ by esterification of its allylic alcohol with triethylorthoformate 197. 
(Scheme 2.1.5.)







Yield = 81 °A
R = NCbz
Schem e 2.1.5. Preparation, deprotection and cyclisation of an N-CBZ amino ester 194 
affording a late stage intermediate 196 for the synthesis of nothapodytine B, mappicine 
and camptothecin.
It was proposed that alkylation of the aza-enolate of lactim ethers might provide an 
alternative route to this class of a-alkyl lactams, and as a consequence a brief review of 
the literature precedent for this class of transformation is now described.
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2.1.3. Literature precedent for the alkylation of lactim ethers
In 1974 Trost et al. showed that the aza-enolate of valerolactim ether 15 could be 
alkylated by electrophiles when he compared the alkylation properties of enolates of 
valerolactim ether 15 with the corresponding A-methyl lactam 198.113 They reported 
the use of this methodology for the synthesis of several a-substituted lactim ethers 199- 
202 in poor to moderate 31-60% yields. (Scheme 2.1.6.)
Kl . i) LDA, THF, -78°C, 2hrs .. .
O '








Schem e 2.1.6. Trost’s alkylation of valerolactim ether 15 using LDA to generate the 
aza-enolate.
Trost also reported that the reaction did not proceed when nBuLi was used as a base, 
and that only LDA and A-cyclohexyl-N-isopropyl amide were suitable for generating 
the desired aza-enolate species. This methodology has not been widely adopted by the 
synthetic community however, and we believed that its potential usefulness as 
methodology for the synthesis of a-alkyl co-amino esters clearly warranted further 
investigation.
In contrast, a large number of reports have appeared in the literature in recent years 
describing the use of Schollkopfs bis-lactim ether methodology for the asymmetric 
synthesis of a-am ino acids. 5/s-lactim  ether 203 is deprotonated via the action of nBuLi 
at low temperatures to afford a stabilised aza-Qnolate 204 that reacts with incipient 
electrophiles to afford a rrans-alkylated-6/.s-lactim ether 205 in high yields and d.e.114' 
119 Subsequent deprotection of the rrans-alkylated &/s-lactim ether 205 via mild acid 
catalysed hydrolysis affords the desired enantiopure a-am ino ester 206. (Scheme 2.1.7.)
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Schem e 2.1.7. Schollkopf’s asymmetric alkylation of the <zz<z-enolate of a fo's-lactim 
ether 204, with subsequent hydrolysis to afford an enantiopure a-am ino ester 206.
Further to the well documented methodology of Schollkopf detailing the alkylation of 
aza-enolates of this type of cyclic lactim ethers, Bergbreiter and Newcomb published 
work in 1984 describing the alkylation of aza-enolates of acyclic imino ethers 207 for 
the asymmetric synthesis of chiral a-alkyl carboxylic acid derivatives.120 They reported 
that treatment o f a small range of imino ethers 207 with strong base resulted in 
formation of the corresponding aza-Qnolate, which on treatment with a range of 
electrophiles afforded a series of a-alkyl imino ethers 208-213 in moderate to good 
yield, and generally high d.e. (Scheme 2.1.8.)
R RN N
208-213
R1 = (fl) or (S)-CH(CH2Ph)CH2OMe, (SJ-CHf'POCHaOMe 
R2 = H or Me
R3 = Me, Et, 'Pr, "Pr, "Bu or Bn
Schem e 2.1.8. Asymmetric alkylation of the aza-enolate of a chiral imino ether 207.
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Entry Ligand (R1 =) Electrophile Yield/% d.r. Configuration1
1 (S)-CH(CH2Ph)CH2OMe EtI 70-80 19:1 R
2 GS)-CH(CH2Ph)CH2OMe BnBr 80-85 32:1 R
3 GS)-CH(CH2Ph)CH2OEt M el 44 6:1 S
4 (S)-CH(Ph)CH2OEt nBuBr 80 32:1 S
5 (S)-CH(Ph)CH2OEt BnBr 80 4:1 S
T ab le  2.1.1.
The only other report in the literature that could be found for the a-alkylation of lactim 
ethers was a low yielding synthesis by Lewis et al. of a-benzyl co-amino acid 214 from 
valerolactam 215 in 1994.121 They treated valerolactam 215 with dimethyl sulfate to 
afford the intermediary valerolactim ether 15, which they then treated with LDA in 
HM PA to afford the aza-enolate 216 which they alkylated with benzyl bromide to 
afford a-benzyl valerolactim ether 217 that was then hydrolysed to afford the 
corresponding a-benzyl co-amino acid 218 in 8% overall yield. This methodology was 
disregarded as a synthetic protocol owing to the very low yield and use of carcinogenic 
solvents. (Scheme 2.1.9.)
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Schem e 2.1.9. Formation and alkylation of the aza-enolate of valerolactim ether 15 
with subsequent hydrolysis to the corresponding a-benzyl co-amino acid 218.
1 Configuration of the new stereocentre
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2.1.4. Nucleophilic substitution reactions of lactim ethers
There is also contrasting literature precedent describing nucleophilic substitution
1 ^  /co H(\ 100
reactions of lactim ethers with alkyl lithium or Grignard reagents. ’ ’ ’ These
substitution reactions proceed at low temperatures, with corresponding displacement of 
the alkyloxy group of the lactim ether by the nucleophilic alkyl fragment to afford 
cyclic imines 96. In the presence of a large excess of alkyl lithium reagents the
n'}
formation of tertiary dialkyl cyclic amine products 97 has been reported. (Scheme 
2 . 1. 10 .)
✓ N^ O M e  1 e q- RL|. Et2 ° -  -78 °c  
\ J  Yield = 4-85%
39
5 eq. RLi, Et20 , -78°C
96
Yield = 49-75%




Schem e 2.1.10. Preparation of imines 96 and amines 97 from the parent lactim ether 39 
via nucleophilic substitution.
2.1.5. Summary of literature precedent
These reports are paradoxical since the action of alkyl lithiums on lactim ethers can 
clearly result in the formation of different products arising from different reaction 
pathways, depending on whether the alkyl lithium acts as a nucleophile or as a base. 
For example, Schollkopf s az<z-enolate alkylation methodology is well documented to 
proceed in high yield to afford a-alkyl lactims, with no reports of the formation of any 
imine or amine products arising from a competing nucleophilic substitution 
pathway.123' 126 Alternatively, Glushkov, Lukes, Cervinka and Smith have all reported 
that nucleophilic substitution reactions of simple lactim ethers occur in preference to 
aza-enolate alkylation reactions.13, 70, 72, 73 However, Smith et al. did note some 
evidence of an aza-enolate alkylation reaction for butyrolactim ether 39, where they 
reported the formation of a-methyl butyrolactim ether 99 by a competing by product in 
15% yield.73 (Scheme 2.1.11.)
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Schem e 2.1.11. Preparation of a-methyl butyrolactim ether 99 from a competing side 
reaction noted by Smith.73
It was felt that these unreconciled reports were worthy of further investigation, with a 
view to developing effective aza-o,nolate alkylation methodology applied to simple 
mcwo-lactim ether substrates, as success would afford methodology for the synthesis of 
divergent libraries of both a-alkyl co-amino acids/esters, and a-alkyl lactams.
2.1.6. New approach to the synthesis of a-alkyl amino esters and 
lactams
An alternative strategy for the synthesis of a-alkyl lactams was proposed, in which a 
lactam was first converted to its more labile lactim ether, that would be deprotonated 
via the action of a base such as ‘BuLi at low temperatures to afford an azcz-enolate that 
would react with an electrophile to afford an a-alkyl lactim ether. The lability of the 
lactim ether bond could then be exploited using mild acidic hydrolysis to afford the 
corresponding co-amino ester which would be isolated as its hydrochloride salt. While 
this type of co-amino ester represents a valuable compound in a variety of disciplines, 
neutralisation would afford an intermediary amino ester which could potentially cyclise 
to afford an a-alkyl lactam. (Scheme 2.1.12.)




l\L .OMea alkylation NL .OMea
cyclisation neutralisation hydrolysis
Schem e 2.1.12. Projected synthetic pathway to a-alkyl lactams using lactim ether 
substrates.
It was proposed that this synthetic protocol would provide versatile methodology that 
was superior to previous approaches for the synthesis of these class of compounds due 
to the improved physical properties of the lactim ether.18, 47'50 Furthermore, it was 
proposed that several steps described in scheme 2.1.12. could potentially be combined 
into single pot transformations; for example hydrolysis of the a-alkyl lactim ether with 
mild acid followed by basification should directly afford a mono-alkyl lactam. 
Furthermore, as described in the introduction to this thesis, a wide range of 
methodology is available for converting lactim ethers into different functionalities. 
Thus, the resultant mono-alkyl lactim ethers would represent useful substrates for the 
synthesis of a wide range of heterocycles, amidines, amino acids, imines and amines. 
(Scheme 2.1.13.)










97Schem e 2.1.13. Potential reaction products using a-alkyl lactim ethers as substrates. ’
73 ,96 , 126-129
2.2 Development of an effective synthetic protocol
Valerolactam 215 was initially chosen as a model substrate for aza-enolate alkylation 
studies due to its commercial availability, and was employed for the preparation of its 
corresponding lactim ether 15.
2.2.1 Preparation of valerolactim ether 15 using methyl 
trichloroacetimidate 3
Methyl trichloroacetimidate 3 represents a facile reagent for the preparation of lactim 
ethers and as such was prepared on a multigram scale according to literature precedent.4 
This Pinner synthesis proceeded cleanly via addition of methanol to 
trichloroacetonitrile under catalytic basic conditions, affording the desired compound 3 
in 83% yield after purification by distillation. (Scheme 2.2.1.)
N = — CCI3
10 mol% NaH, MeOH
Yield = 83% MeO CCI3 
3
Schem e 2.2.1. Preparation of methyl trichloroacetimidate 3.
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Reactions aimed at O-alkylation of valerolactam 215 using methyl trichloroacetimidate 
3 were carried out using a catalytic amount of TMSOTf, which afforded the desired 
lactim ether 15 in moderate yields ranging from 30-68%. (Scheme 2.2.2) However, this 
O-alkylation procedure proved capricious, and this fact coupled with the cost and 
handling difficulties associated with using moisture sensitive trimethylsilyl triflate, led 
to the development of an alternative approach for the synthesis of 15.
Schem e 2.2.2. Preparation of 15 from valerolactam 215 using methyl 
trichloroacetimidate 3.
2.2.2. Preparation of trimethyloxonium tetrafluoroboronate 221 
(Meerwein’s salt)
Trimethyloxonium tetrafluoroboronate 221 (Meerwein salt), M e30 .BF4, was then 
chosen as an O-alkylating reagent as it represented a reliable and facile reagent for the 
preparation of lactim ethers.18,130 Furthermore, it is a commercially available reagent, 
that can be stored for relatively long periods, is safe to use, and is highly
chemoselective for O-alkylation over iV-alkylation.13
Although M eerwein salt was commercially available there were some drawbacks
associated with using this source of supply. The quality of reagent and delivery times
from commercial suppliers was highly variable, whilst the cost of its use for large scale 
synthesis was also prohibitive.2 W hilst initial work in this thesis employed
commercially sourced Meerwein salt, it was quickly realised that significant quantities 
of this reagent would be required over the period of the research project. Consequently,
2 Avocado, 2003-2004 catalogue, pg. 1369, cat. no. A15175, 50g, £103.
3 , TMSOTf, DCM
215 15
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a reproducible synthesis of Meerwein salt was required that would enable its synthesis 
on a large multigram scale.
The preparation of M e30 .BF4 has been reported by several groups, However, the 
method described by Bull et a l m  in 1998 involving modification of the original 
protocol of Curphey et al.m  was selected. This reaction involves addition of BF3.0Et2 
to a stirred solution of dimethyl ether and epichlorohydrin in CH2CI2 at -20 °C. 
Coordination of the Lewis acid to the epoxide allows nucleophilic attack by dimethyl 
ether, resulting in ring opening to afford an intermediary oxonium compound 219. This 
oxonium species 219 is then attacked by a second molecule of dimethyl ether to afford 
the desired trimethyloxonium core 220, with sequential reactions affording the desired 
trimethyloxonium tetrafluoroboronate 221, and a trihaloalkyl borate by-product 222. 
(Scheme 2.2.3.) Fortunately, Me30 .BF3 is insoluble in CH2CI2, and can be simply 
purified via filtration, thus affording 90% yields on a multigram scale.
i) BF3 .OEt2 Me
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Scheme 2.2.3 M echanism for the formation of trimethyloxonium tetrafluoroboronate 
221.
2.2.3. Attempted preparation of tribenzyloxonium tetrafluoroboronate 
223
Trialkyloxonium tetrafluoroboronates represent excellent reagents for (9-alkylation of 
amides, being mild, selective, easy to use and safe to handle, however, only the 
trimethyl and triethyl versions are commercially available. Given the ease with which 
the trimethyloxonium salt had been prepared it was speculated that the potentially
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useful tribenzyloxonium tetrafluoroboronate might also be prepared using this 
methodology.
However, repetition of the oxonium salt forming reaction using dibenzyl ether in place 
of dimethyl ether under a variety of conditions, failed to afford the desired 
tribenzyloxonium tetrafluoroboronate. This conclusion was confirmed via *H NMR 
analysis o f the crude reaction product since no salts were precipitated during the course 
of the reaction. Precedent for the formation of triethyioxonium tetrafluoroboronate 
indicated that this reaction might require gentle heating at reflux to proceed, therefore 
the reaction was repeated using dibenzyl ether at 40 °C, which once again failed to 
afford the desired product. In a final attempt the reaction temperature was increased to 
80 °C, however, once again no formation of any tribenzyloxonium tetrafluoroboronate 
was observed. (Scheme 2.2.4.)
i), ii) or iii)
a / S n  * —  Bn=°BF<
i) Epichlorohydrin, BF3 .OEt2, CHCI3, -20°C
ii) Epichlorohydrin, BF3.OEt2l CHCI3, 40°C
iii) Epichlorohydrin, BF3.OEt2, CHCI3, 80°C
Schem e 2.2.4 Unsuccessful attempted preparation of tribenzyloxonium 
tetrafluoroboronate.
2.2.4. Preparation of valerolactim ether 15
Synthesis o f valerolactim ether 15 was then carried out via treatment of valerolactam 
215 with M eerwein's salt in CH2CI2 at room temperature, followed by neutralisation 
under basic conditions. Initial attempts to prepare valerolactim ether 15 were plagued 
by low yields of product associated with loss of the volatile product during removal of 
solvent during work up of the reaction. Furthermore, the lactim ether 15 is initially 
formed as its tetrafluoroboronate salt which is a highly acidic species that must be 
carefully neutralised at basic pH to prevent premature acidic hydrolysis of the lactim 
ether bond. Previous reports on the synthesis of Schollkopf’s bis-lactim ether chiral 
auxiliary stated that this could be achieved by addition of the highly acidic solution of 
related lactim ether salt to a rapidly stirred saturated aqueous solution of potassium
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carbonate.130 Adoption of this protocol enabled the lactim ether 15 to be reproducibly 
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Schem e 2.2.5. Preparation of 15 from valerolactam 215 using trimethyloxonium 
tetrafluoroboronate.
NL .O M e
CX.
15
Analysis of the NM R spectrum of valerolactim ether 15 revealed that it had been 
formed in high purity. Diagnostic resonances were observed for the methoxy group at 8 
3.55 (s), the a  methylene protons at 8 2.01 (dt, J  6.8 and 1.2 Hz) and the 8 methylene 
protons at 8 3.41 (dt, J  5.7 and 1.2 Hz). The infrared spectrum showed a strong band at 
1674 cm '1 corresponding to the lactim ether functionality, as well as a molecular ion of 
114.0914 (M+, Cr1-) in its mass spectrum.
2.2.5. Alkylation of valerolactim ether 15 to afford a-benzyl 
valerolactim ether 217
Following the precedent of Schollkopf s Z?/.s-lactim ether methodology, it was decided
to carry out initial aza-enolate alkylation attempts under similar conditions involving
treatment with an alkyl lithium in THF at -78 °C for 5 minutes, followed by addition of 
1an electrophile. Since there was precedent for alkyloxy displacement reaction of 
lactim ethers by alkyl lithiums to afford their corresponding imines, it was decided to 
employ lBuLi as a sterically demanding base which was less likely to react in a 
nucleophilic manner. This assumption followed from the observations of Smith et al.
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who recorded far lower yields for the production of alkyl imines from lactim ethers 







"BuLi, RX / N-
+ LiOMe
Schem e 2.2.6. Potential pathways for the reaction of lactim ether 15 with alkyl 
lithiums.
Preliminary aza-enolate alkylation reactions involved treatment of valerolactim ether 
15 with 1.5 equivalents of lBuLi in THF at -78 °C, for five minutes, followed by 
addition of 1.5 equivalents of benzyl bromide and allowing the reaction mixture to 
warm to room temperature overnight. The reaction mixture was then quenched by 
addition of dilute potassium carbonate solution in order to prevent premature hydrolysis 
of the lactim ether bond under acidic conditions. (Scheme 2.2.7.) This method failed to 
afford the desired benzylated lactim ether 217, instead returning quantitative amounts 
of starting material 15, with no reaction occurring even when large excesses of lBuLi 
(up to five equivalents) were employed under identical conditions. (Scheme 2.2.7.)
Schem e 2.2.7. Unsuccessful attempted benzylation reaction of valerolactim ether 15.
It was speculated that the lactim ether 15 had not been deprotonated by lBuLi at -78 °C, 
so the reaction conditions were modified by treating the lactim ether with lBuLi in THF 
at -78 °C, allowing the reaction mixture to warm to room temperature for 15 minutes, 
before recooling to -78 °C, prior to addition of benzyl bromide. This method was
Chapter 2 83 Results and Discussion
successful affording the desired a-benzylated lactim ether 217 as the only observable 
product in the *H NMR spectrum of the crude reaction product. (Scheme 2.2.8.)
Schem e 2.2.8. Successful alkylation of the aza-enolate of valerolactim ether 15 to 
afford a-benzyl valerolactim ether 217.
Purification of a-benzyl valerolactim ether 217 to homogeneity by column 
chromatography was attempted, however, significant decomposition on silica was 
observed as a result of the acidic and hygroscopic nature of silica with between 50- 
100% of crude product being lost during the chromatographic process. Attempts to 
resolve these decomposition problems by adding 1% triethylamine to the eluent were 
unsuccessful, whilst switching to alumina as a neutral stationary phase was only 
partially successful in affording better yields of the lactim ether product 217. It was 
found however, that stringent drying of the silica in an oven at 130 °C did succeed in 
affording the benzylated lactim ether product 217 in moderate 51-81% yields. As a 
result of these difficulties an alternative distillation approach for purification of these 
lactim ether products was investigated, despite the fact that it has been reported that 
lactim ethers could undergo thermal rearrangement to their corresponding N-alkyl 
lactams 223. (Scheme 2.2.9.)
i) 'BuLi, THF, -78°C
ii) rt, 15 minutes
iii) -78°C
Me
Schem e 2.2.9. Chapman rearrangement of a-benzyl valerolactim ether 217.
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It was pleasing therefore to find that Kugelrohr distillation of the crude product resulted 
in very little loss of material affording a-benzyl valerolactim ether 217 in 87% overall 
yield, thus providing a simple purification route to this class of compound.
Analysis of the NMR spectrum of a-benzyl valerolactim ether 217 revealed the 
appearance of resonances at 8 2.55 and 8 3.12 as doublet of doublets, corresponding to 
the diastereomeric benzylic protons ( /gem 13.2 Hz). The methoxy fragment was still 
present as a 3H singlet at 8 3.61, whilst a resonance corresponding to a single a-proton 
was observed as a multiplet at 8 2.38-2.49. Further to this, was the appearance of a 
broad m ultiplet between 8 7.07-7.25 corresponding to the five aryl protons of the 
benzyl fragment. The 13C NMR spectrum revealed the presence of eleven resonances, 
whilst the IR spectrum revealed an absorption at 1674 cm '1 for the lactim ether bond.
2.2.6. Preparation of a range of a-alkyl valerolactim ethers
Given the excellent results obtained for alkylation of the aza-enolate of valerolactim 
ether 15 with benzyl bromide, work was undertaken to prepare a representative range of 
alkylated lactim ethers. In order to investigate the scope and limitations of this protocol 
a range of six electrophiles were employed as alkylating agents for these aza-enolate 
alkylation studies.
Methyl iodide was chosen as the second electrophile, as it represented a non-sterically 
demanding electrophile with moderate reactivity. The third electrophile of choice was 
allyl bromide as an electrophile with comparable reactivity to benzyl bromide, whose 
adducts would afford the opportunity for future functionalisation of the alkene bond via 
cross-metathesis, ozonolysis or hydroboration protocols. The fourth electrophile was 
propargyl bromide (as an 80% solution in toluene) which could potentially suffer from 
a competing side reaction involving deprotonation o f the terminal alkynyl proton. 
(Scheme 2.2.10)
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i) 'BuLi, THF, -78°C
ii) rt, 15 mins. Li
N OMe N ^ O M e  Br . N _ . O M e  Br
f J  ----------------------------- -  I l l ^  . H - ^ ^ -----f --------   f T + Li---- = -----'
15 216 15
Schem e 2.2.10. Competing deprotonation pathway of propargyl bromide by the aza- 
enolate 216.
The fifth choice was ethyl bromide as a test of the nucleophilicity of the aza-enolate 
towards a competing E2 elimination pathway. Finally, ‘butyl bromide and ‘propyl 
bromide were chosen as sterically demanding electrophiles that were readily available 
within the laboratory. (Scheme 2.2.11.)
i) 'BuLi, THF, -78°C
ii) rt, 15 mins. 
m ••') *78°C
S  iv) 'PrBr
OMe ^ 2




Schem e 2.2.11. Competing E2 pathway of sterically demanding ‘BuBr by <zz<z-enolate 
216.
Consequently treatment of the aza-enolate of valerolactim ether 15 with these six 
electrophiles under optimised conditions afforded their corresponding mcwo-alkylated 
lactim ethers 224-229 in 63-87% yield after purification by Kiigelrohr distillation. 
(Scheme 2.2.12.) Analysis of the ]H NMR spectra of the crude reactions products of 
aza-enolate reactions using electrophiles that could undergo a competing E2 
elimination pathway (Table 2.2.2, entry 5-7) revealed the presence of some starting 
material 15, although in <10% yield in each case. This indicates that the aza-enolate of 
15 is non-basic and is an excellent nucleophile for both activated and sterically 
hindered electrophiles.
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i) 'BuLi, THF, -78°C
ii) rt, 15 mins.
, N v .OMe "'J'-TJ00 . N ^ . O M eS  iv) RX S  <5-^
k / *  Yield = 63-87% R
15 224-229
RX = Mel, BnBr, Allyl Br, Propargyl Br, EtBr, 'BuBr, ‘PrBr
Schem e 2.2.12. Alkylation of the az<z-enolate of valerolactim ether 15 with a range of 
electrophiles to afford a-alkyl valerolactim ethers 224-229.
Entry Electrophile Yield %3 6h OMe 5h a-H IR/cnT
1 BnBr 87 3.61 2.38-2.49 1674
2 M el 63 3.55 2.24 1674
3 Allyl Br 66 3.53 2.34-2.44 1674
4 Propargyl Br 78 3.54 2.52 1678
5 EtBr 68 3.53 2.04-2.15 1675
6 ‘BuBr 64 3.52 2.13-2.24 1675
7 ‘PrBr 83 3.53 2.13-2.24 1675
T ab le  2.2.2
All compounds were isolated and fully characterised demonstrating physical and 
spectroscopic data consistent with the formation of the monoalkyl lactim ether.












F igure  2.2.13. The range of a-alkyl valerolactim ethers 224-229 produced.
2.2.7. Preparation of a,a-dialkyl lactim ethers
Having established conditions that enabled mono-alkylation of valerolactim ether 15 
attention then turned to the preparation of a,a-dialkyl valerolactim ethers. In order to
3 After purification via Kugelrohr distillation
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provide a challenging test of this methodology attempts to prepare a,a-di‘butyl 
valerolactim ether 230 were carried out, since it was considered that the steric demands 
of the ‘butyl group, in conjunction with its potential to undergo an E2 elimination 
pathway, would make the a,a-di'butyl lactim ether 230 a challenging target to test the 
effectiveness of this dialkylation protocol.
Initial attempts to alkylate the a-‘butyl lactim ether 228 under standard conditions 
developed previously involving addition of lBuLi in THF at -78 °C followed by 
warming to room temperature and subsequent recooling to -78 °C after 15 minutes, 
afforded only recovered starting material 228 in quantitative yield. At this point it was 
speculated that lBuLi might be too sterically demanding to deprotonate a -‘butyl lactim 
ether 228, whilst exposing it to this aggressive base at room temperature for lengthy 
periods of time would lead to the formation of a large number of unwanted side 
products. As a result it was decided to investigate the use of other bases, and after 
screening a range of conditions it was found that using a mixture of either nBuLi with 
KOlBu, or lBuLi with KOlBu (Schlosser’s base) was successful in affording bis- 
alkylated lactim ether 230. Therefore, treatment of a solution of a-‘butyl valerolactim 
ether 228 in TH F at -78 °C with 1.5 equivalents of KOlBu, followed by addition of 1.5 
equivalents of lBuLi, warming to room temperature for 15 minutes and consequent 
recooling to -78 °C, before addition of ‘butyl bromide afforded the desired a,a-di‘butyl 
lactim ether 230 in 64% yield. The structure of a ,a-d i‘butyl valerolactim ether 230 was 
implicit from the simplicity of its *H NMR and 13C NMR spectra as expected for this 
type of a,a-dialkyl lactim ether, which was confirmed from the observation of a 
molecular ion of 226.2165 in its mass spectrum. (Scheme 2.2.14.)
i) KO’Bu, tBuLi, THF, -78°C
ii) rt, 15 mins
iii) -78°C, 'BuBr
228 230
Schem e 2.2.14. Preparation of a ,a-d i‘butyl valerolactim ether 230 from a-‘butyl 
valerolactim ether 228.
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Formation of the aza-enolate of a-benzyl valerolactim ether 217 and subsequent 
alkylation with benzyl bromide under analogous conditions afforded a,a-dibenzyl 
valerolactim ether 231 in 87% yield, whose spectroscopic data was consistent with the 
formation of this product. (Scheme 2.2.15.)
Schem e 2.2.15. Benzylation of the aza-tnolate of a-benzyl valerolactim ether 217 to 
afford a,a-dibenzyl valerolactim ether 231.
The ability of this aza-cnolate alkylation methodology to afford these type of sterically 
congested a,a-dialkylated valerolactim ethers is particularly noteworthy and testifies to 
the powerful nucleophilic character of this type of aza-tnolate intermediate. In this 
regard, it was concluded that other types of disubstituted lactim ethers should be readily 
available using this methodology. As a final test of the efficacy of this protocol an 
unsymmetrical a,a-dialkyl lactim ether 232 containing a quaternary carbon stereocentre 
was then prepared via either methylation of the aza-enolate of a-benzyl valerolactim 
ether 217, or benzylation of a-methyl valerolactim ether 224, which proceeded in 
essentially identical 70-72% yields. (Scheme 2.2.16.)
i) KO'Bu, 'BuLi, THF, -78°C
ii) rt, 15 mins
iii) -78°C, BnBr
217 231
i) KO'Bu, lBuLi, THF, -78°C i) KO'Bu, 'BuLi, THF, -78°C
ii) rt, 15 mins
iii) -78°C, Mel
ii) rt, 15 mins
iii) -78°C, BnBr
217 232
Schem e 2.2.16. Preparation of a-benzyl a-methyl valerolactim ether 232.
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2.3. Application of aza-enolate alkylation methodology to 
seven and eight membered lactim ethers
2.3.1. Synthesis of a-alkyl caprolactim ethers
The next extension of the use of this aza-enolate methodology was for the synthesis of 
a-alkyl caprolactim ether derived from caprolactam 10. The caprolactim ether 16 was 
first prepared in 78% yield via treatment of caprolactam 10 with M e30 .BF4 in CH2CI2 
according to the previously established procedure. Unfortunately, attempts to alkylate 
the aza-enolate of caprolactim ether 16 using lBuLi as a base under standard conditions 
were unsuccessful affording only recovered starting material. However, the use of the 
mixed ^uLi/K C^Bu basic system developed previously did afford the desired 
monobenzylated lactim ether 233 in 78% yield. A similar result was obtained using 
allyl bromide as an electrophile, which gave mono-allylated lactim ether 234 in 74% 
yield. (Scheme 2.3.1.) The spectroscopic and physical data of 233 and 234 were 





i) 'BuLi, KO’Bu, THF, -78°C 
OMe '■) rt*15 minutes 
iii) -78°C, RBr
Yield = 78%, R = Bn 
Yield = 74%, R = allyl
OMe
R = Bn, 233 
R = Ally), 234
Schem e 2.3.1. Preparation and alkylation of the aza-enolate of caprolactim ether 16.
Unfortunately, attempts to prepare a,a-dibenzyl caprolactim ether 235 via alkylation of 
the aza-e nolate of a-benzyl-caprolactim ether 233 with benzyl bromide under a range 
of conditions were unsuccessful. Similar attempts to benzylate the aza-enolate of a- 
allyl caprolactim  ether 234 were also unsuccessful, affording only returned starting 
material. (Scheme2.3.2.)
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i) 'BuLi, KO'Bu, THF, -78°C
OMe ii) rt, 15 minutes 
iii) -78°C, RBr
Schem e 2.3.2. Unsuccessful attempted alkylation of a-alkyl caprolactim ethers 233 and 
234.




% yield of 
dialkyl product
% yield of 
recovered 233
1 15 1.5 0 78
2 60 1.5 0 65
3 15 3.0 0 81
4 60 3.0 0 71
T ab le  2.3.1
Attention then turned to the alkylation of the a^ -en o la te s  of eight membered lactim 
ethers.
2.3.2. Unsuccessful attempts to prepare a-alkyl oenantholactim ethers
Preparation of the eight membered lactim ether 237 using M e30 .BF4 proceeded in 80% 
yield, giving similar spectroscopic detail to that observed for the six and seven 
membered lactim  ether analogues 15 and 16.
Alkylation attempts on the aza-enolate of 237 under a wide range of conditions failed, 
including the use of the previously successful mixed base system (lBuLi and KC^Bu, 15 
minutes at room temperature). This was a surprising result since the aza-e nolate of the 
seven membered lactim ether 16 had alkylated readily under these conditions in high 
yield and purity, however no alkylation product was ever observed for this eight 
membered lactim ether substrate 237. The aza-enolate alkylation reaction was 
attempted under a variety of conditions, including lengthy deprotonation times of two 
hours at room temperature, and a variety of base systems including “BuLi, lBuLi,
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KHM DS, LHMDS, NaH and LDA. However, analysis of the ‘H NMR spectra of the 
crude reaction products arising from any of these methods revealed no evidence of any 
of the desired a-benzyl oenantholactim ether product 238. (Scheme 2.3.3.)
B ase  = "BuLi, 'BuLi, KHMDS, 
LHMDS, NaH or LDA
Schem e 2.3.3. Preparation and failed alkylation of oenantholactim ether 237.











1 nBuLi/KO‘Bu 60 2.0 0 65
2 tBuLi/KO tBu 60 2.0 0 71
3 nBuLi 60 2.0 0 70
4 ‘BuLi 60 2.0 0 72
5 KHMDS 60 2.0 0 80
6 LHMDS 60 2.0 0 82
7 NaH 60 2.0 0 85
8 LDA 60 2.0 0 45
T able 2.3.2.
2.3.3. Preparation of benzyl capro and oenantholactim ethers using 
benzyl trichloroacetimidate 4
W hilst the use of methyl caprolactim ether 16 in aza-enolate alkylation reactions would 
provide a valuable route to the seven membered open chain amino esters 239, this 
methodology was unlikely to be useful for the preparation of a-alkyl lactams 240 due to 
the difficulties encountered for the cyclisation of seven membered rings due to 
unfavourable torsional interactions in the transition state that generally favour 
oligomerisation of this class of monomer. (Scheme 2.3.4.)
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N32CO3
Schem e 2.3.4. Failed cyclisation of a long chain amino ester 239.
Therefore, an alternative strategy was sought for the synthesis of seven membered a- 
alkyl caprolactams involving a benzyl lactim ether substrate. This new benzyl lactim 
ether 241 would afford the possibility of directly affording a lactam ring, since 
hydrogenation would lead directly to the desired a-alkyl caprolactam 240, whilst still 
allowing the alternative hydrolysis to its corresponding a-alkyl benzyl ester 239. 





Schem e 2.3.5. Alternative synthetic pathway for the formation of large ring size 
lactams 240.
Initial attempts to prepare capro 241 and oenantho 242 benzyl lactim ethers through the 
use of benzyl trichloroacetimidate methodology were plagued by poor yields, 
unreliability and problematic purification. Optimisation of the previously reported 
synthetic conditions,6 involving treatment of the appropriate lactam with benzyl 
trichloroacetimidate 4 and a catalytic amount of TM SOTf in CH2CI2 at 0 °C resulted in 
production of benzyl capro and oenantholactim ethers 241 and 242 in 45% and 37% 
yields respectively after column chromatography. It was found that the use of 0.5 
equivalents of TM SOTf as a Lewis acid were required to achieve these relatively 
modest yields, which contrasts with previous reports that low catalytic levels of 10
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mol% TM SOTF had afforded the best results for O-alkylation of lactams.6 It was 
shown that losses in yield occurred primarily during purification of the crude reaction 
mixtures, with both chromatography and distillation resulting in significant losses in 
product, presumably via acid catalysed decomposition of benzyl lactim ether products 
241 and 242. (Scheme 2.3.6.)
Schem e 2.3.6. Preparation of benzyl capro 241 and oenantholactim ethers 242 using 
benzyl trichloroacetimidate methodology.
2.3.4. Preparation of benzyl capro and oenantholactim ethers 241 and 
242 using a transesterification approach with benzyl alcohol
Since the use of benzyl trichloroacetimidate 4 had proven unsatisfactory in providing 
good yields of benzyl lactim ethers 241 and 242, attention turned to the synthesis of 
benzyl lactim ethers 241 and 242 through transesterification of the methoxy unit of the 
corresponding methyl lactim ethers 16 and 237 using benzyl alcohol. Reports in the 
literature suggested that facile removal of methanol from the reaction mixture via 
distillation would afford the desired benzyl lactim ethers 241 and 242 in good yield.41, 
43,44 However, this method failed to produce the benzyl lactim ethers 241 and 242 in a 
reliable or reproducible yield which was ultimately ascribed to the lactim ether product 
being lost through distillation on account of the low yields of crude material reaction 
product recovered.
It was speculated that displacing the equilibrium of the transesterification reaction 
through addition of a large excess of benzyl alcohol (30 equivalents) should afford 
benzyl capro and oenantholactim ether 241 and 242 in increased yield under mild 
conditions. W hilst lH  NMR spectroscopic analysis of the crude reaction product 
showed that this method was successful in providing 241 and 242 in good conversion,
NH
4 , TMSOTf, DCM, 0°C
n = 1 , 1 0  
n = 2, 243
n = 1,241 
n = 2, 242
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major problems were encountered during purification due to the large excess of benzyl 
alcohol used for the reaction, and whilst a pure sample of 241 and 242 could be 
obtained in poor yield through rigorous column chromatography this tedious approach 
was abandoned as impractical. (Scheme 2.3.7.)
n = 1,16





n = 1, 241 
n = 2. 242
Schem e 2.3.7. Transesterification of capro and oenantholactim ethers 16 and 237 with 
benzyl alcohol to afford 241 and 242.
Previous reports had suggested that use of an alkoxide would result in a more efficient 
transesterification reaction.1 It was found that when sodium benzoxide was employed 
as a nucleophile the rate of the transesterification reaction was retarded and the yield of 
benzyl lactim ethers 241 and 243 were found to be inferior to those achieved under 
neutral conditions. However, the use of acidic conditions to catalyse the 
transesterification reaction resulted in a higher yield of the desired benzyl lactim ether 
in good yield. Therefore, treatment of methyl lactim ethers 16 and 243 with benzyl 
alcohol in toluene in the presence of 1.3 equivalents of TFA and 5A molecular sieves 




BnOH, 10 mol% NaH, toluene, 
5A molecular sieves, 16 hours 
-------------- X----------------
OMe
n = 1 ,16 
n = 2, 237
BnOH,10 mol% TFA, toluene, 
5A molecular sieves, 16 hours
OBn
Yield = 67%, (n = 1,241) 
Yield = 53%, (n = 2, 242)
Schem e 2.3.8. Transesterification of caprolactim ethers 16 under basic and acidic 
conditions.
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2.3.5. Hydrogenation of benzyl lactim ethers
W ith benzyl lactim ethers 241 and 242 in hand, it was next demonstrated that they 
could be directly deprotected to their parent lactams via hydrogenation. As expected, 
treatment of benzyl lactim ethers 241 or 242 with catalytic levels (5 mol%) of 
palladium dihydroxide under one atmosphere of hydrogen in ethyl acetate resulted in 
clean O-debenzylation to afford their parent lactams 10 and 243 in excellent 96% and 
97% yields. (Scheme 2.3.9.)
5 mol% Pd(OH)2/C, EtOAc, 1 atm. H2
n = 1 ,10  Yield = 96% (n = 1,10)
n = 2, 243 Yield = 97% (n = 2, 243)
Schem e 2.3.9. Hydrogenation of benzyl lactim ethers 241 and 242 to afford their parent 
lactams 10 and 243.
2.3.6. Attempted alkylation of the aza-enolates of benzyl capro and 
oenantholactim ethers
Repeated attempts to alkylate the aza-enolates of benzyl lactim ethers 241 and 242 
using conditions that had previously proven successful for the seven membered methyl 
caprolactim ether 16 were unsuccessful in affording any a-alkyl benzyl lactim ether 
products 244, instead affording crude reaction mixtures of several products that could 
not be separated after exhaustive chromatography. (Scheme 2.3.10.) This was 
accounted for by the increased reactivity of the benzyloxy fragment of benzyl 
caprolactim ether 241 that had been observed previously during chromatographic 
purification. Identical results were recorded for benzyl oenantholactim ether 242.
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i) 'BuLi, KO'Bu, THF, -78°C
,OBn ii) rt, 15 mins 
ii) -78°C, RBr
--------------X—
R = Allyl or benzyl
,OBn
R
n = 1, 241 
n = 2, 242
n = 1,244 
n = 2,245
Schem e 2.3.10. Attempted alkylation of the aza-enolates of benzyl lactim ethers 241 
and 242.
As a result attempts to alkylate 241 and 242 shifted to employing alternative conditions, 
including lBuLi, “BuLi, KOlBu, NaH, LHM DS, KHMDS and MeLi as well as varying 
the amount of time allowed for deprotonation at room temperature between 5 and 15 
minutes. However, in all these cases all conditions proved unsuccessful in affording the 
desired a-alkyl products 244 and 245.
Therefore, while these results clearly demonstrated that hydrogenation of benzyl lactim 
ethers provided a good route to the formation of large ring size lactams conditions I was 
unable to identify conditions that would enable their aza-enolate to be generated and 
alkylated in good yield.
2.4. Investigation into alkylation of the aza-enolate of 
butyrolactim ether 39
Having identified conditions that would enable the aza-enolates of six and seven 
membered lactim ethers to be alkylated in good yield, attention turned to five 
membered butyrolactim  ether substrates.
2.4.1. Preparation of a-alkyl butyrolactim ethers
The five m embered butyrolactim ether 39 was prepared via treatment of butyrolactam 
246 with M e30 .BF4 in dichloromethane, as described previously for the six, seven and 
eight membered lactim  ethers, in 85% yield. (Scheme 2.4.1.)
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H
Me3O.BF4, PCM t ^ N< v ^ O M e
\ ___/  Yield = 85% \ ___ /
246 39
Schem e 2.4.1. Preparation of lactim ether 39 from the parent lactam 246.
Alkylation of the aza-enolate of butyrolactim ether 39 did not proceed as expected, 
since the original conditions developed for the valerolactim series resulted in formation 
of numerous products in the *H NMR spectra of the crude reaction mixture. This 
implied that the five membered ring substrate 39 was more reactive than its six 
membered counterpart 15, since the valerolactim ether 15 had required 15 minutes at 
room temperature to be fully deprotonated, whilst the butyrolactim ether 39 was 
completely destroyed under these conditions. (Scheme 2.4.2.)
Large number of compounds
i) ‘BuLi, THF, -78°C





Schem e 2.4.2. Unsuccessful alkylation of the aza-enolate of butyrolactim ether 39.
In an attempt to reduce the number of side reactions produced in this reaction nBuLi 
was em ployed as base at -78 °C, however, once again a large number of products were 
formed, with extensive purification by column chromatography failing to afford any 
clean products. Given the number of compounds produced, and the inability to purify 
any compounds to homogeneity, it was impossible to predict if the desired a-benzyl 
butyrolactim ether 247 had been formed. At this point a large number of bases 
including LDA, LHM DS, NaH, KOlBu and MeLi were screened, all of which returned 
trace amounts of starting material 39 as well as complex mixtures of products. (Scheme 
2.4.3.)
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/ N,v ^ O M e  Base, BnBr, THF, -78°C / N<s_-O M e
\ I  -----------------------------------► Mixture of products + \ j
39 Base = "BuLi, ’BuLi, KHMDS, 39
LHMDS, NaH or LDA
Schem e 2.4.3. Unsuccessful alkylation of butyrolactim ether 39.
Consequently, attention was diverted from attempting to form the a-benzyl 
butyrolactim ether 247 to discovering the identity of some of these unknown 
compounds, in the hope that elucidation of their structure would enable an effective 
aza-Qnolate alkylation protocol to be developed. Upon repeating the reaction with 
"BuLi as base and allyl bromide as electrophile a number of products were once again 
evident in the NMR and 13C NMR spectra of the crude product. However, it became 
immediately apparent from the *H NMR spectrum that an allylated product had been 
formed in significant yield, which after exhaustive column chromatography afforded a 
single compound, in 12% isolated yield.
NMR and 13C NM R spectroscopic analysis of this unknown compound revealed a 
structure that contained both a nbutyl group and an allyl side chain, with no resonance 
corresponding to a methoxy group. Since the synthetic protocol had involved treatment 
of butyrolactim ether 39 with excess "BuLi, followed by warming to room temperature, 
recooling to -78 °C and addition of allyl bromide at -78 °C, two structures 248 and 249 
were proposed for this unknown product. (Figure 2.4.1.)
F igure 2.4.1. Two possible products arising from treatment of butyrolactim ether 39 
with “BuLi and allyl bromide.
Analysis of the COSY spectrum of the unknown compound revealed that the methine 
proton a  to the imine functionality was coupled to the methylene protons of the “butyl 
group as well as to the two vinylic methylene protons. (Figure 2.4.2.)
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H
F ig u re  2.4.2. Observed COSY coupling resonances for inline 248.
Consequently, the structure of the unknown product was assigned as 248, whose 
structural assignment was confirmed from the appearance of eleven resonances in its 
13C NM R spectrum, and a molecular ion of 166.1590 in its mass spectrum.
Formation of imine 248 therefore occurs by initial nucleophilic displacement of the 
m ethoxy unit of butyrolactim ether 39 by "BuLi, affording a cyclic imine structure 250, 
which is then deprotonated exocyclic to the imine functionality by excess “BuLi to 
afford a lithiated enamine anion 251 that then reacts with allyl bromide. It is 
noteworthy that no products arising from deprotonation at the alternative endocyclic ex­
position of imines 248 or 250 within the five membered ring occurs. This may reflect 
the difficulty involved for these ring a-protons adopting a conformation where they are 
orthogonal to the imine functionality, due to ring strain within the five membered ring. 
This contrasts with the exocyclic a-methylene protons, which can easily adopt a 
conformation where they are orthogonal to the imine functionality via free rotation of 
the butyl fragment around its C2-C4H 11 bond. (Scheme 2.4.4.)
Yield = 12%





Schem e 2.4.4. M echanism accounting for the observed exo-alkylation of imine 248.
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In order to gain more evidence for this mechanistic pathway the reaction was repeated 
in the absence of an electrophile in an attempt to isolate the intermediate cyclic imine 
250. Thus, treatment of 39 with "BuLi at -78° C in THF followed by warming to room 
temperature for 15 minutes before recooling to -78 °C, and quenching by addition of 
water afforded 250 as a crude product in approximately 21% yield after column 
chromatography.73 (Scheme 2.4.5.)
Schem e 2.4.5. Preparation of butyl imine 250 through nucleophilic substitution of the 
methoxy group of butyrolactim ether 39.
2.4.2. Mechanism of aza-enolate formation versus imine formation for 
lactim ethers
Therefore, it appears from these studies that butryolactim ether 39 cannot be readily 
deprotonated to afford its corresponding aza-enolate intermediate, with the competing 
nucleophilic displacement reaction occurring in preference. This result obviously 
contrasts with the observed results for the six and seven membered analogues, whose 
aza-enolates are readily generated at room temperature and alkylated at their a  position 
with no evidence of any imine species having been formed. It was proposed that these 
contrasting results might be explained by considering the mechanism and 
stereoelectronic requirements of <2za-enolate formation.
It is proposed that in order to understand the conditions required for the formation of 
the flzfl-enolate intermediate the orbital alignment of the a-hydrogen atoms of the 
lactim ether relative to its imidic n orbitals must be considered. In order for 
deprotonation to occur the a-C-H  a  orbital must be aligned in a coplanar fashion with 
the n orbitals of the imidic bond thus enabling transfer of electron density through the 
7t-system onto the nitrogen atom of the resultant <zz<z-enolate. (Scheme 2.4.6.)
i) nBuLi, THF, -78°C
ii) rt, 15 mins
iii) -78°C, H20
39 250
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H H
Schem e 2.4.6. Proposed essential orbital alignment of a lactim ether during 
deprotonation.
It is possible that for six and seven membered lactim ethers 15 and 16 that there is 
sufficient conformational flexibility within the ring system for this orbital alignment to 
occur, whilst in the case of the five membered lactim ether 39 the ring structure is 
comparatively rigid and unable to readily achieve the desired orbital overlap. (Scheme 
2.4.7.)
n = 1,15 39
n = 2 , 16
Schem e 2.4.7. Orbital alignments of valerolactim ether 15 compared with butyrolactim 
ether 39.
Furthermore it is proposed that the coordinative interactions between the base and the 
lactim ether prior to deprotonation must also be considered. Lactim ethers contain two 
centres of Lewis basicity, the imidic nitrogen atom and the oxygen atom of the alkyloxy 
unit, both of which are available for coordination to the lithium counterion of the alkyl 
lithium base. Coordination of the alkyl lithium to the oxygen atom of the alkyloxy 
moiety would result in conformationally flexible complexes for both five and six 
membered lactim ethers which would lead to the same reaction products for both 
substrates. Since this was not observed it was reasoned that any coordination of the 
base to the lactim ether substrates was occurring through their imidic nitrogen atoms. 
(Scheme 2.4.8.)







Schem e 2.4.8. Coordination of organolithium species to the alkoxy units of butyro 39 
and valerolactim ethers 15, leading to aza-enolate formation.
It was speculated therefore, that for valerolactim ether 15 coordination of the lithium 
counterion to the nitrogen atom of the lactim ether occurs followed by formation of a 
secondary complex involving coordination of a second equivalent of organolithium 
reagent. This would afford an assembly that would be capable of bridging to the ex- 
protons of the lactim ether substrate, thus enabling deprotonation of the substrate to 
occur. (Scheme 2.4.9.)
Schem e 2.4.9. Coordination of two equivalents of BuLi to valerolactim ether 15 to 
effect deprotonation and afford the az<z-enolate.
For the case of butyrolactim ether 39 a similar N-coordination pathway for the nBuLi 
could occur, however the five membered ring structure is sufficiently rigid, and the 
bond angles sufficiently acute, to prevent deprotonation from occurring. Therefore the 
inability of two alkyl lithiums to bridge to the a-protons of butyrolactim ether 39 results
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Schem e 2.4.10. ^/-coordination of two equivalents of “BuLi to butryolactim ether 39 
results in nucleophilic substitution to afford imine 248.
It should be noted that Seebach et al. have reported that the az<z-enolate of a highly
1functionalised five membered lactim ether 252 could be alkylated in high d.e. 
However, in this case the proposed mechanism for deprotonation is likely to involve 
coordination of the organolithium base to the oxygen atom of the carbamate protecting 
group which would serve to facilitate deprotonation. (Scheme 2.4.11.)
Yield = 40-90%
Schem e 2.4.11. Seebach’s deprotonation of a complex butyrolactim ether substrate and 
subsequent alkylation.
Indeed, comparison o f the conditions required to deprotonate valerolactim ether 15 with 
those required to generate the aza-enolate of Schollkopf’s 6 /s-lactim ether 203 illustrate 
the importance of lithium coordination in these reactions, Therefore, formation of the 
aza-enolate o f valerolactim ether 15 requires the use of lBuLi at room temperature for 
15 minutes whilst deprotonation of the bis-lactim ether 203 occurs in 5 minutes with 
“B u li  at -78 °C .117 (Scheme 2.4.12.)
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Schem e 2.4.12. Formation of the aza-enolates of Schollkopf’s fo’s-lactim ether 203 and 
valerolactim ether 15 under widely different reaction conditions.
W hilst the pKz of bis-lactim ether 203 is considerably lower than the pA'a of 
valerolactim ether 15, both nBuLi and *BuLi are extremely strong bases that can readily 
deprotonate both substrates. Therefore, it is likely that the increased reactivity of bis- 
lactim ether 203 is a consequence of the ability of the lone pair of electrons of the 
nitrogen atom that is proximal to the methylene group being able to coordinate to the 
lithium counterion of nBuLi, and thus facilitate deprotonation at its ortho position. 
(Scheme 2.4.13.)
Schem e 2.4.13. N-coordination of nBuLi to Schollkopf’s bis-lactim ether 203 results in 
rapid deprotonation to afford an aza-enolate 204.
Therefore in conclusion, conditions have been established that enable well behaved, 
highly nucleophilic aza-enolate of six and seven membered lactim ethers to be 
generated, which react with electrophiles to afford a-alkyl lactim ethers in good yield. 
The corresponding aza-e,nolate alkylation reactions of five membered lactim ethers 
were unsuccessful, instead affording products arising from nucleophilic attack of the 
alkyl lithium species employed as base.
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2.5. Preparation of a range of a-alkyl amino esters 
hydrochloride salts
With a range of a-alkyl lactim ethers 217, 224-229 in hand, the next step was to 
identify conditions that would enable clean hydrolysis of the a-alkyl lactim ethers to 
their corresponding a-alkyl co-amino esters.
2.5.1. Hydrolysis of a-alkyl valerolactim ethers
a-methyl valerolactim ether 224 was initially selected as a model compound to optimise 
conditions for this type of hydrolysis reaction as it exhibited a diagnostic doublet 
resonance for its methyl group in its !H NM R spectrum at 6 1.07. (Scheme 2.5.1.) 
Hydrolysis of the lactim ether functionality has been reported to be a facile process that 
proceeds under very mild conditions,24,48‘50 however, it was found that treatment of a- 
methyl lactim ether 224 with 0 .1M HCl(aq) failed to afford the desired amino ester salt 
253 in a good yield. It was proposed that lactim ether 224 was only sparingly soluble in 
aqueous solution and as a result it was decided to employ an organic co-solvent in the 
hydrolysis reactions. Initial efforts concentrated on commonly used water miscible 
organic solvents to increase the solubility of the lactim ether in the aqueous media, 
however all these homogenous mixed solvent systems failed to afford quantitative 
conversion to the desired co-amino ester. Remarkably however, it was found that the use 
of CHCI3 as an immiscible cosolvent with 0.1M HCl(aq) was successful in affording the 
desired co-amino ester 253 in excellent yield.
0.1 M HCI, cosolvent
224 224 253 254
Scheme 2.5.1 Hydrolysis of a-methyl valerolactim ether 224.
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Entry Co-solvent % yield of 
lactim ether
% yield of 
amino ester
% yield of amide
1 None 34 60 6
2 THF 60 27 13
3 M eCN 86 12 <5
4 Acetone <5 30 69
5 M eN 0 2 92 8 0
6 M eOH 94 5 <5
7 CHCI3 0 >95 0
T able 2.5.1.
Therefore, a simple hydrolytic protocol was developed in which the lactim ether 224 
was dissolved in CHCI3 before addition of 0.1M  HCl(aq) and the reaction mixture 
allowed to stir vigorously overnight, before the solvents were removed in vacuo to 
afford the amino ester hydrochloride salt in 92% yield. W hilst resolution problems were 
encountered when the NMR spectrum of 253 was run in CDCI3 it was found that 
employing ^ -m ethano l as solvent resulted in a clean well resolved lH  NMR. The !H 
NMR spectrum of 253 revealed a doublet at 5 1.07 (7 7.0 Hz), and a new methyl ester 
singlet at 8 3.56, whilst the 13C NMR spectrum showed seven peaks, including a 
resonance at 178.6 ppm corresponding to an ester carbonyl, as well as the expected 
molecular ion of 146.1172 in its mass spectrum. Interestingly, IR data of 253 revealed 
an absorption at 1643 cm*1 in a region more normally associated with an amide bond, 
which may have resulted from the amino ester spontaneously cyclising on the KBr disc 
when the solvent was removed.
2.5.2 Preparation of a range of a-alkyl co-amino ester hydrochloride 
salts
These optimised cleavage conditions were then applied to the hydrolysis of the 
remaining mono substituted lactim ethers 217, 225-229, which cleanly afforded their 
corresponding a-alkyl co-amino esters 253-259 in good yield as their hydrochloride 
salts. (Scheme 2.5.2.) It was found that the stability of the a-alkyl lactim ethers
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increased as the bulk and lipophilicity of the a-alkyl group increased, proving most 
problematic for the 'butyl 258 and 'propyl lactim ether 259, which required 0.3M  HC1 
solution for complete hydrolysis to occur.
.N . .OMe 
S  Y  0.1MHCI,CHCI3
217, 224-229
Yield = 81-97% MeO' NH2 HCI
253-259
R = Benzyl, allyl, propargyl, ethyl, 'butyl and 'propyl
Schem e 2.5.2. Hydrolysis of a-alkyl valerolactim ethers 217, 224-229.
Entry Alkyl group % yield 5h a-H 8h -C //2NH2.HC1 C 0 2Me
1 Me 92 2.41 2.80 3.56
2 Bn 95 2.7 2.58-2.87 3.48
3 Allyl 90 2.47-2.58 2.93 3.67
4 Propargyl 97 2.52 2.81 3.60
5 Ethyl 81 2.19-2.33 2.83 3.60
6 ‘Butyl 91 2.41 2.76-2.85 3.59
7 'Propyl4 Quantitative 2.47-2.56 3.18-3.39 3.81
T ab le  2.6.2.
All compounds were isolated and characterised demonstrating physical and 
spectroscopic data consistent with the formation of the a-alkyl co-amino methyl ester 
hydrochloride salts.( Figure 2.5.1.)
4 Run in D 20  as an NMR experiment





Figure 2.5.1. The range of a-alkyl co-amino ester hydrochloride produced.
It was found that a-benzyl and a-allyl caprolactim ethers also readily underwent 
hydrolysis under these conditions to afford the corresponding a-alkyl co-amino esters in 
89 and 87% yields respectively. Neutralisation afforded the free amino esters, which 
were fully characterised and demonstrated spectroscopic and physical data consistent 




Figure 2.5.2. The a-alkyl co-amino ester hydrochlorides produced from the 
corresponding a-alkyl capro lactim ethers.
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2.5.3. Direct formation of a,a-alkyl valerolactams
Attempted hydrolysis of the a ,a-d i‘butyl valerolactim ether 230 under these conditions 
did not result in formation of the expected a-alkyl co-amino ester 260, but instead 
resulted in clean formation of the corresponding a,a-dialkyl valerolactam 261 in 
quantitative yield. (Scheme 2.5.3.)
.OMe0.1MHCI, CHCI3
MeO' Yield = 97%
260
230 261
Schem e 2.5.3. Direct conversion of o^a-dfbutyl valerolactim ether 230 to a ,a-d i‘butyl 
valerolactam 261 under acidic conditions.
The direct formation of lactam 261 under these conditions was remarkable since co­
amino ester hydrochloride salts normally require neutralisation to its free amine before 
cyclisation can occur. It was therefore proposed that formation of 261 had occurred via 
a different mechanism, involving protonation of the imine functionality of lactim ether 
230, followed by nucleophilic attack of water at the methyl group of the methoxy 
group. This pathway would be favoured by the presence of the tertiary a-carbon of 230 
which would sterically block nucleophilic attack of the incipient water nucleophile at 




Schem e 2.5.4. M echanism for the formation of a ,a-d i‘butyl valerolactam 261 from 
parent lactim ether 230.
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Indeed, it is likely that the a-alkyl lactams by-products observed previously during 
optimisation of the hydrolysis reactions of a-methyl valerolactim ether 224 were 
probably formed via this nucleophilic cleavage pathway. (Scheme 2.5.1. and Table
2.5.1.)
2.5.4. Preparation of a-alkyl valerolactams
Attention then turned to identifying conditions that would enable facile cyclisation of 
the a-alkyl co-amino esters to afford their corresponding a-alkyl valerolactams. 
Attempts to cyclise the hydrochloride salt of a-methyl co-amino ester 253 via treatment 
with a methanolic suspension of sodium hydrogencarbonate were unsuccessful. 
However, repeating this transformation using sodium hydrogencarbonate in a mixed 
solvent of methanol and water (85:15) afforded a quantitative yield of the desired a- 
methyl lactam 262. Applying these conditions to the other co-amino esters 254-259 also 






R = Benzyl, allyl, propargyl, ethyl, 'butyl and 'propyl
Schem e 2.5.5. Preparation of a-alkyl valerolactams 262-268 from the corresponding 
amino ester hydrochloride salt 253-260.
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Entry Alkyl group 8h cl-H 5h Ctf2NH Vmax(C=0) % yield
1 Methyl 2.27 3.19 1665 94
2 Benzyl 2.48 3.17-3.25 1642 95
3 Allyl 2.35 3.20-3.26 1661 98
4 Ethyl 2.33-2.43 3.23-3.29 1670 92
5 Propargyl 2.04-2.16 3.11-3.19 1658 92
6 'Butyl 2.13-2.26 3.13-3.22 1636 93
7 'Propyl 2.30 3.03-3.19 1632 94
Table 2.5.3.
Therefore, conditions have been established that enable a-alkyl lactims to be 
hydrolysed to their corresponding a-alkyl co-amino esters, and subsequently cyclised to 
the a-alkyl lactams in good overall yield.
Figure 2.5.3. The range of a-alkyl valerolactams 262-268 produced
2.6. Summary
This chapter has described detailed investigations into the alkylation of aza-enolates of 
butyro, valero, capro and oenantholactim ethers. It was found that aza-enolates of 
valero and caprolactim ethers readily undergo alkylation with a wide range of 
electrophiles to afford a range of a-alkyl compounds in good yield. Limitations of this 
methodology were discovered using five and eight membered lactim ethers as 
substrates, since competing nucleophilic substitution of the alkyloxy substituent occurs 
to afford the corresponding imine. a-alkyl lactim ethers could be hydrolysed under mild
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conditions to afford the corresponding a-alkyl co-amino esters, which in turn could be 
cyclised to afford a-alkyl lactams in excellent yield.
W hile this approach represents an excellent synthetic route to this class of a-alkyl co­
amino esters and a-alkyl lactams, most biologically active compounds are required in 
enantiopure form, thus expansion of the methodology to include the formation of 
enantiopure lactim ethers represents a desirable arena of research. I was therefore 
interested in applying this methodology to the preparation of a-alkyl co-amino esters 
and a-alkyl lactams in enantiopure form, and my attempts to realise the goal using with 




Asymmetric alkylation strategies for the 
alkylation of aza-enolates of lactim
ethers
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Chapter 3. Asymmetric alkylation of aza-enolates of lactim 
ethers 
3.1. Introduction
The preceding chapter described the development of novel methodology for the 
synthesis of a-alkyl co-amino acids and a-alkyl lactams through the alkylation of the 
aza-enolate of the corresponding lactim ether. All of the target compounds described 
contain single stereogenic centres and were prepared in racemic form. However, there 
is an increasing demand for the synthesis of enantiopure compounds for incorporation 
into libraries of drug like molecules, and as a consequence attention turned towards the 
development of an asymmetric variant of the previously described <zz<z-enolate 
methodology.
3.1.1. A chiral auxiliary approach
Initial attempts were directed towards the development of a three step chiral auxiliary 
strategy approach for the asymmetric synthesis of enantiomerically pure lactim ethers, 
according to the protocol described in Scheme 3.1.1. The strategy proposed would 
involve the following three step protocol:
• Introduction of the chiral auxiliary fragment into the lactim ether skeleton via a 
transesterification reaction
• Formation of the aza-enolate of the chiral lactim ether, with subsequent 
asymmetric alkylation to ideally afford a diastereomerically pure a-alkyl lactim 
ether
• Removal of the chiral auxiliary fragment via transesterification with a simple 
alcohol to afford enantiomerically pure lactim ethers capable of further 
transformation to enantiopure a-alkyl co-amino esters, or a-alkyl lactams.
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aN -OMe 7rans-esterification+ x -O H MeOH
Recyclisation Alkylation
+ M e-O H
7rans-esterification
Schem e 3.1.1. Overview of the proposed chiral auxiliary strategy for the formation of 
enantiopure a-alkyl lactim ethers.
3.1.2. Synthesis of enantiopure a-alkyl valerolactim ethers
This chapter of the thesis describes attempts to develop methodology for the 
asymmetric synthesis of enantiomerically pure lactim ethers that can be easily 
converted into enantiopure a-alkyl lactams or a-alkyl co-amino esters. Consequently a 
brief discussion of the current strategies used for the production of this type of 
enantiopure compounds now ensues.
3.1.3. Biological relevance of enantiopure a-alkyl lactams and a-alkyl 
co-amino esters
In recent years many groups have become interested in the pharmacological properties 
of long chain amino acids and lactams.110,134 Various reports have demonstrated their 
use as potential pharmacophores for drug discovery, or as peptide mimics capable of 
affording tertiary structures that are more stable than those found in conventional 
peptides derived from a-am ino acids.
For example, 4-aminobutanoic acid 269 is an inhibitory neurotransmitter in the
mammalian nervous system, associated with several neurological disorders such as
Parkinson’s disease, whilst epilepsy has been implicated with its deficiency. As a
consequence several enantiopure analogues of 269 have been synthesised that
1«
demonstrate a broad spectrum of pharmaceutical activity. (Figure 3.1.1.)




R = H or Me
O O O
HO
F igure  3.1.1. 4-aminobutanoic acid 269 and some related analogues.
In 2003 Seebach et al. reported the synthesis of a dipeptide derived from two y-amino 
acids 270 as a model for pLE’ turns of an a-peptide as part of research into the affinities
showed that the secondary N -methyl amide forms a stable hydrogen bond with the 
napthylamide carbonyl group, thus affording a stable fourteen membered secondary 
ring structure. (Figure 3.1.2.)
F igure  3.1.2. Seebach’s peptide mimetic 270 comprised from two y-amino acids, and 
the secondary structure proposed to form in solution.
Enantiopure a-alkyl lactams have also been shown to exhibit biological activity. For
1 ^ 6example, in 1999 Dragovich prepared a protease 3C inhibitor 271, containing an a- 
alkyl valerolactam, as a potential therapy for rhinoviruses which are members of the 
picomavirus family that are the most significant cause of the common cold. (Figure
3.1.3.)
of long chain amino acid peptides for human somatostatin receptors hssti.110 The author
n r 2r 3
NHMe
RJ = H or Bn 
R4 = H or Me
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Figure 3.1.3. Rhinovirus 3C inhibitor 271.
Therefore, it is clear that there is much current demand for efficient protocols for the 
asymmetric synthesis of both class of compound.
3.1.4. Current methodologies for the production of enantiopure a-alkyl 
lactams and a-alkyl ca-amino esters
Both a-alkyl co-amino esters and a-alkyl lactams are important synthetic units and as 
such several approaches have been developed for their asymmetric synthesis. The most 
commonly used methods involve preformation of the stereogenic centre before ring 
closure to afford the desired lactam, alkylation of a lactam in the presence of a chiral 
auxiliary, or asymmetric hydrogenation of an existing lactam containing an a,p- 












Scheme 3.1.2. Current methodology for the production of enantiopure a-alkyl lactams.
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For example in 2001 Seebach et al. employed a chiral auxiliary approach for the 
synthesis of a series of a,p-dialkyl butyrolactams 272, and their corresponding 5-amino 
acids 273.137 They prepared the amino ester core through Michael addition of the 
titanium enolate of an enantiopure /V-acyl-oxazolidinone 274 to an a,p-unsaturated nitro 
acceptor 275, before reducing the nitro group to an amine that then underwent 
intramolecular cyclisation with concomitant removal of the auxiliary. Treatment of the 
resultant a-alkyl lactams 272 with lithium hydroxide allowed formation of the 
corresponding co-amino acids 273, containing two stereocentres in high d.e. (Scheme
3.1.3.)
P o
II j j  1 II M 7
275 , TiCI4, NEt2 Pr





R1 = H, Me, ‘Pr or *Bu
R2 = H, Me, !Pr, 'Bu, Ph or N-Methyl-1 R-indol-3-yl
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Scheme 3.1.3. Preparation of diastereomerically pure a,p~dialkyl butyrolactams 272 
through an asymmetric conjugate addition strategy.
Enders et al. reported an enantioselective synthesis of a-alkyl butyro, valero and
138caprolactams via alkylation of the enolates of chiral N-dialkylamino lactams. The 
group prepared a series of W-amino lactams 276 from their corresponding co- 
chloroalkanohydrazides 277, which were reacted with ID A  to afford the desired 
enolates that were alkylated with a range of electrophiles in high d.e. Subsequent 
reductive cleavage of the N-N  bond of 278 using lithium in liquid ammonia afforded a 
range of lactams in good overall yields (20-61%, over 3 steps), and moderate to good 
e.e (75-96%). (Scheme 3.1.4.)
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i) 2M HCI, reflux
ii) Dowex, 50 WX8
Overall yield = 20-61%
d.e. = 75-96%
OTBDMS
R = Me, Et, Pr, Bu, Bn, 3,4,5-tri-OMe-Bn or 2,4-di-CI-Bn 
n = 1, 2 or 3
Schem e 3.1.4. Production of enantiopure a-alkyl lactams using a chiral hydrazine 
auxiliary 276.
Asymmetric hydrogenation of a,P-exo-unsaturated lactams represents a facile route to 
enantiopure a-alkyl lactams, that Yue et al. have employed this approach for the 
preparation of a series of 3-benzylpiperidin-2-ones.139 The group formed the desired 3- 
alkylidene lactam substrates 279 through aldol reaction of the potassium enolate of N- 
trifiuroacetate protected valerolactam 280 with the corresponding aldehyde, followed 
by in situ dehydration of the aldol product 281. Optimisation studies revealed that 
asymmetric hydrogenation using 2,4-6w(diphenylphosphino)pentane (BDPP) as a 
chiral ligand for [(COD)2Ir].BF4 (see entry 1 table 3.1.1.) delivered the desired a-alkyl 
lactams in high yield and e.e. (Scheme 3.1.5.)
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X = p-F, p-CF3, p-anisyl, 2-furanyl, 3-furnayl and nPr
Catalyst
Schem e 3.1.5. Production of a-alkyl valerolactams through a catalytic asymmetric 
hydrogenation strategy.
Entry M etal precursor Diphosphine Conversion % e.e.
ligand
1 [(COD)2Ir].BF4 BDPP 100 91
2 (COD)Ru(M eAl)2.2HBr BICP 30 85
3 (COD)Ru(M eAl)2.2HBr Fe-PPh3-PBu2 100 70
4 (COD)Ru(MeAl) + BF3/HBF4 M e-Pennphos 100 70
5 [(COD)2Rh].BF4 BDPP 100 69
6 [(COD)2Ir].BF4 DIOP 85 66
T able 3.1.1.
3.1.5. Precedent for asymmetric alkylations of aza-enolate of imino 
ethers using chiral auxiliaries for stereocontrol
As described, chiral auxiliaries have been employed previously for asymmetric aza-
1 onenolate alkylation reactions of imino ethers. In 1984 Bergbreiter et al. synthesised a 
series of chiral A-a-methoxybenzyl imino ethers 270a-f as substrates for asymmetric 
aza-enolate alkylation reactions. The group found that deprotonation of these imino 
ethers in TH F at -78 °C afforded intramolecularly chelated aza-enolates, which when
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treated with electrophiles afforded a-alkyl imino ethers 208-213 in moderate to good 
d.e. (60-98%). (Scheme 3.1.6.)
Schem e 3.1.6. Asymmetric alkylation of a range of imino ethers.
Furthermore, they demonstrated that intramolecular chelation of the methoxy group of 
the chiral auxiliary in the lithium aza-enolate played a large role in the efficient relay of 
stereochemical information. They synthesised a non-chelating analogue 282 via 
substitution of the methoxy fragment of 283 for a methyl group, which upon treatment 
with lithium diethylamide in THF at -78 °C afforded the a-alkyl imino ether product 
284 as a mixture of two diastereomers in only 66% d.e. compared to the much 
increased 90% d.e recorded for the methoxy containing species 285. (Scheme 3.1.7.)
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Schem e 3.1.7. Alkylation of the aza-Qnolate of chelating 282 and non-chelating 283 
imino ethers with loss of diastereomeric control for the non-chelating analogue.
3.1.6. Alkylation of Schollkopf’s bis-lactim ether chiral auxiliaries
Many reports have appeared in the literature detailing the asymmetric alkylation of bis- 
lactim ethers since Schollkopf et al. first demonstrated their use for the synthesis of 
enantiopure a-am ino esters in 1981.119 Zh’s-lactim ether chiral auxiliary 203 are formed 
from the corresponding naturally occurring L-valine from the corresponding 
diketopiperazine 23, which in turn was formed in two steps from the Leuch’s anhydride 
of L-valine 287. They showed that treatment of the bis-lactim ether auxiliary 203 with 
nBuLi in THF at -78 °C, afforded the corresponding aza-enolate 204 which reacted with 
an electrophile to afford the rrans-alkylated auxiliary 205 in high yield (>90%) and d.e. 
(>95%). Facile hydrolysis of 205 under aqueous acidic conditions then afforded the 
enantiopure a-alkyl a-am ino ester 206 in good yield. (Scheme 3.1.8.)
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Schem e 3.1.8. Overview of the 6/s-lactim ether chiral auxiliary methodology developed 
by Schollkopf.
Bergbreiter and Schollkopf’s work clearly demonstrates good precedent for the use of 
chiral auxiliaries for the enantioselective formation of chiral a-alkyl lactim ethers. 
However, to date, there remain no reported examples of asymmetric synthesis using 
simple lactim ether substrates that employ a readily removable chiral auxiliary. 
Consequently, it was decided to attempt to develop efficient methodology that would 
enable chiral auxiliaries to be used for stereocontrol in the alkylation of <zza-enolates of 
simple lactim ethers.
3.1.7. New approach to the synthesis of enantiomerically enriched a- 
alkyl lactim ethers
In chapter 2 of this thesis it has been shown that aza-cnolates of valero and caprolactim 
ethers may be a-alkylated in good yield. Consequently a new route to the synthesis of 
enantiomerically enriched a-alkyl lactams was proposed in which the lability of the 
lactim ether alkyloxy bond could be exploited to introduce and remove a chiral 
auxiliary fragment via a transesterification strategy. Deprotonation of the resultant 
chiral lactim ether would result in an aza-enolate which would react with electrophiles
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under the control of the chiral auxiliary fragment to generate enantiopure a-alkyl lactim 
ether, ideally as a single diastereomer. Subsequent removal of the chiral auxiliary 
fragment via a transesterification with methanol, followed by hydrolysis would then 
afford the desired a-alkyl co-amino ester or a-alkyl lactams in good yield. (Scheme 
3.1.9.)
OOMe .(XTrans-esterification f  ^  Alkylation C C
Trans-esterification
H n
a O „ .... I? , . .N. .OMeNeutralisation II Hydrolysis f ---------  HC,H2N ^ ^ ^ O M e - -------  ^  'rl  d  n
Schem e 3.1.9. Alkylation of chiral lactim ethers and further conversion into a-alkyl co­
amino esters or a-alkyl lactams.
Since this approach relies on the use of a chiral auxiliary for stereocontrol a brief 
discussion of the factors that were considered in choosing suitable chiral auxiliary for 
asymmetric synthesis now follows.
3.1.8. Review of the use of chiral auxiliaries
Chiral auxiliaries represent a facile method for the introduction of new stereocentres 
into a prochiral molecule. There are many examples where chiral auxiliaries have been 
used for asymmetric synthesis, however they normally operate in a similar manner. The 
chiral auxiliary is first attached to a prochiral substrate to generate an enantiopure 
compound which is then functionalised under the control of the chiral auxiliary to 
afford a new product containing one or more new stereocentres in high d.e. Purification 
of this mixture of diastereomers to homogeneity, followed by cleavage of the chiral 
auxiliary fragment, affords the desired product in enantiopure form and allows the 
chiral auxiliary to be recycled. (Scheme 3.1.10.)
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Schem e 3.1.10. Generic overview of the use of chiral auxiliaries for asymmetric 
synthesis.
The ideal properties of a chiral auxiliary have been well documented and they should 
ideally demonstrate the following features:
•  Inexpensive enantiopure substrates
• Commercially available
• Both enantiomers are readily available
• Facile attachment of the auxiliary to the substrate
•  Applicable to a broad variety of substrates
•  Stable under a wide range of reaction conditions
• High and predictable levels of stereoselectivity
• Simple purification of intermediates and products e.g. crystalline 
intermediates
•  Facile cleavage of the auxiliary from the derivatised substrate
• Recyclable and robust
A fter consideration of the range of commercially available chiral alcohols that were 
available as chiral auxiliary fragments for my proposed lactim ether transesterification 
strategy, it was decided to employ a cheap terpene derived alcohol for stereocontrol due 
to their ready availability from the chiral pool.
(-)-Menthol was selected as the initial auxiliary owing to its immediate availability 
within the laboratory, its fulfilment of the criteria listed above, and the fact that (-)- 
menthol has been previously employed as a chiral auxiliary to control facial selectivity 
for a wide range of asymmetric transformations. For example, in 2003 Barluenga et al.
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employed (-)-menthol as a chiral auxiliary for the diastereoselective dearomatisation 
and alkylation of substituted furans.140
Schem e 3.1.11. The employment of (-)-menthol as a chiral auxiliary in the 
diastereoselective dearomatisation of a furan.
3.2. Development of effective asymmetric aztf-enolate 
alkylation methodology
3.2.1. Preparation of (-)-menthoI lactim ether 288
A review of the literature for approaches towards the formation of lactim ethers 
revealed several methods that were available for the synthesis of a lactim ether 
containing a menthol chiral auxiliary 288. Three approaches were initially chosen for 
investigation; creation of an intermediate iminoyl halide followed by quenching with 
menthol; the use of a (-)-menthol derived trichloroacetimidate reagent; or introduction 
of (-)-menthol through a transesterification strategy. (Scheme 3.2.1.)
i) RLI, Et20 , -80°C
ii) MeOTf, -80°C to rt(CO)5Co<js ^04 (CO)5Co^,0K
T xMe















Schem e 3.2.1. Formation of (-)-menthol valerolactim ether 288 and 290 through 
formation of an iminoyl halide, trichloroacetimidate or transesterification strategy.
3.2.2. Attempted formation of a (-)-menthol derived valerolactim ether 
via an iminoyl halide intermediate
Initial attempts to synthesise chiral lactim ether 288 via an iminoyl halide intermediate
17followed the precedent of Jurczak et al. However, attempts to prepare a (-)-menthol 
lactim ether 288 via treatment of valerolactam 215 with phosgene, followed by 
alcoholysis with (-)-menthol, proved unsuccessful with quantitative return of starting 
materials. Parallel control reactions employing benzyl alcohol and methyl alcohol, as 
alternative nucleophiles, were also unsuccessful, once again returning recovered 
valerolactam 215 as the only product. (Scheme 3.2.2.)
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Schem e 3.2.2. Attempted formation of 288 through an iminoyl halide strategy.
3.2.3. Attempted preparation of terpene derived lactim ethers via 
trichloroacetimidate methodology
As described in section 1.4.5. trichloroacetimidate reagents represent a mild and 
selective reagent for the preparation of lactim ethers. Furthermore, they are relatively 
easy to prepare through treatment of the desired alcohol with trichloroacetonitrile in a 
base catalysed Pinner synthesis. No examples of chiral variants of this methodology 
exist however, despite the synthetic opportunities that this transformation might offer. 
(Scheme 3.2.3.)
NH
‘OH CI3C - = N  Base CCI3
NH
TMSOTf, R O ^ C C I3 ' N^  ' ° RCT
215
Schem e 3.2.3. Attempted formation and employment of trichloroacetimidates for the 
synthesis of lactim ethers.
It was proposed that the use of (-)-menthol as a nucleophile in the base catalysed Pinner 
synthesis would afford (-)-menthol trichloroacetimidate 289, which could then act as a 
suitable O-alkylating source for the formation of (-)-menthol valerolactim ether 290 
from valerolactam 215. It should be noted that reaction of (-)-menthol 
trichloroacetimidate 289 with a valerolactam 215 in this manner would result in 
inversion of the stereogenic centre of the resultant chiral lactim ether 290, via an Sn2 
type process. (Scheme 3.2.3.)







Schem e 3.2.3. Formation of menthol derived valerolactim ether 290 through the use of 
(-)-menthol trichloroacetimidate 289.
Unfortunately attempts at preparing the required (-)-menthol trichloroacetimidate 289 
were unsuccessful, returning only unreacted (-)-menthol. This was a most unexpected 
result given the success enjoyed previously in the preparation of benzyl 
trichloroacetimidate 4 which had proceeded readily in high purity and yield, and may 
reflect the increased steric demand of (-)-menthol as a nucleophile.
3.2.4. Preparation of terpene derived lactim ethers via 
transesterification
Given the lack of success in the synthesis of the desired chiral lactim ether from 
valerolactam 215, attention then shifted towards an alternative approach, involving 
transesterification of valerolactim ether 15 with (-)-menthol. It was found that stirring 
valerolactim ether 15, (-)-menthol and 1.3 equivalents of TFA in toluene for 16 hours in 
the presence of 5A molecular sieves resulted in formation of the desired (-)-menthol 
lactim ether product 288 in approximately 60% conversion. Purification of the crude 
reaction product by column chromatography afforded the (-)-menthol derived lactim 
ether product 288 as a white crystalline solid. (Scheme 3.2.4.)
, TFA, PhMe, 5A molecular sieves
Schem e 3.2.4. Transesterification of valerolactim ether 15 with (-)-menthol.
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Examination of 'H  NMR spectrum of (-)-menthol valerolactim ether 288 revealed 
diagnostic resonances for the CHO position of the terpene fragment at 5 4.61 (td, J  10.9 
and 4.3 Hz), and the 8 methylene protons a to the imidic nitrogen at 8 3.90 (app. ttt, J
7.1, 5.7 and 1.1 Hz). Few other *H NMR resonances could be assigned unequivocally 
due to the overlapping nature of the large number of methylene ring protons in this 
molecule. Analysis of the 13C NMR spectrum was more forthcoming revealing 15 
resonances, whilst the infra red spectrum revealed an absorption at 1694 cm '1. GC mass 
spectroscopy did not reveal the expected parent ion of 237, however fragmentation of 
the parent ion could be readily observed, involving loss of a methyl group at 222, loss 
of an ‘propyl group at 194, and loss of a (-)-menthol fragment at 100. Accurate mass 
spectroscopy revealed a parent ion of 238.2168.
Chiral lactim ether 288 was found to be crystalline and was submitted for crystal X-ray 
analysis, which served to confirm its structure. Thus, the crystal structure revealed that 
the two ring systems lie orthogonal to each other, with the (-)-menthol cyclohexane ring 
demonstrating a well defined chair conformation, with the sterically demanding ‘propyl, 
lactim ether and methyl substituents, all adopting equatorial positions. The lactim ether 
ring adopts an open book conformation due to the presence of the sp2 carbon and 
nitrogen atoms of the imidic bond with little evidence of any steric interactions between 
the terpene and lactim ether ring systems. (Figure 3.2.1.)
F igure 3.2.1. X-ray crystal structure of (-)-menthol valerolactim ether 288.
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3.2.5. Preparation of a-allyl menthol lactim ether 291c and 292c
Allyl bromide was selected as a model electrophile for the aza-enolate alkylation 
studies on (-)-menthol lactim ether 288 due to its excellent reactivity and the fact that 
the resultant a-allyl (-)-menthol lactim ether product 291c/292c would display 
diagnostic resonances in its *H NMR spectrum at 8 4.5-6.0. Initial attempts employed 
conditions that had previously been shown to be successful for alkylation of the aza- 
enolate of the simple methyl lactim ether analogue. Unfortunately, addition of 1.5 
equivalents of lBuLi to 288 in THF at -78 °C, followed by warming to room 
temperature for 15 minutes before recooling to -78 °C and addition of allyl bromide 
resulted in recovered starting material with no a-alkyl product 291c/292c being formed. 
(Scheme 3.2.5.)
i) ‘BuLi, THF, -78°C
ii) 15 min. rt
iii) -78°C, allyl Br 
 X---------■
291c/292c
Schem e 3.2.5. Attempted alkylation of the aza-enolate of (-)-menthol lactim ether 288.
Having resolved previous problems with sluggish aza-enolate alkylation reaction of 
lactim ethers using Schlosser’s base system (lBuLi and KC^Bu in THF at -78 °C), these 
conditions were also employed however, once again they returned only starting 
material 288. (Scheme 3.2.6.)
291 c/292c
Schem e 3.2.6. Attempted alkylation of the aza-enolate of 288 using Schlosser’s base 
conditions.
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Partial success was observed via treatment of lactim ether 288 with 1.5 equivalents of 
lBuLi in E t20 with subsequent warming to room temperature for 15 minutes before 
recooling to -78 °C and addition of allyl bromide. This reaction afforded a crude 
reaction product possessing new allyl containing compounds 291c and 292c, as well as 
50% recovered starting material 288. Screening a range of conditions including 
increasing the concentration of reactants, varying the number of equivalents of base, 
and varying the reaction times did not drive the alkylation reaction to completion with 
40-70% recovered starting material 288 being recovered in each case. As a result an 
alternative protocol was sought that would provide superior consistency in terms of 
both yield and reproducibility. (Scheme 3.2.7.)
i) 'BuLi, Et20 , -78°C
ii) rt, 15 mins
iii) AllylBr, -78°C
Schem e 3.2.7. Partial alkylation of the aza-enolate of 288 using lBuLi as base.
It was proposed that the only difference between the (-)-menthol system and the 
original methyl lactim ether 15 appeared to be the additional steric bulk of the chiral 
auxiliary fragment, which might be retarding approach of the ‘butyl anion thus 
preventing deprotonation of the acidic a  protons. Bearing in mind this rationale, it was 
proposed that changing the base from sterically demanding ‘BuLi to “BuLi might afford 
the desired a-allyl (-)-menthol lactim ethers 291c/292c in superior yield. After a series 
of optimisation studies it was found that treatment of lactim ether 288 with 2.4 
equivalents of "BuLi in THF with subsequent warming to room temperature for one 
hour before recooling to -78 °C, followed by addition of allyl bromide, afforded a 
quantitative conversion of 288 to its diastereomeric a-allyl (-)-menthol lactim ethers 
291c/292c. (Scheme 3.2.8.)
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Scheme 3.2.8. Optimised alkylation conditions for (-)-menthol lactim ether 288 using 
"BuLi as base.
*H NMR spectroscopic analysis of the optimised reaction of the aza-enolate of (-)- 
menthol lactim ether 288 with allyl bromide appeared to show formation of two 
diastereomeric products 291c/292c in a 4:1 ratio. The *H NMR spectrum of the mixture 
of the diastereoisomers was not particularly diagnostic, however partially overlapping 
resonances of the allylic fragments of the two diastereoi somers could be observed 
centred at 5 4.90 and 5 4.82 (dm, J  10.0 Hz), 6 4.93 and 5 4.79 (dm, J  17.0 Hz) and 5 
5.62 and 5 5.51 (ddq, J  17.0, 10.0, 7.0 Hz) in a 4:1 ratio. (Figure 3.2.2.)
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm
Figure 3.2.2. !H NMR spectrum of a-allyl (-)-menthol valerolactim ethers 291c/292c.
This diastereomeric ratio was confirmed by analysis of the 13C NMR spectrum of the 
crude reaction product that revealed two sets of resonances in a 4:1 ratio, with peaks
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corresponding to virtually all of the resonances expected from a 4:1 ratio of 
diastereomers. (Figure 3.2.3.)
T TT T T T T T T
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
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Figure 3.2.3. 13C NMR spectrum of a-allyl (-)-menthol valerolactim ethers 291c/292c 
clearly showing the presence of diastereomeric resonances.
Unfortunately, all attempts to purify either of the major or minor diastereomers of the 
4:1 mixture of 291c/292c to homogeneity via exhaustive column chromatography 
proved unsuccessful. Both diastereomers exhibited identical Rf values on TLC, whilst 
no evidence of any fractionation of the 4 :1 diastereoisomeric ratio was evident from 
analysis of early or late chromatographic fractions.
Given the inseparability of the two diastereomers 291c/292c by chromatographic 
methods characterisation of their diastereomeric ratio was best achieved by the use of 
gas chromatographic mass spectroscopy. The results of this analysis revealed the 
presence of two new compounds with similar retention times and identical 
fragmentation patterns, expected for the a-allyl (-)-menthol lactim ether diastereomers 
291c/292c. Therefore, fragments corresponding to loss of a methyl group at 262, loss of 
an ‘propyl at 234, as well as the lactim ether core produced from bond fission either 
side of the alkyloxy bond at 140 and 122 were observed. Integration of the intensities of 
the gas chromatography of the baseline resolved peaks of the diastereomers enabled the
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diastereomeric excess of this aza-tnolate alkylation reaction to be confirmed as 45%
d.e.
3.2.6. Formation of a series of diastereomerically enriched a-alkyl (-)- 
menthol lactim ethers
The optimised enolate alkylation conditions for chiral lactim ether 288 were then 
applied to a representative series of electrophiles to afford a range of a-alkyl lactim 
ethers. Therefore, lactim ether 288 was treated with 2.4 equivalents of nBuLi in THF at 
-78 °C, before warming to room temperature for one hour, recooling to -78 °C, 
followed by addition of 3 equivalents of the appropriate electrophile. These alkylation 
reactions proceeded uneventfully, affording quantitative conversion of starting material 
to a-alkyl product 291a-f/292a-f as witnessed by NMR spectroscopic analysis. TLC 
analysis of each of these crude reaction products revealed a single spot for all of the 
crude reaction products, whilst exhaustive column chromatography of the methylated 
lactim ether crude reaction product once again failed to afford any diastereomeric 
enrichment.
Consequently, each of these (-)-menthol lactim ether aza-enolate alkylation reactions
1 I
were characterised as mixtures of diastereomers using H  NMR, C NMR, IR and 
GCMS analysis, that demonstrated physical and spectroscopic data consistent with the 
formation of mixtures of mono-alkyl (-)-menthol lactim ether diastereomers. GCMS 
was once again employed as the main diagnostic tool for determining the 
diastereomeric excesses of these a-alkyl species, with all mixtures of diastereoisomers 
being base line resolved with each peak affording mass spectrum fragmentation 
patterns consistent with those expected for this class of compound. This GCMS 
analysis revealed that a range of a-alkyl lactims 291a-f/292a-f had been formed in 37- 
61% d.e. in essentially quantitative yield, with notably higher d.e.’s being recorded for 
less reactive electrophiles such as ethyl and ‘propyl bromide. (Scheme 3.2.9.)
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291 a-f * 292a-f
RX = Mel, Bn Br, Allyl Br, propargyl Br, ethyl Br, ‘propyl Br
Schem e 3.2.9. Alkylation of the aza-enolate of 288 with a range of electrophiles.
Entry Electrophile 8h % yield d.e.
1 M el 1.06 (Me) 92 57
2 BnBr 2.43 and 3.05 (2 x CHaH bA t) 95 37
3 AllylBr 4.90,4.92 and 5.62 (3 x allyl) 92 45
4 EtBr 0.82 (CH3) <90 46
5 PropargylBr 1.85 (O C-fl) 94 38
6 ‘PrBr 0.78, 0.87 (CH(Cff3)2) <90 61
T able 3.2.1.
3.2.7. Removal of the (-)-menthol chiral auxiliary via 
transesterification
Despite the inability to purify the major a-alkyl diastereomers to homogeneity, my 
attention then turned to identifying conditions that would enable replacement of the 
mentholoxy chiral group of chiral lactim ether 288 by methanol, thus affording their 
corresponding a-alkyl valerolactim ethers.
Given that (-)-menthol lactim ether 288 had been formed from reaction of the parent 
valerolactim ether 15 with excess (-)-menthol using 1.3 equivalents of TFA as catalyst, 
it was proposed that these conditions could also be employed to transesterify (-)- 
menthol lactim ether 288 with methanol. Therefore, (-)-menthol lactim ether 288 was 
treated with a 30 fold excess of methanol using 1.3 equivalents of TFA in toluene, 
resulting in clean removal of the (-)-menthol auxiliary after 16 hours to afford 
valerolactim ether 15 in 68% yield, after Kiigelrohr distillation. (Scheme 3.2.10.)
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MeOH, 20 mol% TFA, toluene
Scheme 3.2.10. Removal of the (-)-menthol chiral auxiliary of (-)-menthol valerolactim 
ether 288 via transesterification with methanol.
However, application of these conditions to the 4:1 mixture of the two a-allyl (-)- 
menthol valerolactim ether diastereomers 291c/292c with 30 equivalents of methanol in 
the presence of 1.3 equivalents of TFA did not result in transesterification, instead 
returning recovered starting material in quantitative yield. As a result the reaction was 
modified by heating to reflux, however once again this reaction did not to produce the 
desired lactim ether product, once again returning recovered starting material 
291c/292c. Therefore, it appears that the acid catalysed transesterification reaction of 
lactim ethers appears to be highly sensitive to the presence of a-alkyl substituents, 
which presumably act to sterically block approach of the incipient nucleophilic alcohol 
at the imine carbon atom of the lactim ether. (Scheme 3.2.11.)
MeOH, 20 mol% TFA, toluene, A
Scheme 3.2.11. Attempted transesterification of 291c/292c.
3.2.8. Preparation of co-amino a-allyl (-)-menthol ester 293
Since conditions could not be identified for the removal of the menthol chiral auxiliary 
fragment, attention then turned to the development of methodology for direct 
hydrolysis of the lactim ether bond of (-)-menthol lactim ether 288. The use of standard 
hydrolysis conditions using 0.3M HC1, in the presence of a small amount of CHCI3 as 
cosolvent, resulted in conversion of the parent mentholoxy lactim ether into the desired 
amino (-)-menthol ester hydrochloride product 293 in essentially quantitative yield. 
(Scheme 3.2.12.)




Schem e 3.2.12. Hydrolysis of 288 to afford co-amino (-)-menthol amino ester 293.
Analysis of the *H NMR spectrum of co-amino ester 293 revealed the diagnostic 
resonances of the (-)-menthol group unshifted at 5 4.61 (td, J  10.9, 4.5 Hz), however 
the a  and 6 methylene groups displayed a marked shift from 8 2.05 (m) to 8 2.24 (t, J 
7.0 Hz) and from 5 3.90 (app. ttt 17.1,5.7, 1.1 Hz) to 8 2.62 (t, J  7.0 Hz). The 13C NMR 
spectrum of 293 revealed the expected 15 resonances with the most diagnostic peak 
corresponding to the ester carbonyl at 171.1 ppm, which represented a shift of 9 ppm 
from the previously seen imidic carbon atom of the lactim ether at 162.0 ppm.
Attempts to promote intramolecular cyclisation of co-amino (-)-menthol ester 293 via 
neutralisation of the hydrochloride salt via treatment with Na2C03(aq) to afford (-)- 
menthol and valerolactam 215 were unsuccessful, instead merely resulting in 
neutralisation to afford 293 as its free amine 294. The reason for this failure to cyclise 
was attributed to the steric bulk of the (-)-menthol group blocking intramolecular attack 
of the incipient co-amino nucleophile, at the imine carbon. (Scheme 3.2.13.)
i) 0.1MHCI
ii) Na2C 0 3
Schem e 3.2.13. Unsuccessful cyclisation of the co-amino ester of (-)-menthol 
valerolactim ether 293.
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3.2.9. Hydrolysis of a-allyl (-)-menthol valerolactim ether
Given the successful hydrolysis conditions (0.3M HC1, CHCI3) established for (-)- 
menthol valerolactim ether 288 these conditions were then applied to the hydrolysis of 
the diastereomeric mixture of a-allyl lactim ethers 291c/292c. Surprisingly, it was 
found that application of these hydrolysis conditions to a-allyl lactim ether were 
unsuccessful, returning only quantitative amounts of protonated starting material. This 
observation was confirmed via neutralisation of the protonated material with potassium 
carbonate solution, which returned a 4:1 mixture of a-allyl (-)-menthol lactim ether 
diastereomers 291c/292c once more. (Scheme 3.2.14.)
K2C 0 3(aq)
Schem e 3.2.14. Attempted hydrolysis of 291c/292c.
Consequently the reaction was repeated under more forcing condition, involving 
heating to reflux for 16 hours, the *H NMR spectrum revealed the formation of a 









Schem e 3.2.15. Hydrolysis of 291c/292c to its esters 295/296.
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As treatment of 291c/292c under standard conditions had failed to afford cleanly the 
desired co-amino esters 295/296 in good yield, the hydrolysis reaction was repeated 
using a mixture of THF and 0.3M HCl(aq) solution, reasoning that this mixed solvent 
system would afford a homogenous solution of the hydrophobic lactim ether. Thus, it 
was found that dissolving the 4:1 diastereomeric mixture of lactim ether 291c/292c in 
5:1 THF:0.3M  HC1 solution resulted in clean hydrolysis to afford a 4:1 mixture of a- 
alkyl co-amino esters 297/298 in quantitative yield. This observation clearly indicates 
that hydrolysis under these conditions occurs with no epimerisation of the a-alkyl 
position of the ester, since the 4:1 ratio of diastereomers was conserved throughout this 
hydrolysis reaction. (Scheme 3.2.16.)
,I\L ^O.




Schem e 3.2.16. Hydrolysis of 291c/292c to its co-amino esters 297/298.
Attempted purification of the 4:1 mixture of diastereomers of the neutralised free amine 
of 297/298 via column chromatography was unsuccessful resulting in no diastereomeric 
enrichment and a low return of the diastereomers. Therefore, the diastereomeric amines 
were A-protected as their carbamates 299/300 in order to reduce their polarity. Thus, 
treatment of the 4:1 mixture of diastereomers of amino esters 297/298 in acetonitrile 
with BOC anhydride in the presence of 2 equivalents of triethylamine afforded a 4:1 
diastereomeric mixture of 299/300 in 91% yield. (Scheme 3.2.17.) Unfortunately, 
numerous attempts to purify the carbamate protected amine 299/300 via exhaustive 
column chromatography once again proved unsuccessful in affording 
diastereomerically pure samples. This inability to separate this mixture of diastereomers 
was particularly frustrating, since it meant that three attempts to separate the 4:1 
mixtures of a-allyl (-)-menthol lactim ethers 291c/292c, co-amino ester 297/298, and A-
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BOC oo-amino esters 299/300 had all failed, with all pairs of diastereomers exhibiting 
identical Rf values. Therefore, it was decide to try and attempt to identify a better chiral 
auxiliary fragment that would afford improved diastereocontrol in the aza-enolate 
alkylation reaction, as well as affording diastereomers that could be separated by 
chromatography.










Schem e 3.2.17. BOC protection of a-allyl amino (-)-menthol esters 297/298.
Finally, it should be noted that the configuration of the major diastereomers 291a- 
f/292a-f in these aza-cnolate alkylation reactions currently remains undetermined. This 
is a result of the fact that the major and minor diastereomers could not be separated, 
whilst their NM R spectra were very similar with many overlapping peaks that 
prevented NOE studies from being carried out. Preparation of an authentic sample of an 
a-alkyl co-amino acid 298 using Evans’ enolate alkylation methodology was 
considered, since its comparison as an authentic standard would enable the 
configuration of the major diastereomer 306 to be determined. However, given time 
constraints, and the fact that only moderate diastereocontrol had been observed in aza- 
enolate alkylation reactions, and the inability to purify the major diastereomers to 
homogeneity, it was decided to concentrate on identifying a more stereoselective chiral 
auxiliary for asymmetric synthesis. (Scheme 3.2.18.)
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Schem e 3.2.18. Formation of an authentic sample of (S)-a-methyl a-am ino pentanoic 
acid 298 via an Evans’ enolate alkylation strategy.
3.3. Attempts to develop alternative asymmetric aza-enolate 
alkylation methodology
3.3.1. Preparation of enantiopure a-alkyl lactim ether derived from a 
chelating chiral auxiliary
The use of (-)-menthol as a chiral auxiliary for the a-alkylation of the aza-enolate of 
valerolactim ether 288 had occurred in only moderate d .e.’s whilst purification of the 
resultant mixture of diastereomers had proven unsuccessful. It was proposed that the 
reason that (-)-menthol had produced moderate d.e.’s was due to the fact that the 
terpene fragment of the aza-enolate could enjoy free rotation around its carbon-oxygen 
bond, which would result in insufficient energy differences between attack of the 
electrophile at the re- or si- faces of the aza-e nolate. As a consequence an alternative 
chiral auxiliary fragment was chosen for transesterification that was capable of 
intramolecular chelation to the lithium counterion of the aza-e nolate of the lactim ether. 
This might afford a more rigid transition state similar to that described previously by 
Bergbreiter et al. for their imino ether chiral auxiliary system ,120 which should give 
higher levels of diastereocontrol than was observed for the (-)-menthol analogue. 
(Scheme 3.3.1.)
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Scheme 3.3.1. Proposed approach for the use of intramolecularly chelating chiral 
auxiliary.
Commercially available (lS,2S)-2-methoxycyclohexanol 301 was selected as a chiral 
auxiliary for this task since it offered the possibility of affording a rigid chair 
conformer, as well as providing an exogenous methoxy group capable of acting as a 
chelating group to the lithium counterion of a derived aza-enolate. Transesterification 
of valerolactim ether 15 was effected in the usual manner via treatment with alcohol 
301 in the presence of 1.3 equivalents of TFA, which after purification through 
Kiigelrohr distillation afforded lactim ether 302 in 53% yield. (Scheme 3.3.2.)
OMe
HO/.
OMe^  i..N-----..OMe ^ O /,
S  301 , TFA, toluene S
15 302
Scheme 3.3.2. Transesterification of valerolactim ether 15 with (lS,2S)-2- 
methoxycyclohexanol 301.
Analysis of the !H NMR spectrum of lactim ether 302 revealed new resonances 
corresponding to the C\ and Cj protons of the cyclohexyloxy fragment at 8 4.71 (ddd, J  
9.6, 8.5 and 4.9 Hz) and 6 3.11 (ddd, J  9.6, 8.5, 4.1 Hz), with a new methoxy resonance 
at 5 3.34 (s). The 13C NMR spectrum revealed the predicted 12 resonances, whilst the 
infra red and mass spectrum returned the expected 1681 cm ' 1 and 212.1642.
Chapter 3 145 Results and Discussion
3.3.2. Attempted preparation of a-allyl (lS,2S)-2- 
methoxycyclohexyloxy lactim ether 303
Attempts to form the az<z-enolate of (15',2lS)-2-methoxycyclohexyloxy lactim ether 302 
were carried out using a the full range of conditions previously developed for the (-)- 
menthol derived valerolactim ether 288. Therefore, addition of 1.3 equivalents of "BuLi 
and warming to room temperature for 1 hour before recooling to -78 °C with 
subsequent addition of allyl bromide, resulted in recovered starting material 302, as a 
well as a trace amount of (lS,2S)-2-methoxycyclohexanol 301. (Scheme 3.3.3.) 
Repetition of the reaction using excess base (3 equivalents); nBuLi, LDA or Schlosser’s 
base, did not afford the desired a-alkyl lactim ether 303, returning good yields of 302, 
with small amounts of (lS ,2S)-2-methoxycyclohexanol 301.
OMe OMe
302
Schem e 3.3.3. Attempted alkylation of chiral lactim ether 302.
Close examination of the *H NMR spectra of all three reactions revealed that there was 
evidence of a small amount of new product containing a triplet at 8 0.91 (t, J  7.0 Hz) 
and methylene groups at 5 1.27 (2H, t, J  7.0 Hz) and 1.44-1.59 (4H, m). Therefore, it 
was proposed that these reactions had not afforded an aza-enolate intermediate due to 
the occurrence of an alternative reaction pathway involving coordination of the lithium 
counterion of the nBuLi to the oxygen atom of the methoxy unit of the chiral auxiliary 
fragment, followed by delivery of butyl anion as a nucleophile to the imine carbon atom 
of 302. However, this reaction represented a minor pathway as the yield from the *H 
NMR spectra of the crude reaction product was <10% in each case. (Scheme 3.3.4)








Schem e 3.3.4. Reaction of lactim ether 302 with to afford the BuLi to afford an nbutyl 
imine 304 and (15,25)-2-methoxycyclohexanol 301.
3.4. Asymmetric alkylation of lactim ethers using a chiral 
ligand approach
3.4.1. Alkylation of the aza-enolate of lactim ethers in the presence of 
(-)-sparteine as a chiral ligand
Concurrent to the chiral auxiliary studies described above, I attempted to develop a 
chiral ligand strategy to carry out symmetric aza-enolate alkylation reactions. The use 
of chiral ligands in stereoselective organic reactions is well documented with many 
chiral ligand systems have been reported in the literature, however (-)-sparteine 306 
remains the most notable example. (-)-Sparteine 306 was first reported as a chiral 
ligand in 1968, however, it was not regularly employed for asymmetric synthesis until 
Hoppe et al. reported its use in asymmetric lithiation and substitution reactions in 1990. 
It has subsequently been employed for a wide range of asymmetric transformation, 
including for the alkylation of N -BOC pyrrolidine 307 via enantioselective lithiation 
using a sBuLi/(-)-sparteine combination, that afforded a-alkyl pyrrolidinones 308 in 
high e.e .141 (Scheme 3.4.1.)
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Schem e 3.4.1. Asymmetric alkylation of A-BOC pyrrolidinone 307 via a (-)-sparteine 
306 mediated approach.
3.4.2. Asymmetric synthesis of a-methyl valerolactim ether 224 using 
(-)-sparteine 306 as a chiral ligand
My attempts to synthesise a-alkyl lactim ether 224 in enantiopure form followed a 
variation of the precedents Beak and of O ’Brien ,141'143 employing two equivalents of 
(-)-sparteine 306 which was mixed with two equivalents of “BuLi in THF at -78 °C for 
15 minutes, before lactim ether 15 was added as a pre-cooled solution in THF. The 
resultant solution was then allowed to warm to room temperature and stirred for one 
hour in an attempt to form a (-)-sparteine aza-enolate complex, before being recooled to 
-78 °C, and methyl iodide added dropwise before the reaction mixture was allowed to 








Schem e 3.4.2. Proposed approach for the production of chiral a-methyl lactim ethers 
224 using (-)-sparteine.
Analysis of the crude *H NMR and 13C NMR spectra of 303 was difficult due to the 
presence of excess (-)-sparteine 306 in the crude reaction product, however it was
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determined that the aza-Qnolate reaction had proceeded in high conversion from the 
presence of a new methoxy resonance at 5 3.53 (s), CH2N resonances 8 3.39 (tt, J  5.8 
and 1.2 Hz), as well as a distinctive methyl doublet 8 1.09 (d, J  7.0 Hz), that was 
partially obscured by the upfield resonances of (-)-sparteine 306. Purification of a- 
methyl lactim ether 224 by exhaustive column chromatography was attempted, 
however all attempts were unsuccessful due to (-)-sparteine 306 co-eluting with the 
methylated product 224. However, Kiigelrohr distillation did prove successful in 
affording a pure sample of a-methyl lactim ether 224 in good yield (73%).
Analysis for any signs of enantiomeric excess for this sample of a-methyl lactim ether 
224 was initially carried out via determination of its specific rotation. Disappointingly, 
the specific rotation measured for a-methyl lactim ether 224 was essentially zero. This 
suggested that a-methyl lactim ether 224 had been formed in essentially racemic form 
with the (-)-sparteine chiral ligand 306 acting as a simple spectator in the reaction. In 
order to confirm this conclusion, a-methyl lactim ether 224 was hydrolysed to its a- 
methyl co-amino ester 315 whose enantiomeric excess was then determined using a new 
chiral derivitising protocol recently developed in the Bull group.
This approach involves treatment of a primary amine with enantiopure BINOL and 2- 
formyl boronic acid, which results in a three component coupling reaction to afford a 
mixture of diasteromeric BINOL-imine-boronate complexes. For the case of racemic 
amines and enantiopure BINOL the two diastereomeric complexes that are formed have 
been shown to display well resolved *H NMR and 13C NMR spectra for a wide range of 
substrates, whose resonances may be integrated to determine the enantiomeric excess of 
a sample of amine. For example, treatment of a-phenylglycine methyl ester 309 of 90%
e.e. with this chiral derivitisation agent, was shown to afford a 95:5 mixture of amine- 
BINOL-boronate complexes (S,S)-310/(S,R)-311 via *H NMR spectroscopic analysis 
(see Appendix B). (Scheme 3.4.3.)
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Schem e 3.4.3. Formation of (S)-BINOL-imine-boronate complex from phenyl glycine.
Furthermore, it has been shown that this chiral derivitising agent is capable of 
discriminating between stereocentres that are remote from the point of attachment of 
the amine, thus making it potentially ideal for determining the enantiomeric excess of 
a-methyl co-amino ester 253.
The (-)-sparteine mediated sample of a-methyl co-amino ester hydrochloride salt 253 
was treated with caesium carbonate in CDCI3 in the presence of one equivalent of 2- 
formyl boronic acid and one equivalent of (S)-BINOL for five minutes in the presence 
of 4A m olecular sieves. Subsequent 400MHz NMR spectroscopic analysis revealed 
that a clean three component self-assembly reaction had occurred to afford a 50:50 
mixture of two diastereomeric boronate-BINOL-imine complexes (5,5)-310/(5,/?)-311. 
This 50:50 ratio of diastereomers was determined from analysis of the equal intensities 
of the two methyl doublet resonances of each diastereomer at 8 0.85 and 5 0.87 which 
were baseline resolved. Importantly, the 50:50 mixture of diastereomers in the *13 NMR 
spectrum of the (-)-sparteine derived a-methyl co-amino ester-boronate-(iS)-BINOL 
derivitisation reaction was identical to the ]H  NMR spectrum of the (S)-BINOL- 
boronate complex of an authentic racemic sample of a-methyl co-amino ether 253 
prepared previously.











Schem e 3.4.3. Self-assembly diastereomeric complexes derived from a-methyl co­
amino ester 253, 2-formyl phenyl boronic acid and (S)-BINOL.
Clearly, the potential for racemisation of the stereocentre of the a-methyl valerolactim 
ether 224 during the derivitisation process must be considered. Firstly, it was shown 
previously that no epimerisation of the 4:1 mixture of a-allyl menthol valerolactim 
ether diastereoisomers 291c/292c occurred during hydrolysis to their corresponding a- 
alkyl co-amino esters 297/298 under mildly acidic conditions. Secondly, derivitisation 
of a wide range of other primary amines with this chiral derivitising agent has been 
shown to occur without racemisation occurring.144 For example, easily racemisable 
enantiopure a-arylglycine methyl ester 309 has been shown to afford single 
diastereomeric BINOL-imine-boronate complexes when treated with this chiral 
derivitising agent under these conditions. Therefore, these spectroscopic analyses, 
coupled with the lack of specific rotation for a-methyl lactim ether, indicate that a- 
methyl valerolactim  ether 224 was formed in racemic form during the (-)-sparteine 
mediated aza-Qnolate alkylation reaction.
Finally, the ability of this chiral derivitising agent to discriminate the a-methyl 
stereocentre o f co-amino ester 253 that is four bonds from the point of attachment of the 
amine to the imine is particularly noteworthy, and contrasts with commonly employed 
M osher’s amide derivatives that generate only discriminate between diastereoisomers 
with a-stereocentres. This ability is likely to be due to the formation of rigid
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diasteromeric complexes, in which the aryl units of the BINOL fragment exert different 
anisotropic shielding effects on each diastereomer.
3.5. Conclusion
The principle of employing a chiral auxiliary to control facial selectivity for the 
diastereoselective alkylation of the <zz<z-enolate of valerolactim ether has been 
demonstrated. (-)-Menthol has been used as a chiral auxiliary fragment for this purpose, 
with effective strategies having been developed for introducing and removing the chiral 
auxiliary via an acid catalysed transesterification approach. The diastereoselectivity 
observed in the alkylation of the aza-enolate of a (-)-menthol derived lactim ether was 
moderate, ranging from 38-61% d.e., whilst the m ajor and minor diastereomers could 
not be separated by chromatography. This inability to purify the major diastereomer to 
homogeneity ultimately renders this approach ineffective for the preparation of 
enantiopure a-alkyl co-amino esters (or a-alkyl lactams).
Attempts to employ (lS,2S)-methoxycyclohexanol as a chiral auxiliary was 
unsuccessful due to the occurrence of a competing nucleophilic addition pathway, 
whilst the use of (-)-sparteine as an exogenous chiral ligand proved ineffective, 
affording racemic products in good yield.
Clearly, the asymmetric aza-Qnolate alkylation methodology described in this section 
needs further development, however I believe that the original principle has been 
demonstrated and offers a good precedent for developing alternative chiral auxiliary 
based system that offers improved stereocontrol. Current work ongoing in the Bull 
group is directed towards screening a range of chiral alcohols as chiral auxiliaries, in an 




Isotopic labelling of fos-lactim ether 
chiral auxiliaries for the production of 
isotopically labelled phenylalanines
Chapter 4 153 Results and Discussion
Chapter 4. Extension of Schollkopf’s bis-lactim ether 
methodology 
4.1. Schollkopfs Zus-lactim ether methodology
4.1.1. Formation of enantiopure amino esters using fc's-lactim ether 
methodology
Schollkopfs bis-lactim ether methodology represents one of the most commonly used 
protocols for the synthesis of enantiopure a-am ino esters owing to its highly 
stereoselective aza-tnolate alkylation step,119,126 and the mild conditions employed for 
lactim ether bond hydrolysis. This aza-enolate methodology has been applied to many 
electrophilic sources, thus affording a multitude of different types of a-substituted a- 
amino ester products. Initial work by Schollkopf et al. showed that the aza-enolate of 
bis-laciim ethers could be frarcs-alkylated with electrophiles to afford rrans-alkylated 
lactim ethers, that could be purified to homogeneity and hydrolysed to their component 
a-am ino esters in excellent yield,117,118,126 (Scheme 4.1.1.)
Schem e 4.1.1. Formation and alkylation of the aza-znolate of bis-lactim ether 203.
Since this first report on aza-enolate alkylations, effective protocols have been 
developed that employ bis-lactim ether 203 for asymmetric aldol,145 conjugate 
addition,146 halogenation147 and fr/s-alkylation117,118,148 reactions. (Scheme 4.1.2.)















Schem e 4.1.2. Alkylation of fr/s-lactim ether 203.
The success of this chiral auxiliary for asymmetric synthesis is clear from the wide 
range of a-am ino esters that have been reported to date, with over 2000 examples of its 
use having been detailed to date. (Figure 4.1.1.)
OMe
F igure  4.1.1. Structures of six a-amino esters recently synthesised via Schollkopfs 
methodology .149'154
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4.2. Potential improvements of Schollkopf’s fas-lactim ether 
chiral auxiliary methodology
It was proposed that two important discoveries relating to the chemistry of lactim ethers 
described in chapter 2 might have important applications for the chemistry of 
Schollkopfs 6fs-lactim ether methodology.
4.2.1. Transesterification precedent for lactim ethers
Firstly it has been shown in section 2.3.4. that lactim ethers readily undergo 
transesterification reaction with alcohols in the presence of acid to afford lactim ether 
products containing a new alkyloxy fragment. For example, this approach was 
employed using capro 16 and oenantholactim methyl ether 237 substrates to afford their 
corresponding benzyl lactim ethers 241 and 242 in good yield. (Scheme 4.2.1.)
BpOH, TFA, toluene, 16 hrs, 
5A molecular s ieves
Yield = 67%
16 241
Schem e 4.2.1. Transesterification of caprolactim ether 16 with benzyl alcohol.
Further work in this area has shown that the presence of an a-alkyl substituent within 
the lactim ether substrate retarded this transesterification reaction dramatically. For 
example, in the case of a-benzyl caprolactim ether 233 it was found that no 
transesterification reaction occurred upon treatment with benzyl alcohol in the presence 
of 1.3 equivalents of TFA, with an essentially quantitative yield of a-benzyl methyl 
caprolactim ether 233 being recovered. (Scheme 4.2.2.)
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N /O M e  BpOH, TFA, toluene, 16 hrs, 
5A molecular s ieves
Schem e 4.2.2. Unsuccessful attempted transesterification of a-benzyl caprolactim ether 
233 with benzyl alcohol.
4.2.2. Isotopic labelling precedent for lactim ethers
Secondly it was found that when valerolactim ether 15 was left in ^-m ethanol for 
several weeks that an isotopically labelled ^ -m ethoxy  fragment was incorporated into 
the alkyloxy position of the lactim ether 318. However, it was also noted that the 
integration of the resonance at 8 3.41 (dt, J  5.7 and 1.2 Hz) corresponding to the two 
methylene protons at the a-position also decreased in intensity over a similar timescale. 
This was attributed to slow tautomerisation of the lactim ether occurring in the presence 
of a readily available deuterium source resulting in slow incorporation of deuterium at 
its a-centre.
H
. I k  .OMe .N k  .OM e ^ ^  , . N .  .Ocfe-Me
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Yield = 10%
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Schem e 4.2.3. Isotopic labelling of the alkyloxy and a-position of valerolactim ether 
15.
Furthermore, it was also noted that the presence of an a-alkyl group within the lactim 
ether substrate retarded this deuteration reaction, since treatment of a-benzyl 
valerolactim ether 217 with ^ -m ethanol failed to afford a-deuterated a-benzyl 
valerolactim ether 319 even after being left for several months. (Scheme 4.2.4.)
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Schem e 4.2.4. Unsuccessful isotopic labelling of a-benzyl valerolactim ether 217.
It was recognised that these observations had potentially useful applications for the use 
of Schollkopfs Z?/s-lactim ether methodology, and now described is the investigation 
into this area.
4.2.3. Potential applications of transesterification and isotopic labelling 
reactions on Schollkopf’s bis-lactim ether methodology
It was proposed that both the transesterification and isotopic labelling reactions 
described above could have potential applications if applied to Schollkopfs &/s-lactim 
ether chiral auxiliary. For example, regioselective transesterification reaction of bis- 
lactim ether 203 would result in a Ms-lactim ether 320 containing chemically 
inequivalent alkyloxy groups. Aza-tnolate alkylation of 320 followed by acidic 
hydrolysis would afford a-am ino esters with differing ester groups that could improve 
separation of the chiral auxiliary L-valine methyl ester fragment from the desired a -  
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Schem e 4.2.5. Transesterification strategy for affording orthogonally protected bis- 
lactim ethers 320.
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Alternatively, deuteration of fo's-lactim ether 203 with d \-methanol might potentially 
afford selective access to a fos-lactim ether chiral auxiliary 321 isotopically labelled 
with deuterium at its C6, which in turn would afford enantiopure isotopically labelled 01- 
alkyl a-am ino esters 322. As described previously, the presence of an a-alkyl group 
hinders the enamine tautomerisation process of lactim ethers, which should prevent 
incorporation of deuterium at the C3 'propyl stereocentre of the bis-lactim ether 203, 





Schem e 4.2.6. Deuteration of bis-lactim ether 203 at its Ce without racemisation of the 
C3 stereocentre.
4.3. Synthesis and use of orthogonally protected to-lactim  
ether
4.3.1. Practical problems associated with the use of Schollkopfs chiral 
auxiliary
As described, Schollkopf’s chiral auxiliary is one of the most widely employed 
synthetic routes to enantiopure a-am ino esters, however, despite its popularity there 
remains a m ajor problem associated with its use. This occurs on hydrolysis of the trans- 
alkylated £w-lactim ether substrate to its component a-am ino esters, which must be 
separated via either chromatography or distillation. This separation is often far from 
ideal, particularly if the target molecule is a low molecular weight a-am ino ester that is
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required on a significant scale. Recognising this problem, Richter et al. developed an S- 
protected penicillamine derived &/s-lactim ether 323 for asymmetric synthesis, which 
they synthesised in a moderate 40% overall yield from S-PMB penicillamine 324.155 
They reported that the alkylation of its aza-enolate with propargyl bromide proceeded 
in reduced 64% yield to afford the rraws-propargylated bis-lactim ether 325. 
Subsequent cleavage of rrans-propargylated fc/s-lactim ether 325 in aqueous acetonitrile 
in the presence of five equivalents of TFA afforded a mixture of the S-PMB 
penicillamine derived chiral auxiliary ethyl ester 326, and the desired a-am ino ethyl 
ester 327 as their TFA salts in 84% yield. This mixture of a-am ino esters was then 
separated by simple partition between CH2CI2 and water, since S-PMB penicillamine 
ethyl ester TFA salt was soluble in CH2CI2, whilst the newly formed a-am ino ester 
remained in the aqueous phase. (Scheme 4.3.1.)
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Schem e 4.3.1. Formation of (S')-a-propargyl a-am ino ethyl ester 327 using 
penicillamine bis-lactim ether 323.
However, penicillamine 326 is an expensive non-proteinogenic amino acid that 
ultimately limits the use of this methodology for the asymmetric synthesis, and as a 
consequence it was proposed that this separation problem might also be resolved if the 
orthogonally protected bis-lactim ether 328 was used for synthesis. It was proposed that 
treatment of Schollkopfs bis-lactim ether chiral auxiliary 203 with benzyl alcohol in 
the presence o f TFA might result in a selective transesterification to afford an O-methyl
Chapter 4 160 Results and Discussion
O-benzyl &/s-lactim ether 328. It was suggested that once this chiral auxiliary was 
trans-alkylated and hydrolysed, then facile purification of the resultant mixture of L- 
valine methyl ester and the desired enantiopure a-am ino benzyl ester 329 could then be 
achieved by simple hydrogenolysis. This hydrogenolytic step would therefore result in 
a mixture of the desired a-amino acid 330 and L-valine methyl ester which could be 
easily separated via partition between water and an organic solvent. (Scheme 4.3.2.)




















Schem e 4.3.2. Overview of the proposed methodology for the use of O-methyl O- 
benzyl bis-lactim ether 328.
4.3.2. Synthesis of dipeptide species using orthogonally protected bis- 
lactim ether
Dipeptides represent a core functionality that are common in many natural and 
medicinally active products, and as such represent valuable synthetic targets.156, 157 
Current methodology for the production of this class of compound usually employ 
amide bond coupling reactions between a-am ino esters through judicious choice of 
nitrogen and ester protecting groups as well as coupling reagents such as DCC and 
HOBt. (Scheme 4.3.3.)
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Scheme 4.3.3. DCC coupling of N-BOC valine and phenylalanine methyl ester.
It was proposed that the presence of the two different alkyloxy units of bis-lactim ether 
328 might also enable an orthogonal deprotection strategy to afford dipeptide products. 
For example, alkylation of the aza-enolate of Schollkopfs chiral auxiliary 328 would 
afford its trans-alkylated O-methyl O-benzyl bis-lactim ether 331 which on 
hydrogenation would afford a masked cyclic dipeptide derivative 332, containing both 
amide and lactim ether bonds. Taking into account the differing reactivities of these 
two functionalities, mild acidic hydrolysis should result in selective cleavage of the 
lactim ether bond to selectively afford the desired dipeptide 333. (Scheme 4.3.4.)
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Scheme 4.3.4. Overview of the synthesis of dipeptides from O-methyl O-benzyl bis- 
lactim ether 328.
W hilst the example described is for an L-valine derived bis-lactim ether 328, this 
protocol is potentially applicable to other bis-lactim ethers available from other a- 
amino esters, thus potentially affording access to a wide range of proteinogenic and 
non-proteinogenic dipeptides.
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4.3.3. Preparation of Z>w-lactim ether 328
5/s-lactim  ether was prepared via a four stage literature synthesis starting from L- 
1valine. The initial step involved formation of the Leuch’s anhydride of L-valine via 
treatment with 20% phosgene solution in toluene to afford Leuch’s anhydride 287 in 













Schem e 4.3.5. Formation of the Leuch’s anhydride of L-valine 287.
Leuch’s anhydrides readily undergo nucleophilic ring opening reactions with 
concomitant loss of carbon dioxide, thus treatment with an a-am ino ester results in 
dipeptide formation. Therefore, reaction of Leuch’s anhydride 287 with glycine methyl 
ester afforded an unstable intermediary dipeptide methyl ester 334 which was cyclised 
without isolation via heating to reflux in toluene to afford (S)-3-isopropylpiperazine- 
2,5-dione 23 in 92% yield over two steps. (Scheme 4.3.6.)
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Schem e 4.3.6. Ring opening of Leuch’s anhydride 287 with glycine methyl ester to 
afford diketopiperazine 23.
Thus treatment of diketopiperazine 23 with three equivalents of trimethyloxonium 
tetrafluoroboronate 221 afforded bis-lactim ether 203 in 72% yield after careful 
neutralisation of the resultant ^/^-tetrafluoroboronate salt under basic conditions. 
(Scheme 4.3.7.)
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Schem e 4.3.7. Formation of 6/s-lactim ether 203 from the corresponding 
diketopiperazine 23 via the use of M eerwein’s salt.
4.3.4. Production of O-methyl O-benzyl -lactim ether 328
With multigram quantities of &fs-lactim ether 203 in hand, attention turned towards 
developing an efficient transesterification protocol for the synthesis of O-methyl O- 
benzyl bis-lactim ether 328. Thus, treatment of bis-lactim ether 203 with one equivalent 
of benzyl alcohol in the presence of 1 equivalent of TFA and 5A molecular sieves for 6 
hours succeeded in the formation of 6/s-lactim ether 328 in a low 7% yield after column 
purification. (Scheme 4.3.8.)
Schem e 4.3.8. Transesterification of bis-lactim ether 203 with benzyl alcohol under 
acidic conditions to afford a 7% yield of O-methyl O-benzyl fos-lactim ether 328.
resonances relating to the ‘propyl group at 5 0.63 (d, J  7.0 Hz) and 8 0.94 (d, J  7.0 Hz), 
further to this the presence of two resonances relating to the benzylic methylene protons 
were noted 8 4.98 (d, J  12.2 Hz) and 8 5.18 (d, J  12.2 Hz). The presence of a benzyl 
group was further confirmed by the presence of an aromatic resonance between 8 7.18- 
7.34 (bm). The 13C NMR spectrum revealed the expected thirteen resonances, whilst a 
mass of 261.1598 was present in its mass spectrum.
Analysis of the *H NM R spectrum of the crude reaction mixture revealed that the 
remainder of the reaction mixture was comprised of unreacted starting &/s-lactim ether
BnOH, TFA, toluene, 6  hrs
203 328
Analysis of the !H NMR spectrum of bis-lactim ether 328 revealed the presence of two
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203 and benzyl alcohol, and as a consequence a series of optimisation reactions were 
carried out. These studies revealed that treatment of Ms-lactim ether 203 with 1 
equivalent of benzyl alcohol in the presence of 1 equivalent of TFA and 5A molecular 
sieves for two days afforded an increased 25% yield of O-methyl O-benzyl bis-lactim 
ether 328. However, it was noted from analysis of the ]H NMR spectrum and TLC of 
the crude reaction product that a polar by-product had been formed in approximately 
35% yield, which was eventually isolated through column chromatography. This by­
product was shown to be the motto-lactim ether species 335, which was proposed to 
have been formed through protonation of the bis-lactim ether 203 and subsequent O- 
dealkylation via attack of a molecule of benzyl alcohol, as previously observed during 
hydrolysis of a ,a -d i‘butyl valerolactim ether 230 in section 2.2.10. (Scheme 4.3.9.)
.OMe BnOH, TFA, toluene,
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Schem e 4.3.9. Dealkylation of bis-lactim ether 328 by benzyl alcohol under acidic 
conditions.
As very little mono-lactim ether 335 had been formed in the initial reaction of bis- 
lactim ether 203 with benzyl alcohol over six hours, coupled with the fact that the 
lability of the O-benzyl bond had proven problematic for benzyl caprolactim ether 241, 
it was proposed mowo-lactim ether 335 was formed primarily from nucleophilic attack 
of the benzyl alcohol upon O-methyl O-benzyl 6/s-lactim ether 328, and not from the 
parent Z?/s-lactim ether 203. (Scheme 4.3.10.)
BnOH,TFA
230 328 335
Schem e 4.3.10. Nucleophilic attack of benzyl alcohol on protonated O-methyl O- 
benzyl bis-lactim ether 328 to afford mono-lactim ether 335.
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Optimisation of the reaction time revealed that 16 hours provided the best compromise 
between the formation of unwanted mono-methyl lactim ether 335 and unreacted bis- 
lactim ether 203, affording fo's-lactim ether 328 in 37% isolated yield.
Finally, it was noted that molecular sieves are mildly basic158 and as a consequence the 
number of molecular sieves was limited to avoid unnecessary sequestration of the TFA 
acid source. Thus, it was found that treatment o f fo's-lactim ether 203 in toluene with 
1.5 equivalents of benzyl alcohol in the presence of 1.3 equivalents of TFA and one 
equivalent of 5A molecular sieves resulted in the formation of O-methyl O-benzyl bis- 
lactim ether 328 in 57% isolated yield. (Scheme 4.3.11.)
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Schem e 4.3.11. Transesterification of 6/s-lactim ether 203 with benzyl alcohol to afford 
O-methyl O-benzyl 6/s-lactim ether 328.
4.3.5. Confirmation of the structure of O-methyl O-benzyl fos-lactim 
ether 328
In order to confirm the structure of O-methyl O-benzyl £/s-lactim ether 328 it was 
proposed that facile hydrogenation would allow easy access to the previously reported 
mono-methyl lactim ether 335,130 which I had also isolated as a by-product of the 
transesterification reaction. Therefore, treatment of fr/s-lactim ether 328 with 15 mol% 
Pearlm an’s catalyst in EtOAc under an atmosphere of hydrogen afforded mono-methyl 
lactim ether 335 in 96% yield. (Scheme 4.3.12.)
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MeO N
15 mol% Pd(OH)2, EtOAc, 3 hrs 
Yield = 96% Jx‘r
M eO N 
335
Schem e 4.3.12. Hydrogenation of O-methyl O-benzyl fr/s-lactim ether 328 to afford 
mono-methyl lactim ether 335.
However the !H NMR and 13C NMR spectra obtained for the hydrogenation of bis- 
lactim ether 328 were different from the spectra previously reported by Bull et al. for 
this compound raising doubts over the assigned structure. Closer examination o f the 
previous report by Bull et al. revealed that 335 had been formed as a 2:1 mixture o f the 
mono-methyl lactim ether regioisomers 335 and 336 formed by treatment of 
diketopiperazine 23 with one equivalent of trimethyloxonium tetrafluoroboronate. 
Furthermore, the structures of these two regioisomers had been assigned by virtue of 
relatively small nOe effects that could possibly have been open to misinterpretation. 
Indeed, examination of the *H NMR spectroscopic data assigned by Bull et al. to mono- 
lactim ether 336 revealed it to be essentially identical to the data I had assigned to the 
structure of mono-lactim ether 335. (Scheme 4.3.13.)
I H I H I
> y N Y °  1 equivalent Me3O.BF4, PCM ^
M e O ^ ' T T  O '^ 'N
H H
23 335 336
Schem e 4.3.13. Bull et al. O-alkylation of diketopiperazine 23 to afford the mono­
methyl lactim ether 335 and 336.
Fortunately, mono-methyl lactim ether 335 was a crystalline solid and suitable crystals 
could be isolated for X-ray crystal analysis which revealed the expected structure which 
could only have been derived from the expected O-methyl O-benzyl fo’s-lactim ether 
328. Therefore, the crystal structure clearly revealed the presence of the methoxy group 
distal to the ‘propyl group, with a proximal amidic carbonyl group. The ring system 
adopted a half-boat conformation, with the ‘propyl group occupying a pseudo axial 
orientation shielding one face of the ring. (Figure 4.3.1)
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Figure 4.3.1. X-ray crystal structure of m onolactim  ether 335.
Analysis of the X-ray crystal superstructure of mono-lactim ether 335 revealed that if 
had formed an oligomeric ladder structure through hydrogen bonding between the N-H 
and the carbonyl groups of alternate amide bonds of adjacent mono-lactim ether 
monomers. (Figure 4.3.2.)
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Figure 4.3.2. Crystal structure of mono-lactim ether 335 demonstrating the oligomeric 
ladder structure it forms.
The hydrogen bond lengths observed were; N-H bond 0.885A; H -0  1.978A (2.859A 
overall), whilst the dihedral angle was 173.36°, which represents typical hydrogen bond 
lengths and angles for this type of extended ladder network derived from amidic 
bonds.159 (Figure 4.3.3.)
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Figure 4.3.3. Crystal structure of mono-lactim ether 335.
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Clearly, these crystallographic findings mean that spectroscopic assignments for the 
mono-methyl lactim ether regioisomers 335 and 336 originally reported by Bull et al. 
are incorrect and that the structures of the two isomers assigned to the spectroscopic 
data in this original report should be reversed.
4.3.5. Alkylation of the aza-enolate of O-methyl O-benzyl Z>w-lactim 
ether 328
Attempts to alkylate the aza-enolate of O-methyl O-benzyl fo’s-lactim ether 328 
proceeded well according to documented literature precedent,119’ 126, 132, 160 since 
treatment with nBuLi in THF at -78 °C for 10 minutes under an atmosphere of nitrogen, 
followed by addition of benzyl bromide, gave frans-benzylated O-methyl O-benzyl bis- 
lactim ether 337 in high yield and >90% d.e. The crude product was readily purified to 
homogeneity via column chromatography to afford rrans-benzylated bis-lactim ether 
337 in 73% yield and >95% d.e. (Scheme 4.3.14.)
OBn
MeO'
i) "BuLi.THF, -78°C, 10mins
ii) BnBr, 8  hrs
Yield = 73%, d.e. > 95% JOC©
337
Schem e 4.3.14. Benzylation of the aza-enolate of fcw-lactim ether 328 to afford trans- 
benzylated O-methyl O-benzyl b/s-lactim ether 337.
Analysis of the NMR spectrum of 337 revealed the presence of two resonances 
relating to the ‘propyl group, 6 0.47 (d, J  7.0 Hz) and 8 0.86 (d, J  7.0 Hz), a resonance 
relating to the newly added benzylic methylene group 8 3.02 (d, J  8.3 and 3.4 Hz) and 8 
3.07 (app t, J  3.4 Hz) and a resonance relating to the alkyloxy benzylic methylene 
protons 8 5.03 (d, J  7.7 Hz) and 8 5.11 (d, J  7.7 Hz). The l3C NMR spectrum revealed 
the expected eighteen resonances, whilst a mass of 351 was recorded in its mass 
spectrum.
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4.3.6. Attempted hydrolysis of trans-benzylated O-methyl O-benzyl bis- 
lactim ether 337
Hydrolysis of a small amount (10 mg) of trans-benzylated O-methyl O-benzyl bis- 
lactim ether 337 was attempted using conditions previously developed for the mono- 
alkyl valerolactim ethers. However, treatment with the mixed solvent system of 
CHCI3/O.3M HC1 did not result in clean hydrolysis affording a complex mixture of 
products. Analysis of the !H NMR spectra of the crude reaction product implied 
competing formation of rrans-benzylated mono-methyl lactim ether amide 339 which 
had presumably been formed due to the lability of the O-benzyl bond under acidic 
conditions. This was evidenced by the presence of resonances corresponding to valine 
methyl ester and the phenylalanine benzyl ester 338 hydrochloride salts in the *H NMR 
spectrum, as well as new peaks at 8 5.61 (bs), 8 3.81 (s), 8 0.86 (d, J  7.0 Hz), and 8 0.91 
(d, J  7.0 Hz) assigned to the NH, OMe, and ‘propyl groups of frcms-benzylated mono- 
lactim ether 339. Unfortunately attempts to purify this reaction mixture to homogeneity 
via column chromatography proved unsuccessful due to the small amount (<6 mg) of 
material available. (Scheme 4.3.15.)
Schem e 4.3.15. Attempted hydrolysis of frarcs-benzylated bis-lactim ether 337.
Interestingly Schollkopf et al. have reported previously that hydrolysis of benzyl bis- 
lactim ether 340 had proceeded in only 53% yield, implying that a significant loss of 
material that might also have occurred via this type of debenzylation pathway. (Scheme 
4.3.16.)
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0.25M HCI(aq), 48 hrs
Yield = 53% overall
HCI.H2N ^ / COOBn + HCI.HgN r n n R ^
340
Schem e 4.3.16. Schollkopf’s hydrolysis of frans-benzylated fo's-benzyl lactim ether
340.
Unfortunately, due to a shortage of fcw-lactim ether substrate 203 I was unable to repeat 
the hydrolysis reaction of 337 under these conditions, and this work will now be 
investigated further by another member of the Bull group.
4.3.7. Regioselective demethylation of to-lactim ether 203
The work described above represents a potentially exciting extension to the 
methodology of Schollkopf, however even if the hydrolysis reaction can be optimised, 
then the 57% yield recorded for formation of the parent lactim ether 328 is clearly 
unsatisfactory. It was proposed that access to O-methyl O-benzyl fo's-lactim ether 328 
might be achieved via a step-wise synthesis of mono-methyl lactim ether 335. It was 
proposed that bis-lactim ether 203 had the potential to undergo regioselective O- 
demethylation to afford 335 in the presence of strong acid and an appropriate 
nucleophilic source. As a result, a series of acids were screened for their ability to 
regioselectively demethylate bis-lactim ether 203 to afford a reliable and robust route to 
mono-lactim ether 335. Thus, it was eventually found that treatment of Zn's-lactim ether 
203 with glacial acetic acid for sixteen hours selectively afforded mono-methyl lactim 
ether 335 in essentially quantitative yield. (Scheme 4.3.17.)
AcOH, 16 hours
203 335
Schem e 4.3.17. Regioselective demethylation of &/s-lactim ether 203 using acetic acid.
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It had already been shown by Schollkopf et al. that diketopiperazine 23 could be readily 
converted into 6/s-benzyl lactim ether 340, via treatment of 23 with benzyl 
trichloroacetimidate in the presence of TM SOTf as a Lewis acid. Therefore, treatment 
of mono-lactim ether 335 with benzyl trichloroacetimidate and TM SOTf under these 
conditions should afford a facile route to O-methyl O-benzyl ^w-lactim ether 328. 
(Scheme 4.3.18.)
Schem e 4.3.18. Proposed formation of O-methyl O-benzyl Z?w-lactim ether 328, using 
benzyl trichloroacetimidate 4 and TMSOTf.
4.4. Isotopic labelling of lactim ethers and preparation of 
enantiopure a-deuterated a-amino acids
Concurrent to my studies into the use of orthogonally protected fo’s-lactim ether 328, I 
also sought to identify a viable synthetic route to ^ -labelled  bis-lactim ether 321 with 
the aim of employing it for the asymmetric synthesis of a series of isotopically labelled 
a-am ino esters.
4.4.1. Current uses of isotopically labelled amino acids
a-Deuterated a-am ino acids represent a valuable synthetic tool in many scientific 
disciplines due to their ability to afford compounds that can be interrogated via NMR 
spectroscopy. For example, this ability enables this class of compound to be employed 
as probes for elucidation of biosynthetic pathways,161*164 as well as tools for 
investigation of the secondary and tertiary structures of peptides and proteins.165'168
NH
BnO CCI3
4 , TMSOTf, DCMAcOH, 16 hours
203 335 328
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4.4.2. Current synthetic methods for the production of enantiopure a- 
deuterated a-amino acids
As a result o f their desirability there exist many routes to the synthesis of isotopically 
labelled enantiopure a-amino acids. Many of the routes share a common scheme 
involving introduction of the isotopic atom into an achiral glycine substrate before 
further synthetic manipulation to afford the desired enantiopure deuterated a-am ino 
acid. There are several other methods used for the stereoselective introduction of 
deuterium, including approaches based upon resolution of racemates, enantioselective 
catalysis or the use of chiral auxiliaries. (Scheme 4.4.1.)
II . . . .  Chiral catalysis Enolate alkylation || KILJ
^  / ----------  —  v y " !
o
'•“ x
D D \  /  D D
O
H O' — ' NH2 
Ff 'D
NH, Kinetic resolution /  ^ __________________ Chiral building block
HO^ ' y C  containing deuterium
R D
Schem e 4.4.1. Synthesis of a-deuterated a-am ino acids.
The em ployment of a resolution approach allows traditional achiral methodologies such 
as the Strecker synthesis to be used to prepare a-deuterated a-am ino acids before a 
subsequent resolution step to afford enantiopure isotopically labelled a-am ino acids. 
For example, Schwoen et al. showed that porcine kidney acylase I could selectively 
hydrolyse the acetyl group of the L-enantiomer of a range of //-protected amino acids, 
allowing facile separation of the enantiomers via fractional crystallisation.169 (Scheme
4.4.2.)
Porcine kideny acylase I ^   H
Y  > C  °H  > C  O H + Y  X  OH
J  R D R'' D M D"' R
Schem e 4.4.2. Enzymatic resolution of a-deuterated a-am ino acids.
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Chiral catalysis represents a desirable synthetic route due to the small number of steps 
that the isotopically labelled compound must undergo before isolation. For example, 
Lygo et al. has demonstrated the use of a chiral phase transfer catalyst 341 for the 
catalytic production of isotopically labelled amino acids,170 via enantioselective 
alkylation of the enolate of a preformed 6/s-deuterated Schiff base 342. (Scheme 4.4.3)
o o
D 40%KOD / D20  ou „ II
P h > . ,  2 r  P h ^  . N.  ,y? O Bu Y  0  Bu
Ph 342 Ph D D
H2N 9 . «">■«
D 'R ph D R
Schem e 4.4.3. Formation of a-deuterated a-am ino acids through Lygo’s phase transfer 
methodology.
Stereoselective synthesis represents a desirable pathway as it affords enantiopure 
products, however the isotopically labelled building blocks often represent challenging 
synthetic targets in their own right. In 1998 Young et al. published work detailing the 
synthesis of both isomers of a-deuterated a-propargyl glycine 343 during work aimed 
at uncovering the mechanism of oxidation of propargyl glycines with an oxidase.171 
This was achieved through nucleophilic attack of TM S-protected propargylated anion 
on enantiopure isotopically labelled aziridines 344. This isotopically labelled aziridine 
344 was synthesised via Hofmann rearrangement of a monoamide derived from 
isotopically labelled malic acid, itself formed from treatment of dideuterated 




RX, PhMe, D20 , 5-10°C
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Schem e 4.4.4. Formation of a-deuterated a-propargyl amino esters through ring 
opening of the corresponding aziridine.
Schollkopf’s chiral auxiliary methodology has been used previously to great effect for 
the synthesis of enantiopure a-deuterated a-am ino acids.173, 174 Gani et al. reported 
base-catalysed incorporation of two atoms of deuterium into the Ce position to afford 
enantiomeric frzs-deuterated auxiliary 321, whose aza-enolate was alkylated to afford its 
corresponding isotopically labelled trans-3,6-dialkyl 6/s-lactim ether 345. Acidic 
cleavage then afforded its corresponding enantiopure isotopically labelled a-am ino 












Scheme 4.4.5. Deuteration and alkylation of Schollkopf’s frw-lactim ether 321.
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4.4.3. A new strategy for the synthesis of isotopically labelled bis- 
lactim ether 321
As described it was proposed that access to frfs-deuterated bis-lactim ether 321 might 
also occur under mild acidic conditions in the presence of a suitable deuterium source. 
Therefore, it was proposed that deuterium might be selectively introduced into the C6 
position of the labile frfs-lactim ether via acidic equilibration of the 6 /s-lactim ether 203 
to its enamine form 346 in deuterated media. It was reasoned that the presence of the 
sterically demanding ‘propyl unit at C3 would prove sufficient to prevent deuterium 
incorporation at this position, as witnessed previously for a-alkyl valerolactim ether 
substrates described in section 4.2.1. Subsequent formation of the aza-tnolate of 321,
117and its reaction with an electrophile would afford the rraws-alkylated auxiliary 345, ’
118 that would then be purified and cleaved to afford the desired a-am ino methyl ester 
322 containing a deuterium label at its a  position. (Scheme 4.4.6.)
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Schem e 4.4.6. Incorporation of deuterium into the Ce position of Schollkopfs bis- 
lactim ether 203.
Given that Schollkopfs methodology is one of the most widely used protocols for the 
synthesis of enantiopure a-amino acids it was proposed that this practical simple 
protocol would provide a useful tool for the synthesis of deuterated analogues due to 
the ease with which the isotopic label could be introduced, coupled with the 
effectiveness of the original methodology.
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4.4.4. Preparation of bis-deuterated lactim ethers
As previously stated in this chapter, deuterium was incorporated into the a-position of 
valerolactim ether 15, when it was dissolved in deuterated methanol and allowed to 
stand for several weeks. As a consequence, synthesis of Z?/s-deuterated valerolactim 
ether 319 was attempted under acidic, neutral and basic conditions in an attempt to 
identify conditions that would rapidly drive the reaction to completion. These 
deuteration reactions were carried out by stirring a solution of the lactim ether in d\~ 
methanol for 24 hours, either with 20 mol% trifluoroacetic acid, or with 20 mol% 
sodium methoxide (generated in situ by addition of sodium hydride). d \-M ethanol was 
selected over ^-m ethanol owing to its lower cost as well as the fact that a 
transesterification reaction would also occur under these conditions, which would also 
lead to unwanted incorporation of a ^-m ethoxy  fragment into the lactim ether product. 
(Scheme 4.4.7.)
Schem e 4.4.7. Zh's-deuteration of valerolactim ether 15 under acidic conditions.
a-position of valerolactim ether 319 had reached a level of >97% after 16 hours in the 
acidic catalysed example, where as for the neutral and base catalysed reactions no 
deuterium incorporation had occurred.
4.4.5. Preparation of fas-deuterated bis-lactim ether auxiliary 321
Following the precedent of the deuterium incorporation study using valerolactim ether 
15 as a model substrate, it was found that treatment of bis-lactim ether auxiliary 203 
under the same acidic conditions resulted in incorporation of two deuterium atoms in 
very high yield.
i), ii) or iii), MeOD
15 319 D
i) 20 mol% TFA, ii) 20 mol% NaOMe, iii) pH 7
The *H NMR spectra of these test reactions revealed that deuterium incorporation at the
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Schem e 4.4.8. Deuteration of 6/s-lactim ether 215.
!H NMR spectroscopic analysis of the resultant 6/s-deuterated &w-lactim ether 321 in 
CDCI3 revealed complete loss of the resonances relating to the two diastereomeric Ce 
ring protons, which had previously overlapped the #3  proton, that now appeared as a 
well resolved doublet with 1H intensity at 5 3.92 (d, J  3.5 Hz). Likewise, the 13C NMR 
spectrum of 321 only displayed eight resonances, failing to exhibit a carbon resonance 
for the Ce carbon, due to quadrapole relaxation because of the presence of the 
deuterium atoms.
Also worthy of note, when the deuteration reaction was repeated in ^-m ethanol it was 
found that incorporation of a ^ -M eO  fragment was only observed at the C5 position, 
thus enabling the two methoxy resonances in the !H NMR spectrum of Z?/s-lactim ether 




Schem e 4.4.9. Deuterium incorporation into the two He protons and the methoxy unit 
of fc/s-lactim ether 203.
Analysis of the specific rotation of bis-deuterated bis-lactim ether 321 revealed an 
[a]o25 of 105.1 (c 1.0 in EtOH), that compared favourably with the [a]o25 of 108.9 (c 
1.0 in EtOH )130 for the parent ^w-lactim ether, further indicating that racemisation had 
not occurred via deuterium incorporation at the C3 position. Finally the mass spectrum 
recorded for this deuterated bis-lactim ether 321 revealed the presence of two 
deuterium atoms at 187.1409.
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4.4.6. Explanation for the lack of racemisation observed via a coplanar 
model
All physical and spectroscopic data recorded for the formation of 6 /s-deuterated 
Schollkopfs bis-lactim ether auxiliary under acidic conditions implied that no 
racemisation or deuterium incorporation had occurred at its C3 stereocentre during 
incorporation of deuterium into the Ce position. It is proposed that this regiocontrol 
could be explained using a similar ‘coplanar’ argument previously developed in section
2.4.2. to explain the differing reactivity of lactim ethers towards alkyl lithiums. 
Therefore, in order for the enamine form of a lactim ether to be accessed, it requires 
that one of its a-protons adopts a conformation with its o-bond coplanar to the n  orbital 
of its proximal imidic bond. (Scheme 4.4.10.)
H H
Scheme 4.4.10. Alignment of the a-proton with the n orbitals of the imidic bond in 
order for the enamine tautomer may be adopted.
It is known that Z?/s-lactim ether 203 adopts a conformation in which its ring system 
adopts a half boat conformation, with its C 3  ‘propyl group occupying a rigid pseudo- 
axial orientation.175, 176 This, in turn fixes the C 3  proton on a pseudo-equatorial 
conformation which cannot align its o-orbital with the 71-orbital of the N 1-C2 imidic 
bond for enolisation to occur, and therefore deuterium incorporation does not occur at 
the C 3  position. In contrast, there is significant conformational flexibility at the Ce 
position of the bis-lactim ether 203, which demonstrates sufficient conformational 
lability to enable both Ce-H a-bonds to overlap with the N 4 -C 5 imidic bond to enable 
&/s-deuteration at the Ce position. (Figure 4.4.11.)
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F igure  4.4.11. Conformers adopted by Schollkopfs bis-lactim ether 203 that allows 
selective deuterium incorporation at the Ce position.
4.4.7. Further investigation of the coplanar model
In order to provide further evidence for this ‘coplanar’ model of deuteration, a sample 
of rra/w-benzylated 6/s-lactim ether 340 was prepared via treatment of lactim ether 203 
with nBuLi in THF at -78 °C followed by addition of benzyl bromide. It was found that 
treatment of this frans-benzylated 6/s-lactim ether 340 with 20 mol% TFA in d\- 
methanol solution for 7 days failed to produce any incorporation of deuterium at either 
the C3 or Ce positions. Therefore, the frans-diaxial conformation adopted by this lactim 
ether is sufficiently rigid to ensure no deuterium incorporation, because the C3 and Ce 
protons are unable to adopt the required pseudo axial environments. (Scheme 4.4.12.)





tfl -MeOD, 20 mol% TFA, toluene
Scheme 4.4.12. Attempted deuteration of rraras-benzylated 6/s-lactim ether 340.
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4.5. Synthesis of enantiopure a-deuterated phenylalanines
Having demonstrated formation of 321 in high yield, attention shifted to alkylation of 
its flza-enolate in order to confirm the usefulness of this methodology for the 
asymmetric synthesis of isotopically labelled enantiopure a-am ino acids.
4.5.1. Synthesis of (35,6i?)-6-benzyl-6-deuterated-3,6-dihydro-3- 
isopropyl-2,5-dimethoxypyrazine
Benzyl bromide was initially chosen as an electrophile for the alkylation of the aza- 
enolate of bis-lactim ether 321, since I already had access to non-deuterated trans- 
benzyl fcw-lactim ether 340 for comparative purposes. The aza-enolate alkylation 
conditions employed were a modification of Schollkopfs original conditions, involving 
deprotonation of the bis-lactim ether 321 with nBuLi in THF for one hour at -78 °C
1 9Aprior to addition of 1.3 equivalents of benzyl bromide. The bis-lactim ether 321 was 
deprotonated for one hour before addition of benzyl bromide in anticipation of any 
deuterium effect that might be operating during the deprotonation step. Under these 
conditions trans-benzyl fcfs-lactim ether 347 was formed cleanly in good yield and 
>95% d.e., which was purified to homogeneity by column chromatography to afford a 
single diastereomer in an overall 80% yield. (Scheme 4.5.1.)
Schem e 4.5.1. 7ra«.s-alkylation of the aza-enolate of 6/s-lactim ether 321 with benzyl 
bromide.
Analysis of the ]H NMR spectrum of trans-benzyl &/s-lactim ether 347 revealed it to be 
identical to that recorded previously for the non-deuterated derivative 340, except for 
the absence of the C6-proton at 8 3.89-3.97, and simplification of the ABX quartet 
relating to the benzylic methylene protons to a simple resonance, 8 2.99 (2H, app s). 
Importantly, the intensity of the integral for the C3-proton was equivalent to one proton,
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indicating that no deuterium (or racemisation) had occurred at this stereocentre in the 
previous deuteration step. The 13C NMR spectrum of 347 revealed the expected 13 
resonances, with no resonance being observed for the Ce position owing to the large 
NOE effect from the neighbouring quadripolar deuterium nucleus, whilst the molecular 
ion of 276.1814 revealed that a single deuterium atom was present in the molecule.
Given the success of this aza-enolate benzylation protocol, it was decided to prepare a 
series of 6-deuterated bis-lactim ethers containing different halogen substituents in their 
aryl ring. Therefore, treatment of the aza-enolate of 6/s-deuterated 6z's-lactim ether 321 
with a series of five different electrophiles afford rrans-alkylated bis-lactim ether 348- 
352 in >90% d.e., that were purified by column chromatography to >95%. (Figure 
4.5.1.) It was pleasing to note that the [a]o reading for the trans-benzyl bis-lactim 347 
ether matched that previously reported by Gani et a l 113











Yield = 70% 
[a]D25 = 62.4




Figure 4.5.1. Trans-alkylated mono-deuterated Schollkopfs 6/s-lactim ethers 347-352.
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All compounds were fully characterised and demonstrated spectroscopic and physical 
data consistent with the formation of rrarcs-benzylated bis-\actim ethers that were 
morco-deuterated at their Ce position.
4.5.2. Preparation of a-deuterated (R)-phenylalanines
Initial attempts to hydrolyse frans-benzylated bis-lactim ether 347 employed the 
conditions previously developed for hydrolysis of a-alkyl valerolactim ethers described 
in section 2.5.1. However, this approach was unsuccessful, failing to afford a clean 
hydrolysis reaction pathway to a-deuterated (R)-phenylalanine methyl ester 353, with 
large amounts of starting fraws-benzylated frfs-lactim ether 347 being recovered. 
(Scheme 4.5.2.)





Schem e 4.5.2. Unsuccessful hydrolysis of 347.
A review of literature precedent revealed that the use of acetonitrile as a polar organic
177 180cosolvent had proven successful for the hydrolysis of related 6fs-lactim ethers. 
Therefore, a solution of &fs-lactim ether 347 in a 1:1 mixture of acetonitrile:0.5M  
HCl(aq) was rapidly stirred for 30 minutes to afford a quantitative mixture of L-valine 
methyl ester and a-deuterated phenylalanine methyl ester 353 as their hydrochloride 
salts. (Scheme 4.5.3.)
.OMe





Schem e 4.5.3. Hydrolysis of bis-lactim ether 347 to afford a-deuterated phenylalanine 
methyl ester 353.
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Separation of the two a-am ino esters was achieved via column chromatography of the 
free amines, generated by treatment of the crude reaction mixture with sodium 
hydrogen carbonate. This afforded a-deuterated (R)-phenylalanine methyl ester 353 as 
its free amine, which was reacidified with 0.5M HCI solution to afford the more stable 
a-deuterated phenylalanine methyl ester hydrochloride salt in 71% overall yield from 
the frarcs-benzylated 6/s-lactim ether 347. (Scheme 4.5.4.)
i) N32C03, H2O
ii) chromatography
iii) 0.3M HCI(aq) NH2.HCI
MeO' MeO' MeO'Yield = 71%
353353
Schem e 4.5.4. Isolation of a-deuterated (R)-phenylalanine 353.
The *H NM R spectrum of 353 matched that of an authentic sample of phenylalanine 
methyl ester except for the expected loss of the proton resonance at the a-position and 
simplification of the ABX mulitplet of the benzylic methylene protons to an AB quartet 
6 3.24 (d, J  14.0 Hz) and 8 3.25 (d, J  14.0 Hz). (Figure 4.5.2.)
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Figure 4.5.2. 'H  NMR spectra of deuterated 353 and non-deuterated phenylalanine 
methyl esters.
The 2D NMR spectrum of a-deuterated (R)-phenylalanine methyl ester revealed a 
resonance for the deuterium atom at 8 4.22 (bs), at the same chemical shift observed for 
the a-proton of phenylalanine methyl ester in its !H NMR spectrum. The l3C NMR
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spectrum afforded six resonances again failing to show a resonance for the deuterated 
centre. This hydrolysis reaction was then repeated for the five further frarcs-benzylated 
£/s-lactim ethers 348-352 to afford a range of six a-deuterated (R)-substituted 
phenylalanines 354-358 that were converted into their free amines and separated from 
L-valine methyl ester by column chromatography. Conversion of these a-am ino esters 
to their hydrochloride salts afforded compounds with spectroscopic data consistent with 
formation of enantiopure a-deuterated phenylalanine methyl esters. It was particularly 
pleasing to find that specific rotation values of the three previously reported 
enantiopure phenylalanine methyl esters 354 and 3585 matched well with the data
1 7 ^  1 Q 1  1 0 9
reported previously for these non-deuterated a-am ino esters. ’ ’ (Figure 4.5.5.)
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Yield = 85% 
[a ]D25 = -24.8° 
lit. 179 [a]D25 = 24°
Figure 4.5.5. Structures of the synthesised enantiopure a-deuterated amino esters 353- 
358.
5 Comparison to the non-deuterated and opposite enantiomers.170,178,179
Chapter 4 187 Results and Discussion
4.5.3. Enantiomeric excess determination via the use of (S)-BINOL- 
boronate chiral derivitisation agent
The enantiomeric excess of (R)-a-deuterated phenylalanine 347 was confirmed through 
the employment of the (S)-BINOL-boronate-imine chiral derivatising agent previously 
described in section 3.4.2. In order to allow for comparative studies authentic boronate- 
imine complexes of racemic phenylalanine methyl ester 359 and (R)-phenylalanine-(S)- 
BINOL 360 were also formed. Analysis of the *H NMR spectrum of the complex 
derived from (/?)-a-deuterated phenylalanine methyl ester 361 showed that there was a 
single pair of resonances relating to the benzylic methylene protons at 5 2.96 (d, J  14.0 
Hz) and 8 3.27 (d, J  14.0 Hz), with a single resonance corresponding to the methyl ester 
group 8 3.70 (s) and a singlet for the imine proton at 8 7.92 (s). Comparison with the *H 
NMR spectra of the complexes formed from rac-phenylalanine methyl ester 359 and 
(R)-phenylalanine methyl ester 360 demonstrated that the raorco-deuterated (R)- 
phenylalanine methyl ester 353 had been formed in enantiopure form and had not 
undergone racemisation of the a-centre. Therefore, this observation provides further 
evidence that no racemisation of the bis-lactim ether 321 had occurred during its 
deuteration with di-methanol under acidic conditions. (Figure 4.5.3. and 4.5.4.)
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a-deuterated  (/^ -Phenylalanine  
methyl ester-{S)-BINOL-boronate
ppm
10 9 8 7 6 5 4 3 2 1 0 ppm
Figure 4.5.3. ’H NMR spectrum of a-deuterated (R)-phenylalanine methyl ester 361- 
boronate-imine complex.
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(S)-Phenylalanine methyl ester-(S)-BINO L-boronate (/^ -Phenylalanine methyl ester-(S)-BINO L-boronate
Figure 4.5.4. lH  NMR spectrum of rac-phenylalanine methyl ester 359-boronate-imine 
complexes.
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4.6. Conclusion
This section of the thesis has detailed work relating to the formation of orthogonally 
protected 6 /s-lactim ethers for the formation and facile separation of enantiopure a- 
amino esters.
It has also detailed work showing that deuterium can be readily and regioselective 
incorporated into the C6 position of bis-lactim ether 230 under mild conditions, and that 
the resultant deuterium labelled fo's-lactim ether 321 can be used for the asymmetric 
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5.1. Summary
In chapter 1 of this thesis the synthetic versatility of imino and lactim ethers was 
demonstrated, with particular reference made to their applicability in the field of 
heterocyclic chemistry and in turn to the arenas of drug discovery and natural product 
synthesis.
The second chapter described the development of methodology relating to the 
formation of the aza-enolates of lactim ethers, for the ensuing production of a-alkyl 
analogues. The methodology reported herein proceeded in high and reliable yields with 
a wide variety of substrates. The applicability of this methodology for the synthesis of a 
wide range of a-alkyl lactim ethers, a-alkyl co-amino esters and a-alkyl valerolactams 
was demonstrated. (Scheme 5.1.1.)
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Schem e 5.1.1. Overview of the alkylation of the aza-enolates of valero and caprolactim 
ethers, with the ensuing hydrolysis and neutralisation reactions to afford the a-alkyl 
valerolactams.
In the case of valerolactim ether it was further shown that the aza-tnolate of an a-alkyl 
valerolactim ether could also be alkylated in good yield, however the resultant 
compounds did not undergo hydrolysis to the corresponding a-alkyl 0 -amino esters, 
instead directly forming the di-alkyl valerolactams. (Scheme 5.1.2.)




R' Yield = 81% 
R1 = R2 = *Bu
Yield = 64-87%
1
R1 = Me, Bn or *Bu 
R2 = Me, Bn or 'Bu
Schem e 5.1.2. Alkylation of the aza-enolate of a-alkyl valerolactim ethers, and 
subsequent lactam formation of the di-‘butyl valerolactim ethers
Given the positive results in the racemic series, chapter 3 of this thesis concentrated on 
the development of analogous chiral systems through the use of chiral auxiliaries and 
chiral ligands. In the first case transesterification methodology was developed to afford 
a reliable route to valerolactim ethers containing chiral alcohol fragments (-)-menthol 
and (lS,2S)-2-methoxycyclohexanol. However, the diastereoselectivity obtained for 
alkylation of the aza-enolate of the (-)-menthol valerolactim ether proved 
unsatisfactory, furthermore the major diastereomer could not be purified to 
homogeneity. Alternatively, the (lS,2,S)-2-methoxycyclohexanol derived valerolactim 
ether did not afford products arising from alkylation of its aza-enolate but instead 
reacted with butyl lithium to afford an imine product. (Scheme 5.1.3.)
HO,
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Schem e 5.1.3. Transesterification of valerolactim ether with chiral alcohols and 
ensuing alkylation of the (-)-menthol valerolactim ether.
The final chapter of work within this thesis detailed research relating to two extensions 
to Schollkopf’s fr/s-lactim ether methodology. The first piece of research described the 
formation o f an orthogonally protected O-methyl O-benzyl bis-lactim ether, that once 
trans-alkylated and hydrolysed would have had the potential for facile separation of the
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amino esters formed through simple hydrogenation of the resultant a-alkyl benzyl 
amino ester to the corresponding a-alkyl amino acid. Further to this it was shown that 
this substrate offered ready access to mono-lactim ether species, that upon hydrolysis 
allowed access to enantiopure dipeptides. Unfortunately work in the area was curtailed 
through the moderate yields obtained during synthesis of the orthogonally protected 








Yield = 80% 
d.e. > 95% MeO'
Hydrogenation
Yield = 81% 
d.e. > 95% MeO'
Schem e 5.1.4. Formation of an orthogonally protected few-lactim ether and alkylation 
of its aza-enolate and hydrogenation to it mono-lactim species.
Concurrently to this orthogonal protection research another extension to this class of 
methodology was developed relating to the regioselective incorporation of a deuterium 
atoms into the auxiliary under mild conditions. The resultant isotopically labelled bis- 
lactim ether was employed for the synthesis of a range of (/?)-phenylalanines that were 
isolated in high yield. (Scheme 5.1.5.)
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Scheme 5.1.5. Deuteration, subsequent alkylation and hydrolysis of the az<z-enolate of 





"...long is the way, and hard
That out of Hell leads up to light.
Paradise Lost, II, 432-3
Chapter 6 197 Experimental
Chapter 6. Experimental
6.1. General conditions
M elting points were measured on a Biichi 535 melting point apparatus and are 
uncorrected. Optical rotations were recorded on an Optical Activity Ltd AA-10 
automatic polarimeter. Infra red spectra were recorded in the range 4000-600 cm ' 1 on a 
Perkin Elm er FT 1605 spectrometer using KBr plates with internal calibration. 
NMR spectra were recorded on a Bruker AM-300 spectrometer at 300 MHz. Chemical 
shifts (6) are expressed in parts per million (ppm), and are relative to residual protic 
solvent CHCI3 (8 h  7.26), CH3 OD (8 h  3.31) or tetramethyl silane (5h 0). The 
multiplicities are presented in the following manner:
-singlet, s 






-broad multiplet, bm 
-apparent, app
Coupling constants (J) are measured in Hz. Diastereomeric excesses were measured 
from GCMS spectra or the relative intensities of the relevant peaks in the 2H NM R 
spectra unless otherwise stated. 13C NMR spectra were recorded in CDCI3, M eOD, 
D 2O, at 75 M Hz using the resonance of CDCI3 (5c = 77.1, t) or ^ -m ethanol (5c = 49.0, 
sept) as the internal reference.
Gas Chromatography Mass spectra were carried out at the University of Bath (Hewlett 
Packard 5890 and Hewlett Packard 5970) and accurate mass spectra were carried out at 
the University of Wales, Swansea (Finnigan M AT 900 XLT) using electron ionisation 
(El) and chemical ionisation (El) techniques.
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Single crystal X-ray diffraction data were collected on a Nonius Kappa CCD machine. 
Structural determination and refinement were achieved using the SHELZ suite of 
programmes; drawings were produced using ORTEX.
Analytical thin layer chromatography was performed on precoated aluminium backed 
silica gel (M achery Nagel Alugram SI1 G/UV254) plates. Plates were visualised under 
ultra violet light (at 254 nm) or by staining with potassium permanganate, vanillin or 
phosphomolybdic acid before heating. Column chromatography was carried out using 
M erck Kieselgel 60H silica gel. Samples were added to the top of the column 
preabsorbed onto either silica or magnesium sulfate.
Tetrahydrofuran and diethyl ether were distilled from sodium benzophenone ketyl 
under nitrogen. Dichloromethane was distilled from CaH2 under nitrogen. Petrol refers 
to light petroleum, bp 40-60 °C and was distilled without drying.
Commercially available starting materials were obtained from Avocado, Sigma- 
Aldrich, Merck, Lancaster, Acros or Fluka and were used throughout without further 
purification. Reactions requiring anhydrous conditions were performed under nitrogen 
in oven or flame dried apparatus.
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6.2. General procedures
General protocol A
0  Me3O.BF4, PCM N QMe
Trimethyloxonium tetrafluoroboronate (1.1 eq.) was added directly to a stirred solution 
of the corresponding lactam (1 eq.) in DCM  at room temperature under a nitrogen 
atmosphere and allowed to stir for 18 hours. Solid K2CO3 (1.5 eq.) was added and the 
reaction stirred until the reaction mixture ceased effervescence, saturated K2CO3 was 
then added and the reaction mixture stirred for a further 5 minutes, before being diluted 
with distilled water and DCM. The organic phase was extracted with DCM  (x 3). The 
combined organic extracts were washed with dilute K2 CO3 (x 3), dried (MgS04) and 
concentrated in vacuo to afford the corresponding O-methyl lactim ether.
General procedure B
lactim ether (1 eq.) in THF at -78  °C under a nitrogen atmosphere, the reaction mixture 
was then allowed to warm to room temperature and to stir for 15 minutes before being 
cooled to -7 8  °C. The corresponding electrophile was then added dropwise to the 
stirred solution and allowed to warm to room temperature over 16 hours. Alkaline 
water (pH >8 via K2 CO3 ) was added and the reaction extracted with E t20 (x 3). The 
combined organic extracts were dried (MgS04) and concentrated in vacuo before 
undergoing Kiigelrohr distillation to afford the corresponding a-alkyl lactim ether.
i) 'BuLi, THF, -78°C
ii) 0°C, 15 minutes 
OMe iii) -78°C, RX, 16hrs
R
A solution of lBuLi in hexanes (1.5 eq.) was added dropwise to a stirred solution of
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General procedure C
.N .  .OMe
i) ’BuLI, KO’Bu, THF, -78°C
ii) 0°C, 15 minutes
iii) -78°C, RX, 16hrs
.l\L .OMe
A solution of lBuLi in hexanes (1.5 eq.) was added dropwise to a stirred solution of 
lactim ether (1 eq.) and KOlBu (1.5 eq.) in THF at -7 8  °C under a nitrogen atmosphere, 
the reaction mixture was then allowed to warm to room temperature and to stir for 15 
minutes before being cooled to -78  °C. The corresponding electrophile was then added 
dropwise to the stirred solution and allowed to warm to room temperature over 16 
hours. Alkaline water (>pH 8 via K2CO3) was added and the reaction extracted with 
Et20 (x 3). The combined organic extracts were dried (MgSC>4) and concentrated in 
vacuo to afford the corresponding a-alkyl, or a,a-dialkyl lactim ether.
General procedure D
A solution of nBuLi in hexanes (2.5 eq.) was added dropwise to a stirred solution of 
lactim ether 288 (1 eq.) in THF at -78  °C under a nitrogen atmosphere, the reaction 
mixture was then allowed to warm to room temperature and to stir for 60 minutes 
before being cooled to -78 °C. The corresponding electrophile was then added dropwise 
to the stirred solution and allowed to warm to room temperature over 16 hours. 
Alkaline w ater (pH >8 via K2CO3) was added and the reaction extracted with E t20 (x 
3). The com bined organic extracts were dried (MgSCU) and concentrated in vacuo to 
afford the corresponding a-alkyl (-)-menthol lactim ether.
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General protocol E
^ y . O M e  0.1MHCW CHCI3  _ _ X ^ . n h , h c
MeO'
0.1M HClaq (1.5 eq.) was added to a stirred solution of the corresponding lactim ether 
in CHCI3 and the reaction mixture stirred vigorously for 16 hours. The reaction was 
then concentrated in vacuo to yield the corresponding a-alkyl co-amino ester 
hydrochloride salt.
General protocol F
H2. Pd(OH)a/C, EtOAc, rt
Lactim ether (1.1 eq) was stirred vigorously in the presence of palladium dihydroxide 
on carbon (0.15 eq) in EtOAc under an atmosphere of hydrogen for 16 hours. The 
reaction mixture was then dried (MgS04) filtered through Celite® and concentrated in 
vacuo to afford the corresponding lactam.
General procedure G
.OMe i) nBuLi, THF, -78°C, 10 mins 
ii) RBr, 16 hrs
nBuLi in hexanes (1.1 eq.) was added dropwise to a stirred solution of fr/s-lactim ether 
in THF under nitrogen at -78 °C, and the reaction mixture allowed to stir for 10 minutes 
at -78 °C. A solution of the electrophile (1.3 eq.) in THF was added dropwise to the 
above stirred solution, and the reaction mixture allowed to stir for 16 hours whilst 
warming to room  temperature. Alkaline water (pH >8 via K2 CO3 ) was added and the 
reaction extracted with E t20 (x 3). The combined organic extracts were dried (MgSCU) 
and concentrated in vacuo to afford the corresponding frcms-alkylated bis-lactim ether.
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General procedure H
IV  ^.OMe i) nBuLi, THF, -78°C, 1hr 
ii) RBr, 16 hrs
MeO MeO'
nBuLi in hexanes (1.1 eq.) was added dropwise to a stirred solution of fos-lactim ether 
in THF under nitrogen at -78 °C, and the reaction mixture allowed to stir for 1 hour at - 
78 °C. A solution of the electrophile (1.3 eq.) in THF was added dropwise to the above 
stirred solution, and the reaction mixture allowed to stir for 16 hours whilst warming to 
room temperature. Alkaline water (pH >8 via K2 CO3 ) was added and the reaction 
extracted with Et20 (x 3). The combined organic extracts were dried (MgS04) and 
concentrated in vacuo to afford the corresponding rrarcs-alkylated fo's-lactim ether.
General procedure I
.OMe i) 0.3M HCI, MeCN
MeO'
MeO' - f x
7><ms-alkylated deuterated fo's-lactim ether (1.0 eq.) was added to a 1:1 stirred solution 
of 0.3M HCI (3 eq.) in M eCN and allowed to stir vigorously for 20 minutes. The 
reaction mixture was then concentrated in vacuo and neutralised with concentrated 
Na2HCC>3 solution (1.5 eq.) before being purified by column chromatography, 
reacidified with 0.3M HCI (1.5 eq.) and the solvent removed in vacuo to afford the 
desired a-deuterated a-am ino ester.
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6.3. Experimental data 
Methyl 2,2,2-trichloroacetimidate 317
NHX
MeO"  ^ ^CCI3 
3
Trichloroacetonitrile (10 ml, 100 mmol) was added to a stirred solution of methanol 
(6.5 ml, 200 mmol) and 60% sodium hydride in mineral oil (0.3901 g, 9.58 mmol) in 
DCM  (100 ml) and the reaction mixture stirred for 16 hours. Alkaline water (pH >8 via 
K2 CO3 ) was added and the reaction extracted with DCM  (3 x 25 ml). The combined 
organic extracts were dried (M gS04) and concentrated in vacuo to afford a crude 
product. The crude product was purified via distillation to afford the title compound 3 
as a clear oil (14.64 g, 83.1 mmol) in 83% yield; 6h(300MHz, CDC13, M e4Si) 3.95 (3H, 
s, Me), 8.28 (1H, bs, NH); Sc(75MHz, CDC13, M e4Si) 56.2, 91.4, 163.7.
Benzyl 2,2,2-trichloroacetimidate 417
4
Trichloroacetonitrile (10 ml, 100 mmol) was added to a stirred solution of benzyl 
alcohol (13 ml, 127 mmol) and 60% sodium hydride in mineral oil (0.4275 g, 10.67 
mmol) in DCM  (100 ml) and the reaction mixture stirred for 16 hours. Alkaline water 
(pH >8 via K2 CO3 ) was added and the reaction extracted with DCM  (3 x 25 ml). The 
combined organic extracts were dried (M gS04) and concentrated in vacuo to afford a 
crude product. The crude product was purified via distillation to afford the title 
compound 4 as a clear oil (17.17 g, 68 mmol) in 68% yield; 5h(300MHz, CDCI3, 
M e4Si) 5.35 (2H, s, CH2), 7.13-7.38 (5H, bm, HAR), 8.30 (1H, bs, NH).
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Trimethyloxonium tetrafluoroboronate130
Me F
M  F_ B®
Me Me I
F
Dimethyl ether (100 g, 2.17 mol) was condensed into a stirred solution of 
epichlorohydrin (10 ml, 128 mmol) in DCM  (125 ml) at -78 °C under nitrogen. The 
reaction vessel was fitted with a dry ice condenser and the reaction mixture was 
warmed to -20 °C. BF3.0 Et2 (10 ml, 63 mmol) was added dropwise to the reaction 
mixture with stirring, after the addition was complete a second aliquot of 
epichlorohydrin (10 ml, 128 mmol) was added and the reaction mixture stirred. This 
process of alternating additions was repeated 7 times in total before the reaction 
mixture was allowed to warm to room temperature. Filtration afforded a crude white 
solid that was washed with CHCI3 (100 ml) to afford the title compound as a white 
solid (147 g, 99.9 mmol) in 92% yield.
3,4-dihydro-5-methoxy-2H-pyrrole 39183
Reaction of butyrolactam 246 (21.50 g, 0.25 mol) with trimethyloxonium 
tetrafluoroboronate (48.61 g, 0.329 mol) in DCM  (50 ml) according to general protocol 
A afforded the title compound 39 as a clear oil (21.06g, 0.21 mol) in 85% yield,
39
v „ / c r a ' '  1652 (C=N); 8h(300MHz, CDCI3, M e4Si) 1.96 (2H, app ttt, J  8.0, 7.0 and 1.2 
Hz, 2 x H3), 2.34 (2H, J  8.0 and 1.2 Hz, 2 x H4), 3.59 (2H, tt, J  7.0 and 1.2 Hz, 2 x 
H2), 3.73 (3H, s, OMe); 5c(75MHz, CDC13, Me4Si) 23.7, 31.2, 55.3, 55.6, 174.1; m/z 
(El) 100.0757 (M-H* requires 100.0757) 100 (100%).




Reaction of valerolactam 215 (22.4 g, 0.23 mol) with trimethyloxonium 
tetrafluoroboronate (43.47 g, 0.29 mmol) in DCM  (50 ml), according to general 
protocol A afforded the title compound 15 as a clear oil (23.03 g, 0.202 mmol) in 88% 
yield, v ^ / c m ' 1 1635 (C=N); 8h(300MHz, CDC13, Me4Si) 1.45-1.54 (2H, bm, 2 x H4), 
1.60-170 (2H, bm, 2 x H3), 2.01 (2H, dt, J  6.8 and 1.2 Hz, 2 x H5), 3.41 (2H, dt, J  5.7 
and 1.2 Hz, 2 x H2), 3.55 (3H, s, OMe); 8c(75MHz, CDC13, Me4Si) 20.7, 22.8, 26.2, 




Reaction of caprolactam 10 (15.2 g, 0.12 mol) with trimethyloxonium
tetrafluoroboronate (23.1 g, 0.16 mol) in DCM  (25 ml), according to general protocol A 
afforded the title compound 16 as a clear oil (11.86 g, 93.3 mmol) in 78% yield, 
V m ax/cm '1 1678 (C=N); 8h(300MHz, CDC13, Me4Si) 1.38-1.52 (4H, bm, 2 x H4 and 2 x 
H5), 1.62-1.72 (2H, bm, 2 x H3), 2.31 (2H, app t6, J  5.7 Hz, 2 x H 6), 3.32 (2H, app tvi, 
J  4.9 Hz, 2 x H2), 3.49 (3H, s, OMe); 8c(75MHz, CDC13, M e4Si) 23.8, 28.3,31.6, 32.4, 
49 .0 ,52 .8 ,170 .1 ; m/z (El) 128.1070 (M-H+ requires 128.1070) 128 (100%).
(T
6 Second order multiplet due to magnetic inequivalence




Reaction of oenantholactam 243 (10.2 g, 72.2 mmol) with trimethyloxonium 
tetrafiuoroboronate (13.90 g, 93.9 mol) in DCM  (15 ml) according to the general 
protocol A afforded the title compound 237 as a clear oil (8.16 g, 57.8 mmol) in 80% 
yield; v ^ / c m ' 1 1665 (C=N); 5h(300MHz, CDC13, M e4Si) 1.24-1.43 (4H, bm, 2 x H4 
and 2 x H5), 1.46-1.65 (4H, bm, 2 x H3 and 2 x H6), 2.24 (2H, t, J  6.3 Hz, 2 x H7), 
3.34 (2H, t, J  5.8 Hz, 2 x H2), 3.54 (3H, s, OMe); 6c(75MHz, CDC13, Me4Si) 24.8,





A solution o f 39 (0.200 g, 2.02 mmol) in THF was allowed to stand in the presence of 
3A molecular sieves (0.010 g) for 15 minutes before being transferred to a via cannular 
to a second round bottomed flask. "Butyl lithium (1.3 ml, 3.03 mmol) was then added 
dropwise to the above stirred solution at -78 °C under nitrogen, the reaction mixture 
was allowed to warm to room temperature and to stir for 15 minutes before being 
cooled to -7 8  °C. The allyl bromide (0.22 ml, 3.03 mmol) was then added dropwise to 
the stirred solution and allowed to warm to room temperature over 16 hours. Alkaline 
water (pH >8 via K2C0 3) was added and the reaction extracted with Et20 (3 x 25 ml). 
The combined organic extracts were dried (M gS04) and concentrated in vacuo to afford 
a crude product. The crude product was purified by silica gel chromatography (20% 
EtOAc/petrol) to afford the title compound 248 (0.39 g, 0.2365 mmol) in 12% yield as
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a clear oil, v ^ / c m '11640 (C=C), 1699 (C=N); 6h(300MHz, CDC13, M e4Si) 0.83 (3H, t, 
J  7.0 Hz, 3 x H I ’), 1.12-1.22 (2H, m, 2 x H 2’), 1.36-1.47 (2H, m, 2 x H 3’), 1.75 (2H, 
app quin, J  7.0 Hz, 2 x H3), 2.18 (2H, app tt, J  7.0 and 1.1 Hz, 2 x H 3” ), 2.33 (2H, tt, J
8.2 and 1.7 Hz, 2 x H4), 2.51 (1H, app q, J 1 2  Hz, 1 x H 4 ’), 3.71 (2H, tt, 7 7 .0  and 1.7 
Hz, 2 x H2), 4.90 (1H, app dq, J  10 and 1.1 Hz, 1 x H I ” cw), 4.94 (1H, ddt, J  17.1, 1.5 
and 1.5 Hz, 1 x H l” trans), 5.66 (1H, ddt, J  17.1, 10 and 7.2 Hz, 1 x H 2” ), 8c(75MHz, 
CHC13, M e4Si) 14.5, 20.9, 22.8, 35.0, 35.0, 37.7, 43.7, 60.6, 116.3, 136.9, 181.3; m/z 
(El) 166.1590 (M-H+ requires 166.1590) 166 (100%)
5-butyl-3,4-dihydro-2H-pyrrole 250184
A solution of 1.7M "BuLi in hexanes (3.26 ml, 5.5 mmol) was added dropwise to a 
stirred solution of 39 (0.5000 g, 5.0 mmol) in THF (10 ml) at -78 °C under a nitrogen 
atmosphere. The reaction mixture was then allowed to warm to room temperature and 
stir for 15 minutes before being recooled to -78 °C and stirred for 5 minutes, water (0.3 
ml, 0.17 mmol) was then added and the reaction mixture allowed to stir for 16 hours. 
Alkaline water (pH >8 via K2CO3) was added and the reaction extracted with Et20 (3 x 
25 ml). The combined organic extracts were dried (M gS04) and concentrated in vacuo 
to afford a crude product. The crude product was purified by silica gel chromatography 
(50% EtOAc/petrol) to afford the title compound 250 (0.0145 g, 0.12 mmol) in 21% 
yield as a clear oil; v ^ / c m ' 1 1690 (C=N); 5h(300MHz, CDCI3, Me4Si) 0.85 (3H, t, J
7.0 Hz, 3 x H I ’), 1.27 (2H, app sept, J  7.0 Hz, 2 x H 2’), 1.44-1.59 (2H, m, 2 x H 3’), 
1.78 (2H, app quin, J  7.5 Hz, 2 x H3), 2.26 (2H, app tt, J  7.5 and 1.5 Hz, 2 x H4), 2.35 
(2H, t, J  8.0 Hz, 2 x H 4’), 3.72 (2H, tt, J  7.5 Hz, 1.5 Hz, 2 x H2); 8c(75MHz, CHCI3, 
Me4Si) 13 .9 ,22 .6 ,22 .7 ,28 .6 , 33 .5 ,37 .1 ,60 .7 ,178 .6 ; m/z (El) 126.0114 (M-H+ requires 
126.0115) 126(100% )
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3,4,5,6-tetrahydro-2-methoxy-3-methylpyridine 224
2 > - N v  ^OMe
(X3V ^ v
224
Reaction of 15 (0.2255 g, 1.98 mmol) in THF (8 ml) with a 1.7M solution of ‘butyl 
lithium in hexanes (1.7 ml, 2.97 mmol) and methyl iodide (0.19 ml, 2.97 mmol) 
according to general procedure B afforded the title compound 224 as a clear oil (0.1595 
g, 1.25 mmol) in 63% yield, vmax/c rn 11674 (C=N); 6h(300MHz, CDC13, Me4Si) 1.09 
(3H, d, 7  7.0 Hz, 3 x H I ’), 1.30-1.64 (3H, bm, 2 x H3 and 1 x H4), 1.73-1.85 (1H, bm, 
1 x H4), 2.24 (1H, app hex, J  7.0 Hz, 1 x H5), 3.39 (2H, dt, J  5.8 and 1.2 Hz, 2 x H2), 
3.53 (3H, s, OMe); 5c(75MHz, CDC13, M e4Si) 18.9, 29.4, 29.8, 31.8, 47.9, 52.6, 166.5; 
m/z (El) 128.1068 (M-H+ requires 128.1070) 128 (100%)
3-benzyl-3,4,5,6-tetrahydro-2-methoxypyridine 217
217
Reaction of 15 (0.2190 g, 1.92 mmol) in THF (8 ml) with a 1.7M solution of ‘butyl 
lithium in hexanes (1.7 ml, 2.89 mmol) and benzyl bromide (0.34 ml, 2.88 mmol) 
according to general procedure B afforded the title compound 217 as a clear oil (0.3396 
g, 1.67 mmol) in 87% yield, vmax/crn '11674 (C=N): 6h(300MHz, CDC13, Me4Si) 1.33- 
1.60 (4H, bm, 2 x H3 and 2 x H4), 2.38-2.49 (1H, bm, 1 x H5), 2.55 (1H, dd, J  13.2 and
3.2 Hz, 1 x H I ’), 3.12 (1H, dd, J  13.2 and 3.6 Hz, 1 x H I ’), 3.41-3.34 (2H, bm, 2 x 
H2), 3.61 (3H, s, OMe), 7.07-7.25 (5H, bm, Hat); 5c(75MHz, CDC13, Me4Si) 21.1,
25.4, 38.3, 38.3, 47.7, 52.4, 126.5, 128.7, 129.6, 140.2, 164.7, m/z (El) 204.1385 (M-H+ 
requires 204.1383) 204 (100%)
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3-allyl-3,4,5,6-tetrahydro-2-methoxypyridine 225
225
Reaction of 15 (0.2500 g, 2.20 mmol) in THF (5 ml) with a 1.7M solution of lbutyl 
lithium in hexanes (2.0 ml, 3.30 mmol) and allyl bromide (0.57 ml, 6.60 mmol) 
according to general procedure B afforded the title compound 225 as a clear oil (0.2223 
g, 1.45 mmol) in 66% yield, v ^ / c m ' 1 1641 (C=C), 1674 (C=N); 5h(300M Hz, CDC13, 
M e4Si) 1.31-1.77 (4H, bm, 2 x H3 and 2 x H4), 2.08-2.29 (2H, bm, 2 x H 3’), 2.34-2.44 
(1H, m, 1 x H5), 3.37 (2H, app q, J  5.6 Hz, 2 x H2), 3.53 (3H, s, OMe), 4.96 (1H, dm, J
10.0 Hz, 1 x H l ’cis), 4.98 (1H, dm, J  17.0 Hz, 1 x H l ,trans), 5.65 (1H, ddt, J  6 .8, 10.0 
and 17.0 Hz, 1 x H 2’); 5c(75MHz, CDC13, Me4Si) 21.4, 25.8, 36.2, 36.7, 47.4, 52.3,
117.1, 136.5,164.7; m/z (El) 154.1226 (M-H+ requires 154.1228) 154 (100 %).
3-ethyl-3,4,5,6-tetrahydro-2-methoxypyridine 226
226
Reaction of 15 (0.2255 g, 1.98 mmol) in TH F (7 ml) with a 1.7M solution of ‘butyl 
lithium in hexanes (1.7 ml, 2.97 mmol) and ethyl bromide (0.44 ml, 5.92 mmol) 
according to general procedure B afforded the title compound 226 as a clear oil (0.1595 
g, 1.25 mmol) in 68% yield; Vn^/cm ' 1 1675 (C=N); 6h(300MHz, CDC13, Me4Si) 0.83 
(3H, t, J 7.5 Hz, 3 x H I ’), 1.31-1.79 (6H, bm, 2 x H3, 2 x H4 and 2 x H 2’), 2.04-2.15 
(1H, m, 1 x H5), 3.33-3.43 (2H, m, 2 x H2), 3.53 (3H, s, OMe); 5c(75M Hz, CDC13, 
Me4Si) 1 1 .6 ,2 1 .6 ,2 5 .3 ,2 5 .8 ,3 8 .0 ,4 7 .5 ,5 2 .3 ,1 6 5 .6 ; m/z (El) 142.1226 (M -H+ requires 
142.1226) 142 (59%), 128 (M-H+ - OMe + NH3, 100) 142 (62).
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3,4,5,6-tetrahydro-2-methoxy-3-(prop-2-ynyl)pyridine 227
227
Reaction of 15 (0.2337 g, 2.05 mmol) in THF (6 ml) with a 1.7M solution of ‘butyl 
lithium in hexanes (1.55 ml, 3.08 mmol) and propargyl bromide (80% in toluene) (0.55 
ml, 6.16 mmol) according to general procedure B afforded the title compound 227 as a 
clear oil (0.2407 g, 1.59 mmol) in 78% yield, vmJ c m l 1678 (C=N), 2118 (C=C), 3296 
(C=C-H); 5h(300MHz, CDC13, Me4Si) 1.39-1.55 (1H, bm, 1 x H4), 1.56-1.76 (2H, bm, 
1 x H3 and 1 x H4), 1.83-1.90 (1H, m, 1 x H3), 1.92 (1H, t, J  2.6 Hz, 1 x H I ’), 2.34 
(2H, m, 1 x H 3’ and 1 x H5), 2.52 (1H, app ddd, /  2.6, 7.35 and 12.6 Hz, 1 x H 3’), 
3.36-3.45 (2H, m, 2 x H2), 3.54, (3H, s, OMe); 5c (75MHz, CDC13, Me4Si) 21.7, 22.0,
26.2, 35.9, 47.4, 52.5, 70.2, 82.1, 163.2; m/z (El) 152.1070 (M-H+ requires 152.1070) 
152 (100%), 138 (M-H+ - OMe + NH3, 17).
3,4,5,6-tetrahydro-3-isopropyl-2-methoxypyridine 229
Reaction of 15 (0.2620 g, 2.30 mmol) in THF (5 ml) with a 1.7M solution of “butyl 
lithium in hexanes (1.4 ml, 3.45 mmol) and ‘propyl iodide (0.79 ml, 7.90 mmol) 
according to general procedure B afforded the title compound 229 as a clear oil (0.2952 
g, 1.90 mmol) in 83% yield, vmJ c m l 1675 (C=N); 5h(300MHz, CDC13, Me4Si) 0.74 
(3H, d, J  7.0 Hz, 3 x H I ’), 0.84 (3H, d, / 7 .0  Hz, 3 x H I ’), 1.34-1.44 (2H, bm, 2 x H4), 
1.55-1.71 (2H, bm, 2 x H3), 2.13-2.24 (1H, bm, 1 x H5), 2.22 (1H, m, 1 x H 2’), 3.17- 
3.30 (2H, bm, 2 x H2), 3.53 (3H, s, OMe); 8c(75MHz, CDC13, M e4Si) 18.0, 20.2, 21.6, 
22.9, 28.9, 42.6, 44.3, 52.3.7 m/z (El) 156.0592 (M-H+ requires 156.0591) 156 (100%)
7 No quaternary peak owing to a weak signal
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3,4,5,6-tetrahydro-3-isobutyl-2-methoxypyridine 228
228
Reaction of 15 (0.2060 g, 1.81 mmol) in THF (5 ml) with a 1.7M solution of “butyl 
lithium in hexanes (1.1 ml, 2.72 mmol) and ‘butyl bromide (0.62 ml, 5.44 mmol) 
according to general procedure B afforded the title compound 228 as a clear oil (0.1963 
g, 1.16 mmol) in 64% yield, vmJ c m l 1675 (C=N), 5h(300MHz, CDC13, Me4Si) 0.81 
(3H, d, 7  6.4 Hz, 3 x H I ’), 0.84 (3H, d, 7  6.4 Hz, 3 x H I ’), 1.13-1.27 (2H, m, 2 x H 3’),
1.34-1.77 (5H, bm, 2 x H3, 2 x H4 and 1 x H 2’), 2.13-2.24 (1H, m, 1 x H5), 3.38 (2H, 
dt, 7  1.2 and 5.6 Hz, 2 x H2), 3.52 (3H, s, OMe), 5c(75MHz, CDC13, Me4Si) 20.8, 21.3,




Reaction of 160 (0.1203 g, 0.71 mmol) in THF (5 ml) with a 1.7M solution of “butyl 
lithium in hexanes (0.63 ml, 1.06 mmol), potassium ‘butoxide (0.0921 g, 0.75 mmol) 
and 'butyl bromide (0.24 ml, 2.12 mmol) according to general procedure B afforded the 
title compound 230 as a clear oil (0.1087 g, 0.48 mmol) in 64% yield, Vmax/cm' 1 1675 
(C=N); 5h(300MHz, CDC13, Me4Si) 0.77 (6H, d, J  6.4 Hz, 3 x H I ’), 0.82 (6H, d, J  6.4 
Hz, 3 x H I ’), 1.17 (4H, dd, 7 4 .0  and 13.6 Hz, 4 x H 3’), 1.47-1.66 (6H, bm, 2 x H3, 2 x 
H4, 2 x H 2’), 3.41 (2H, t, 7 5.65 Hz, 2 x H2), 3.48 (3H, s, OMe); 6c(75MHz, CDC13, 
Me4Si) 21.6, 23.7, 24.9, 26.1, 30.9, 41.4, 47.9, 49.6, 51.7, 167.9; m/z (El) 226.2165 (M- 
H+ requires 226.2165) 226 (100%).




Reaction of 217 (0.0988 g, 0.49 mmol) in THF (5 ml) with a 1.5M solution of “butyl 
lithium in hexanes (0.49 ml, 0.73 mmol), potassium ‘butoxide (0.0862 g, 0.768 mmol) 
and benzyl bromide (0.087 ml, 0.73 mmol) according to general procedure C afforded 
the title compound 231 as a clear oil (0.1251 g, 0.43 mmol) in 87% yield, Vmax/cm'1 
1675 (C=N); 6h(300MHz , CDC13, Me4Si) 1.32-1.42 (2H, m, 2 x H4), 1.48-1.55 (2H, m, 
2 x H3), 2.46 (2H, d, J  13.2 Hz, 2 x H I ’), 2.87 (2H, t, J  5.7 Hz, 2 x H2), 3.20 (2H, d, J
13.2 Hz, 2 x H I ’), 3.65 (3H, s, OMe), 6.86-7.29 (10H, bm, 10 x H a r ) ;  5c(75MHz, 
CDC13, M e4Si) 19.0, 27.4, 32.5, 36.9, 44.2, 50.6, 125.3, 127.3, 128.0, 129.3, 163.6; m/z 
(El) 294.2145 (M -H+ requires 294.2146) 294 (100%).
3-benzyl-3,4,5,6-tetrahydro-2-methoxy-3-methylpyridine 232
2 .N .  .OMe 
4 J ?
232
Reaction of 224 (0.1212 g, 0.95 mmol) in THF (5 ml) with a 1.5M solution of “butyl 
lithium in hexanes (1.0 ml, 1.48 mmol), potassium lbutoxide (0.1785, 1.46 mmol) and 
benzyl bromide (1.7 ml, 1.43 mmol) according to general procedure C afforded the title 
compound 232 as a clear oil (0.1486 g, 0.68 mmol) in 72% yield, Vmax/cm'1 1675 
(C=N); 5h(300M Hz, CDC13, Me4Si) 1.15 (3H, s, 3 x H I ’), 1.35-1.56 (4H, bm, 2 x H3, 2 
x H4), 2.51 (d, J  13.2 Hz, 1 x H 2’), 2.81 (2H, t, J  5.7 Hz, 2 x H2), 3.15 (1H, d, J  13.2 
Hz, 1 x H 2’), 3.64 (3H, s, OMe), 6.95-7.25 (5H, bm, 5 x Hat); 5c(75MHz, CDC13, 
M e4Si) 19.7, 26.4, 28.1, 31.2, 37.2, 45.4, 51.0, 123.2, 127.8, 128.1, 129.8, 164.9; m/z 
(El) 218.1186 (M -H+ requires 218.1186) 218 (100%).
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3-benzyl-3,4,5,6-tetrahydro-2-methoxy-3-methylpyridine 232
Reaction of 217 (0.1298 g, 0.64 mmol) in THF (5 ml) with a 1.5M solution of “butyl 
lithium in hexanes (0.64 ml, 0.96 mmol), potassium lbutoxide (0.1182 g, 0.96 mmol) 
and methyl iodide (0.060 ml, 0.96 mmol) according to general procedure C afforded the 
title compound 232 as a clear oil (0.0974 g, 0.45 mmol) in 70% yield.
2-Methyl-pentanoic acid methyl ester 253
Reaction of 224 (0.0351 g, 0.276 mmol) in CHCI3 (0.5 ml) with 0.1M HC1 (4.1 ml, 
0.414 mmol) according to general procedure E afforded the title compound 253 (0.0460 
g, 0.254 mmol) as a semi crystalline material in 92% yield, Vm ax/cm '1 3441 (NH), 1643 
(C =0); 8h(300MHz, MeOD) 1.07 (3H, d, J  7.0 Hz, 3 x H I ’), 1.30-1.68 (4H, bm, 2 x 
H3, 2 x H4), 2.41 (1H, app hept, J  7.0 Hz, 1 x H2), 2.80 (2H, t, J  6.8 Hz, 2 x H5), 3.56 
(3H, s, OMe), 8c(75MHz, MeOD) 17.9, 26.7, 31.8, 40.5, 41.0, 52.6, 178.6, m/z (El) 
146.1172 (M-H* requires 146.1176) 146 (100%).
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Methyl 5-amino-2-benzylpentanoate hydrochloride 253
MeO' NH2.HCI
254
Reaction of 217 (0.0254 g, 0.125 mmol) in CHC13 (0.5 ml) with 0.1M HC1 (1.9 ml, 
0.186 mmol) according to general procedure E afforded the title compound 253 (0.0305 
g, 0.119 mmol) as a semi crystalline material in 95% yield, V m ax/cm '1 3428 (NH), 1642 
(C =0), 8h(300MHz, MeOD) 1.46-1.64 (4H, bm, 2 x H3, 2 x H4), 2.58-2.87 (5H, bm, 2 
x H I ’, 1 x H2, 2 x H5), 3.48 (3H, s, OMe), 7.02-7.21 (5H, bm, 5 x Ha,); §c(75MHz, 
M eOD) 26.8, 30.3, 3 9 .9 ,4 1 .0 ,4 8 .9 ,5 2 .6 ,1 2 8 .0 ,1 2 9 .9 ,1 3 0 .7 ,1 4 0 .7 ,177.5.8
Methyl 2-(3-aminopropyl)pent-4-enoate hydrochloride 255
MeO'
255
Reaction of 225 (0.0289 g, 0.189 mmol) in CHC13 (0.5 ml) with 0.1M HC1 (2.8 ml, 
0.283 mmol) according to general procedure E afforded the title compound 255 (0.0351 
g, 0.170 mmol) as a semi crystalline material in 90% yield, Vmax/cm' 1 1660 (C =0); 
6h(300MHz, MeOD) 1.54-1.74 (4H, bm, 2 x H3, 2 x H4), 2.26 (1H, dd, J  7.3, 14.1 Hz, 
1 x H 3’), 2.38 (1H, dd, /7 .3 ,  14.1 Hz, 1 x H 3’), 2.47-2.58 (1H, bm, 1 x H2), 2.93 (2H, 
td, J  7.3, 2.5 Hz, 2 x H5), 3.67, (3H, s, OMe), 5.02 (1H, ddd, J  10.7, 1.0, 1.0 Hz, 1 x 
H l ’cis), 5.06 (1H, ddt, J  17.0, 1.7, 1.3 Hz, 1 x H l ’cis), 5.76 (1H, ddt, J  17.0, 10.7, 7.0 
Hz, 1 x H 2’); 6c(75MHz, MeOD) 26.8, 29.9, 37.9, 41.0, 46.4, 52.6, 117.9, 136.8, 
177.5.viii
8 Mass spectrum matched that of the corresponding lactam.
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Methyl 5-amino-2-ethylpentanoate hydrochloride 256
256
Reaction of 226 (0.0151 g, 0.107 mmol) in CHCI3 (0.5 ml) with 0.1M HC1 (1.6 ml, 
0.160 mmol) according to general procedure E afforded the title compound 256 (0.0169 
g, 0.087 mmol) as a semi crystalline material in 81% yield, Vmax/cm' 1 1632 (C =0); 
5h(300M Hz, M eOD) 0.81 (3H, t, 7 7 .0  Hz , 3 x H I ’), 1.41-1.64 (6H, 2 x H 2’, 2 x H3, 2 
x H4), 2.19-2.33 (1H, bm, 1 x H2), 2.83 (2H, t, J  6.0 Hz, 2 x H5), 3.60 (3H, s, OMe); 
§c(75MHz, M eOD) 12.8, 26.9, 26.9, 29.9, 41.1, 48.3, 52.5, 178.2, m/z (El) 131 (-Et 
16), 127 (amide 32) 87 (-C 0 2Me 100%).
Methyl 2-(3-aminopropyl)pent-4-ynoate hydrochloride 257
o
257
Reaction of 227 (0.0270 g, 0.179 mmol) in CHC13 (0.5 ml) with 0.1M  HC1 (2.3 ml, 
0.230 mmol) according to general procedure E afforded the title compound 257 (0.0357 
g, 0.173 mmol) as a semi crystalline material in 97% yield, Vmax/cm*1 1634 (C =0), 
6h(300MHz, M eOD) 1.47-1.70 (4H, bm, 2 x H3, 2 x H4), 2.24 (1H, t, J  2.6 Hz, 1 x 
H I ’), 2.31-2.41 (2H, bm, 2 x H 3’), 2.52 (1H, app quin, J  7.0 Hz, 1 x H2), 2.81 (2H, t, J
7.5 Hz, 2 x H5), 3.60 (3H, s, OMe); 5c(75MHz, MeOD, Me4Si) 22.4, 26.6, 29.8, 41.0,
45.6, 52.9, 72.0, 82.0, 176.5.viii
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Methyl 2-(3-aminopropyl)-4-methylpentanoate hydrochloride 258
MeO' NH2 HCI
258
Reaction of 228 (0.0301 g, 0.178 mmol) in CHCI3 (0.5 ml) with 0.1M HC1 (2.7 ml, 
0.267 mmol) according to general procedure E afforded the title compound 258 (0.0361 
g, 0.162 mmol) as a semi crystalline material in 91% yield, Vmax/cm' 1 1719 (C =0), 
5h(300MHz, MeOD) 0.81 (6H, app t, 7  6.6 Hz, 6 x H I ’), 1.11-1.19 (1H, bm, 1 x H 2’),
1.35-1.62 (6H, bm, 2 x H3, 2 x H4, 2 x H 3’), 2.41 (1H, app hept, 7  4.5 Hz, 1 x H2), 
2.76-2.85 (2H, bm, 2 x H5), 3.59 (3H, s, OMe); 8c(75MHz, MeOD) 22.8, 24.5, 27.0,
27.8, 31.1, 41.0,43.4, 45.0, 52.5,178.5.
Methyl 5-amino-2-isopropylpentanoate hydrochloride 259
o
259
Reaction of 229 (0.0189 g, 0.122 mmol) in D20  (0.7 ml) acidified with conc. HC1 
(0.0191 g, 0.189 mmol) over 10 hours afforded the title compound 259 in a quantitative 
yield as a D 20  solution, removal of the solvent in vacuo afforded the title compound as 
a semi crystalline compound (0.0254 g, 0.0121 mol) in 92% yield; 8h(300M H z, D 20 )  
0.57 (3H, d, 7  7.0 Hz, 3 x H I ’), 0.69 (3H, d, 7  7.0 Hz, 3 x H I ’), 1.33-1.56 (2H, bm, 2 x 
H4), 1.62-1.80 (2H, bm, 2 x H3), 2.12 (1H, m, 1 x H 2’), 2.47-2.56 (1H, m, 1 x H2), 
3.18-3.39 (2H, bm, 2 x H5), 3.81 (3H, s, OMe); Sc(75MHz, D20 )  17.3, 19.1, 19.3,
19.6, 28.7, 43.5,44.0, 5 8 .1 ,178.5.viii
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3-methylpiperidin-2-one 262111
262
Reaction of 253 (0.0112 g, 0.062 mmol) in M eOH (0.6 ml) and D 2O (0.1 ml) with 
potassium carbonate (0.0085 g, 0.066 mol) for 24 hours afforded the title compound 
262 as a methanol:water solution (0.0063 g, 0.056 mmol) in 91% yield; Vmax/cm' 1 1665 
(C =0); 6h(300MHz, CDC13, Me4Si) 1.11 (3H, d, J  7.1 Hz, 3 x H I ’), 1.43 (1H, dddd, J
3.2, 8.5, 9.8 and 13.0 Hz, 1 x H4), 1.55-1.83 (2H, bm, 2 x H5), 1.89 (1H, app dtd, J
13.2, 6 .8, 3.2 Hz, 1 x H4), 2.27 (1H, app hept, J  7.1 Hz, 1 x H3), 3.19 (3H, t, J  5.5 Hz, 
2 x H6), 5.81 (1H, bs, NH)\ 5c(75MHz, MeOD) 18.5, 22.1, 30.3, 37.5, 48.8, 179.3.
3-benzylpiperidin-2-one 263111
263
Reaction of 254 (0.0154 g, 0.059 mmol) in MeOH (0.6 ml) and D 2O (0.1 ml) with 
potassium carbonate (0.0111 g, 0.087 mol) for 24 hours afforded the title compound 
263 as a methanol:water solution (0.0108 g, 0.057 mmol) in 97% yield; Vmax/cm' 1 1642 
(C =0); 8h(300MHz, CDC13, Me4Si) 1.32-1.46 (1H, bm, 1 x H4), 1.51-1.81 (3H, bm, 2 
x H5, 1 x H4), 2.48 (1H, tdd, /  10.0, 5.5, 3.8 Hz, 1 x H3), 2.61 (1H, dd, J  10.0, 13.4 Hz, 
1 x H I ’), 3.17-3.25 (2H, m, 2 x H6), 3.34 (1H, dd, J  13.4, 3.6 Hz, 1 x H I ’), 5.76 (1H, 
bs, NH), 7.10-7.27 (5H, bm, HAr); 8c(75MHz, CHC13, Me4Si) 18.5, 22.1, 30.3, 37.5,
48.8, 127.9, 130.0, 130.8, 141.3, 179.3; m/z (El) 190.1226 (M-H+ requires 190.1229) 
190 (100%).
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3-allylpiperidin-2-one 264185
264
Reaction of 255 (0.0127 g, 0.061 mmol) in M eOH (0.6 ml) and D 2O (0.1 ml) with 
potassium carbonate (0.0121 g, 0.095 mol) for 24 hours afforded the title compound 
264 as a methanol:water solution (0.0079 g, 0.057 mmol) in 94% yield; Vmax/cm' 1 1661 
(C =0), 1637 (C=C); 6h(300MHz, CDCI3, M e4Si) 1.36-1.55 (1H, bm, 1 x H4), 1.58- 
1.92 (3H, bm, 2 x H5, 1 x H4), 2.15-2.35 (2H, bm, 1 x H3, 1 x H 3’), 2.56-2.65 (1H, m 
1 x H 3’), 3.20-3.26 (2H, m, 2 x H6), 4.98 (1H, dm, J  10.0 Hz, 1 x H l ’cis), 5.01 (1H, 
dm, 7 17.0 Hz, 1 x H l ,trans), 5.71 (1H, tdd, 7  17.0, 10.0, 7.0 Hz, 1 x H 2’), 5.80 (1H, bs, 
NH)\ 5c(75MHz, CHCI3, M e4Si) 21.8, 26.1, 36.3, 41.0, 43.0, 117.3, 136.2, 171.5; m/z 
(El) 152.1305 (M-ET requires 152.1074) 152 (100%).
3-ethylpiperidin-2-one 265185
265
Reaction of 257 (0.0051 g, 0.026 mmol) in M eOH (0.6 ml) and D 2O (0.1 ml) with 
potassium carbonate (0.0045 g, 0.035 mol) for 24 hours afforded the title compound 
265 as a methanol:water solution (0.0027 g, 0.021 mmol) in 82% yield; Vmax/cm' 1 1670 
(C =0); 5h(300MHz, CDC13, Me4Si) 0.82 (3H, t, 7 7 .4  Hz, 3 x H I ’), 1.38-1.87 (6H, bm, 
2 x H5, 2 x H4, 2 x H 2’), 2.04-2.16 (1H, bm, 1 x H3), 3.11-3.19 (2H, bm, 2 x H6), 5.91 
(1H, bs, NH)\ 5c (75MHz, MeOD) 12.4, 22.3, 26.0, 26.6, 43.5, 43.7, 178.6; m/z (El) 
128.1075 (M -H+ requires 128.1076) 128 (100%).
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3-(prop-2-ynyl)piperidin-2-one 266
266
Reaction of 258 (0.0168 g, 0.082 mmol) in M eOH (0.6 ml) and D2O (0.1 ml) with 
potassium carbonate (0.0122 g, 0.095 mol) for 24 hours afforded the title compound 
266 as a methanol:water solution (0.0104 g, 0.076 mmol) in 93% yield; Vm^/crrf1 1658 
(C =0); 8h(300MHz, CDC13, Me4Si) 1.64-1.92 (4H, bm, 2 x H5, 2 x H4), 1.93 (1H, t, J
2.5 Hz, 1 x H I ’), 2.33-2.43 (1H, m, 1 x H3), 2.44-2.50 (1H, m, 1 x H 3’), 2.64-2.72 (1H, 
m, 1 x H 3’), 3.23-3.29 (2H, m, 2 x H6), 5.89 (1H, bs, NH)\ 5c(75MHz, MeOD) 22.1,
22.6, 27.3, 41.5, 43.7, 72.1, 83.2, 176.2.
3-isobutylpiperidin-2-one 267139
267
Reaction of 259 (0.0997 g, 0.045 mmol) in M eOH (0.6 ml) and D2O (0.1 ml) with 
potassium carbonate (0.0084 g, 0.066 mol) for 24 hours afforded the title compound 
267 as a methanohwater solution (0.0065 g, 0.042 mmol) in 93% yield; Vmax/cm' 1 1636 
(C =0); 5h(300MHz, CDC13, Me4Si) 0.79 (3H, d, J  6.2 Hz, 3 x H I ’), 0.83 (3H, d, /  6.2 
Hz, 3 x H I ’), 1.14-1.30 (2H, bm, 2 x H 3’), 1.33-1.52 (1H, bm, 1 x H 2’), 1.52-1.67 (2H, 
bm, 2 x H4), 1.69-1.91 (2H, bm, 2 x H5), 2.13-2.26 (1H, m, 1 x H3), 3.13-3.22 (2H, m, 
2 x H 6), 5.79 (1H, bs, NH); 5c(75MHz, MeOD) 18.5, 21.0, 22.1, 22.8, 24.1, 30.3, 37.5,
43.2, 179.3.
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3-isopropylpiperidin-2-one 268
Reaction of 260 (0.0038 g, 0.018 mmol) in M eOH (0.6 ml) and D 2O (0.1 ml) with 
potassium carbonate (0.0041 g, 0.032 mol) for 24 hours afforded the title compound 
268 as a methanol:water solution (0.0023 g, 0.016 mmol) in 90% yield; Vmax/cm' 1 1632 
(C =0); 5h(300MHz, MeOD) 0.73 (3H, d, J  7.0 Hz, 3 x H I ’), 0.86 (3H, d, J  7.0 Hz, 3 x 
H I ’), 1.13-1.29 (1H, m, 1 x H 2’), 1.36-1.63 (2H, bm, 2 x H5), 1.67-1.87 (2H, m, 2 x 
H4), 2.30 (1H, app hexd, J  7.0 and 3.0 Hz, 1 x H3), 3.03-3.19 (2H, m, 2 x H6); 
6c(75MHz, MeOD) 18.4, 21.1, 22.0, 23.2, 29.8, 43.6, 48.0, no carbonyl peak observed
3,3-diisobutylpiperidin-2-one 261
261
Reaction of 230 (0.0076 g, 0.034 mmol) in CHCI3 (0.5 ml) with 0.1M HC1 (0.7 ml, 
0.051 mmol) solution according to general procedure E afforded 261 as a solid (0.0070 
g, 0.033 mmol) in 98% yield; Vmax/cm1 1639 (C =0); 8h(300M H z , CDCI3, M e4Si) 0.80 
(6H, d, J  6.6 Hz, 6 x H I ’), 0.83 (6H, d, J  6.6 Hz, 6 x H I ’), 1.20 (2H, d, J  4.0 Hz, 2 x 
H 3’), 1.25 (2H, d, J  4.0 Hz, 2 x H 3’), 1.52-1.74 (8H, bm, 2 x H5, 2 x H4, 2 x H 2’, 2 x 
H 3’), 3.16-3.23 (2H, m, 2 x H6), 8c(75MHz, CDC13, Me4Si) 20.4, 24.4, 24.9, 25.8, 
2 9 .3 ,4 3 .3 ,48.1.9
9 Neither quaternary peaks observed on account of weak signal.




Reaction of 16 (0.2279 g, 1.79 mol) in THF (10 ml) with a 1.7M solution of lBuLi in 
hexanes (1.6 ml, 1.6 ml, 2.70 mmol) and potassium  ‘butoxide (0.3324 g, 2.72 mol) 
according to general procedure C afforded the title compound 233 as a clear oil (0.3034 
g, 1.40 mmol) in 78%; v ^ / c m ' 1 1668 (C=N); 5h(300MHz, CDC13, Me4Si) 1.16-1.71 
(5H, bm, 2 x H3, 2 x H4, 1 x H5), 1.74-1.86 (1H, bm, 1 x H5), 2.56 (1H, dd, J  8.9, 13.8 
Hz, 1 x H I ’), 2.80 (1H, ddd, J  2.2, 9.0, 8.9 Hz, 1 x H 6), 3.05 (1H, dd, J  6.4, 13.8 Hz, 1 
x H I ’), 3.33 (2H, ddd, J  1.7, 9.0, 13.2 Hz, 2 x H2), 3.50 (3H, s, OMe), 7.08-7.24 (5H, 
bm, H at) ,  6c(75MHz, CDC13, M e4Si) 27.8, 28.6, 29.1, 37.1, 44.5, 47.7, 52.9, 126.4,
128.7, 129.3, 140.9, 169.6; m/z (El) 218.1540 (M-KT requires 218.1539) 218 (100%), 
204 (M-H+ - OMe + NH3, 4)
6-allyI-3,4,5,6-tetrahydro-7-methoxy-2H-azepine 234
Reaction of 16 (0.5756 g, 4.553 mmol) in THF (20 ml) with a 2.4M solution of ‘butyl 
lithium in hexanes (3.7 ml, 6.79 mmol), potassium ‘butoxide (0.83 g, 6.79 mmol) and 
allyl bromide (1.18 ml, 13.58 mol) according to general procedure C afforded the title 
compound 234 (0.5450 g, 3.26 mmol) in 74% yield as a clear oil; Vmax/cm' 1 1668 
(C=N), 1652 (C=C); 5h(300MHz, CDC13, Me4Si) 1.17-1.44 (2H, bm, 2 x H4), 1.51- 
1.67 (2H, bm, 2 x H5), 1.75-1.89 (2H, bm, 2 x H3), 2.06 (1H, ttd, J  15.6, 7.7 and 0.8 
Hz, 1 x H 3’), 2.43 (1H, ttd, 14.0, 6.2, 1.5, 1 x Hz, 1 x H 3’), 2.61 (1H, ddt, J  2.3, 9.6, 
7.0 Hz, 1 x H6), 3.25-3.35 (2H, bm, 2 x H2), 3.52 (3H, s, OMe), 4.94 (1H, ddt, J  1.1, 
1.1, 10.0 Hz, 1 x H l ’cis), 4.97 (1H, ddt, /  1.5, 1.8, 17.1 Hz, 1 x H l ,trans), 5.74 (1H, dddd 
J  7.0, 10.0, 16.2, 17.1 Hz, 1 x H 2’); 6c(75MHz, CDC13, Me4Si) 37.7, 29.1, 29.2, 35.6,
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Reaction of 233 (0.0268 g, 0.123 mmol) in CHC13 (0.5 ml) with 0.1M HC1 (1.6 ml, 
0.160 mmol) according to general procedure E afforded the title compound 362 (0.0257 
g, 0.109 mmol) as a pale yellow oil in 89% yield; Vmax/cm' 1 1738 (C =0); Sh(300M H z , 
CDCI3, Me4Si) 1.12-2.01 (6H, bm, 2 x H3, 2 x H4, 2 x H5), 2.44-3.33 (5H, bm, 2 x 
H I ’, 1 x H2, 2 x H 6), 3.51 (3H, s, OMe), 7.02-7.28 (5H, bm, Hat); 5c(75M H z , CDCI3, 
Me4Si) 28.9, 29.3, 30.0, 37.4, 42.9, 45.5, 52.0, 126.5, 128.8, 129.2, 140.5, 180.7; m/z 




Reaction of 234 (0.0241 g, 0.144 mmol) in CHCI3 (0.5 ml) with 0.1M HC1 (1.6 ml, 
0.160 mmol) according to general procedure E  afforded the title compound 363 (0.0232 
g, 0.125 mmol) as a clear oil in 87% yield; Vmax/cm' 1 1725 (C =0), 1642 (C=C); 
5h(300MHz, CDCI3, Me4Si) 1.27 (2H, app q, J  7.5 Hz, 2 x H4), 1.34-1.73 (4H, bm, 2 x 
H3, 2 x H5), 2.10-2.49 (3H, bm, 1 x H2, 2 x H 3’), 2.71 (2H, t, J  7.1 Hz, 2 x H6), 3.60 
(3H, s, OMe), 4.94 (1H, dm, J  10.0 Hz, 1 x H l ’cis), 4.98 (1H, dm, J  17.0 Hz, 1 x 
H l ,trans), 5.65 (1H, ddt, J  17.0, 10.0, 7.0 Hz, 1 x H 2’); 8c (75MHz, CHC13, Me4Si) 24.9,
31.3, 31.7, 36.8, 41.1, 45.6, 51.9, 117.2, 135.7, 176.4, m/z (El) 226.2165 (M-H+ 
requires 226.2165) 226 (100%).
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7-(benzyloxy)-3,4,5,6-tetrahydro-2H-azepine 241
241
Trifluoroacetic acid (0.38 ml, 5.00 mmol) was added to a gently stirred solution of 16 
(0.5781 g, 4.55 mmol) in toluene (20 ml) in the presence of 5A molecular sieves, and 
the reaction mixture allowed to stir for 16 hours. The reaction was quenched using 
dilute potassium carbonate (0.9626 g, 7.52 mmol) solution (50 ml) and extracted with 
diethyl ether (3 x 25 ml). The combined organic extracts were dried (MgS04) and 
concentrated in vacuo to afford a crude product. The crude product was purified by 
silica gel chromatography (5% EtOAc/petrol) to afford the title compound 241 (0.6917 
g, 3.05 mmol) in 67% yield as a clear oil; v^x /cm ' 1 1677 (C=N), 5h(300M H z, CDCI3 , 
Me4Si) 1.44-1.59 (4H, bm, 2 x H4, 2 x H5), 1.67-1.77 (2H, bm, 2 x H3), 2.41 (2H, m, 2 
x H 6), 3.39 (2H, m, 2 x H2), 4.93 (2H, s, OCH2), 7.19-7.33 (5H, m, H ^), 6c (75M H z, 
CDCI3 , Me4Si) 23.9, 28.4, 31.7, 32.7, 49.2, 67.3, 128.0, 128.2, 128.8, 137.9, 169.6, m/z 
(El) 204.1384 (M-H+ requires 204.1383) 204 (100%).
2-(benzyloxy)-3,4,5,6,7,8-hexahydroazocine 242
Trifluoroacetic acid (0.37 ml, 4.81 mmol) was added to a gently stirred solution of 237 
(0.6111 g, 4.36 mmol) on toluene (20 ml) in the presence of 5A molecular sieves, and 
the reaction mixture allowed to stir for 16 hours. The reaction was quenched using 
dilute potassium (0.9025 g, 7.05 mmol) carbonate solution (50 ml) and extracted with 
diethyl ether (3 x 25 ml). The combined organic extracts were dried (M gS04) and 
concentrated in vacuo to afford a crude product. The crude product was purified by 
silica gel chromatography (5% EtO Ac/petrol) to afford the title compound 242 (0.3885
242
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g, 1.79 mmol) in 41% yield as a clear oil; Vmax/cm' 1 1679 (C=N); 8h(300M H z, CDCI3, 
M e4Si) 1.33-1.71 (8H, bm, 2 x H3, 2 x H4, 2 x H5, 2 x H6), 2.37 (2H, t, J  6.3 Hz, 2 x 
H7), 3.36 (2H, t, J  5.8 Hz, 2 x H2), 4.84 (2H, s, OCH2), 7.10-7.36 (5H, bm, 5 x Hat); 
8c (75MHz, CHCI3, Me4Si) 24.9, 26.4, 28.0, 28.5, 31.5, 49.8, 67.8, 128.0, 128.3, 129.0,
138.0, 170.1; m/z (El) 218.1540 (M-H+ requires 218.1541) 218 (100%).
Caprolactam 10
1 0
Benzyl capro lactim ether 241 (0.0297 g, 0.146 mmol) was treated with Pd(OH )2
(0.0153 g, 0.028 mmol) as described in general procedure F to afford the title
compound 10 (0.0158 g, 0.140 mmol) in 96% yield. Spectroscopic data matched that of 





Benzyl oenantholactim ether 242 (0.0197 g, 0.091 mmol) was treated with Pd(OH )2
(0.0095 g, 0.015 mmol) as described in general procedure F  to afford the title
compound 243 (0.0112 g, 0.088 mmol) in 97% yield. Spectroscopic data matched that 
of an authentic sample of oenantholactam.
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2-((li£, 25,5l£)-2-isopropyl-5-methylcyclohexyloxy)-3,4,5,6- 
tetrahydropyridine 288
A solution of 15 (6.36 g, 56.3 mmol) and (-)-menthol (11.44 g, 73.2 mmol) in toluene 
(50 ml) was allowed to stand in the presence of 5A molecular sieves (9.6 g) for 30 
minutes. Trifluoroacetic acid (5.5 ml, 73.2 mmol) was added to the solution and 
allowed to stir for 18 hours. 1M potassium carbonate solution (12.8 g, 100 mmol) was 
added to the reaction mixture and the reaction was extracted with Et20 (3 x 50 ml). The 
combined organic extracts were dried (MgS04) and concentrated in vacuo to afford a 
crude product, which was purified by silica gel chromatography (3% EtOAc/petrol) to 
afford the title compound 288 as a crystalline white solid (5.65 g, 27.4 mmol) in 48% 
yield, [a]D25 -96 .4  (c 0.79, EtOAc); Vmax/cm' 1 1674 (C=N); mp = 37-38 °C; 
5h(300MHz, CDCIs, Me4Si) 0.69-0.82 (11H, bm), 0.98 (1H, m), 1.26-1.71 (8H, bm), 
1.86 (1H, m, 1 x H 7’), 2.05 (3H, m, 2 x H5, 1 x H6 ’), 3.90 (2H, ttt, 77 .1 , 5.7, 1.1 Hz, 2 
x H2), 4.62 (1H, td, 7 10.9, 4.3 Hz, 1 x H I ’); 5c(75MHz, CDC13, Me4Si) 17.2, 20.9,
21.3, 22.6, 23.0, 24.1, 26.8, 26.8, 31.6, 35.0, 40.2, 47.2, 48.1, 72.8, 162.01, m/z (Cl) 
238.2168 (M -IT  requires 236.2165) 238 (100%); m/z (El) 222 (M+-Me, 1%), 194 (M+- 
C3H7, 6%), 100 (C5H i0NO+, 10%)




Reaction of 288 (0.0977 g, 0.41 mol) in THF (5 ml) with “BuLi (0.43 ml, 1.03 mmol) 
and methyl iodide (0.1 ml, 1.23 mmol) according to general procedure D afforded the 
title compound 297 as a clear oil (0.0969 g, 0.339 mmol) in 94% yield and 57% d.e.; 
Vmax/cm1 1674 (C=N); 5h(300MHz, CDC13, Me4Si) 0.70 (3H, d, J  7.0 Hz), 0.74-0.82 
(8H, bm), 0.98 (1H, m), 1.06 (3H, d, J  7.1 Hz, 3 x H I ” ), 1.32-1.66 (7H, bm), 1.71-1.93 
(2H, bm), 1.94-2.12 (1H, bm), 2.17 (1H, q, J  7.0 Hz, 1 x H5), 3.26-3.45 (2H, m, 2 x 
H2), 4.58 (1H, td, J  10.7, 4.3 Hz, 1 x H I ’); 5c(75MHz, CDC13, Me4Si) 15.1, 17.5, 19.8,
20.0, 21.0, 22.7, 25.4, 28.1, 30.1, 30.1 33.8, 39.6, 46.2, 46.6, 70.9, 163.5; m/z (El) 236 
(M+-Me, 1%), 208 (M+-C3H7, 10%), 114 (C5H ioNO+, 100%)
Data identifiable for the minor diastereomer; 0.67 (3H, m), 1.09 (3H, d, J  7.1 Hz, 3 x 
H I ” ), 4.53 (1H, td, J  10.7, 4.3 Hz, 1 x H I ’); 6c(75MHz, CDC13, M e4Si) 14.9, 17.5,
19.8, 19.9, 22.1, 24.6, 28.2, 30.6, 71.0; m/z (El) 236 (M+-Me, 1%), 208 (M+-C3H7, 




Reaction of 288 (0.1089 g, 0.46 mol) in THF (5 ml) with “BuLi (0.5 ml, 1.15 mmol) 
and benzyl bromide (0.16 ml, 1.38 mmol) according to general procedure D afforded
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the title compound 298 as a crude oil (0.3504g, 0.339 mmol) in a 94% yield and 37% 
d.e. The crude product was purified by silica gel chromatography (3% EtO Ac/petrol) to 
afford the title compound as a clear oil (0.6224 g, 0.19 mmol), in a 41% yield and 37% 
d.e.; Vmax/cm' 1 1674 (C=N); 8h(300MHz, CDCI3, M e4Si) 0.66-0.79 (11H, bm), 0.95 
(1H, m), 1.18-1.59 (8H, bm), 1.81 (1H, m, 1 x H 7’), 2.01 (1H, m), 2.25-2.37 (1H, bm, 1 
x H5), 2.43 (1H, dd, 7  13.0,10.0 Hz, 1 x H I ” ), 3.05 (1H, dd, 7  13.0,4.0 Hz, 1 x H I ” ), 
3.27-3.33 (2H, bm, 2 x H5), 4.58 (1H, td, 7  11.0, 4.0 Hz, 1 x H I ’), 7.02-7.3 (5H, bm, 
HAr); 8c(75MHz, CDCI3, Me4Si) 17.1, 21 .1, 21.3, 22.6, 24.3, 25.5, 27.0, 31.6, 34.0,
38.3, 38.4, 41.1, 47.5, 48.1, 72.8, 126.4, 128.8, 129.1, 138.2, no carbonyl peak 
observed; m/z (El) 312 (M+-Me, 1%), 284 (M+-C3H7, 3%), 190 (C5H I0NO+, 100%), 172 
(C jjH w br, 23%), 95 (C6H9N+, 32%), 77 (Ph+, 6%).
Data observed for the m inor diastereomer; 0.65 (3H, m), 2.42 (1H, dd, J  13.0, 10.0 Hz, 
1 x H I” ), 3.20 (1H, dd, J  13.0, 4.0 Hz, 1 x H I” ), 5c(75MHz, CDC13, Me4Si) 16.6, 
21.5, 23.5, 38.4; m/z (El) 284 (M+-C3H7, 3%), 190 (C5H i0NO+, 100%), 172 ( C ^ H ^ ,  
23%), 95 (C6H9N*, 32%), 77 (Ph+, 6%).
2-((l/?,2S,5/?)-2-isopropyl-5-methylcyclohexyloxy)-3-allyl-3,4,5,6- 
tetrahydropyridine 291c/292c
Reaction of 288 (0.0412 g, 0.17 mmol) in THF (2 ml) with “BuLi (0.18 ml, 0.43 mmol) 
and allyl bromide (0.05 ml, 0.51 mmol) according to general procedure D afforded the 
title compound 299 as an oil (0.0467g, 0.168 mmol) in a 98% yield and 45% d.e.; 
(0.6224 g, 0.19 mmol); Vn^/cm ' 1 1674 (C=N); 8h(300MHz, CDC13, Me4Si) 0.65-0.76 
(12H, bm), 0.94 (1H, m), 1.06-1.69 (7H, bm), 1.80 (1H, m, 1 x H 7’), 1.94 (1H, m),
2.03-2.17 (2H, bm), 2.26-2.35 (1H, bm), 2.38-2.47 (1H, bm), 3.30 (2H, t, 7 5 .6  Hz, 2 x 
H2), 4.55 (1H, td, 7  10.7, 4.3 Hz, 1 x H 3’), 4.90 (1H, dm, J 10.0 Hz, 1 x H l ’cis), 4.93 
(1H, dm, 7 17 Hz, 1 x H I ’1™15), 5.62 (1H, ddt, 7  17.0, 10.0, 7.0 Hz, 1 x H 2’); 
8c(75MHz, CDCI3, Me4Si) 17.1, 21.3, 21.4, 23.0, 24.1, 25.8, 26.8, 30.7, 35.0, 36.8,
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37.0, 41.0, 47.5, 48.0, 72.2, 117.0, 136.8, 163.5; m/z (El) 262 (M+-Me, 1%), 234 (M+- 
C3H7, 3%), 140 (C5HioNO+, 100%), 122 (C8H i2N+, 15%),
D ata observed for minor diastereomer; 8h(300MHz, CDCI3, Me4Si) 0.61 (3H, m), 5.51 
(1H, ddq, J  17.0, 10.0, 7.0 Hz, 1 x H 2’), 5c(75MHz, CDC13, Me4Si) 16.4, 20.9, 21.3,
24.0, 26.2, 36.9, 37.0, 47.1, 48.0, 77.9, 136.9, 163.1; m/z (El) 262 (M +-Me, 1%), 234 
(M+-C3H7, 3%), 140 (C5H 10NO+, 100%), 122 (C8H i2N+, 15%),
2-((l/£,25,5.R)-2-isopropyl-5-methylcycIohexyloxy)-3-ethyl-3,4,5,6- 
tetrahydropyridine 300
Reaction of 288 (0.1088 g, 0.46 mmol) in THF (5 ml) with “BuLi (0.48 ml, 1.15 mmol) 
and ethyl bromide (0.1 ml, 1.37 mmol) according to general procedure D afforded the 
title compound 300 as an oil (0.1197 g, 0.45 mmol) in a 98% yield and 46% d.e.; 
Vmax/cm' 1 1674 (C=N); 5h(300MHz, CDC13, Me4Si) 0.69-0.83 (10H, bm), 0.88-2.17 
(18H, bm), 3.50 (2H, t, J  5 Hz, 2 x H2), 4.60 (1H, td, J  10.5, 4.3 Hz, 1 x H I ’); 
5c(75MHz, CDC13, Me4Si) 17.3, 21.6, 21.8, 22.1, 24.2, 25.4, 25.7, 25.8, 26.7, 34.6,
35.1, 37.4, 41.0, 47.5, 47.2, 73.4, 164.3; m/z (El) 222 (M+-C3H7, 7%), 128 (C7H 14NO+, 
100%).
Data for the minor diastereomer: 5c(75MHz, CDC13, M e4Si) 21.8, 22.0, 24.1, 25.6,
25.7, 25.8, 35.0, 38.1, 164.1; m/z (El) 222 (M+-C3H7, 7%), 128 (C7H i4NO+, 100%).
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2-((l/?,2S,5/?)-2-isopropyl-5-methylcyclohexyloxy)-3,4,5,6-tetrahydro-
3-(prop-2-ynyl)pyridine 301
Reaction of 288 (0.1078 g, 0.45 mmol) in THF (5 ml) with “BuLi (0.47 ml, 1.14 mmol) 
and 80 % propargyl bromide in toluene solution (0,15 ml, 1.36 mmol) according to 
general procedure D afforded the title compound 301 as an oil (0.1140 g, 0.414 mmol) 
in a 92% yield and 38% d.e.; Vmax/cm'1 1674 (C=N); 6h(300M H z , CDCI3, Me4Si) 0.63- 
0.80 (12H, bm), 0.92 (1H, m), 1.20 (1H, m), 1.26-1.87 (6H, bm), 1.85 (1H, U J 2.5 Hz, 
1 x H I ” ), 1.88-2.08 (2H, bm), 2.25-2.36 (2H, bm), 2.39-2.52 (1H, bm, 1 x H5), 3.33 
(2H, t, J  5.5 Hz, 2 x H2), 4.53 (1H, td, J  11.0, 4.3 Hz, 1 x H I ’); 5c(75MHz, CDC13, 
M e4Si) 17.2, 21.4, 21.7, 22.1, 23.0, 24.1, 26.2, 26.3, 32.3, 35.0, 35.7, 40.8, 47.5, 48.1, 
70.2, 72.9, 82.7, 165.0; m/z (El) 260 (M+-Me, 1%), 232 (M+-C3H7, 10%), 138 
(C8H 12NO+, 100%), 122 (CgHi2N+, 15%), 120 (CgH i0N+, 6%).
Data noted for the minor diastereomer: 5c(75M H z, CDCI3, M e4Si) 17.1 ,21.6 , 22 .0 ,




Reaction of 288 (0.1008 g, 0.42 mmol) in THF (5 ml) with “BuLi (0.44 ml, 1.06 mmol) 
and ‘propyl bromide (0.13 ml, 1.27 mmol) according to general procedure D afforded 
the title compound 302 as an oil (0.1018 g, 0.36 mmol) in a 86% yield and 61% d.e.;
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Vmax/cm * 1674 (C=N); 8h(300MHz, CDC13, Me4Si) 0.66-0.76 (6H, bm), 0.78-0.87 (8H, 
bm), 0.99 (1H, m), 1.07-2.30 (14H, bm), 2.32 (1 H, m), 3.38 (2H, t, J  6.0 Hz, 2 x H2),
4.60 (1H, td, J  10.9,4.0 Hz, 1 x H I ’); 5c(75MHz, CDCI3, Me4Si) 17 .2 ,21 .4 ,21 .7 ,22 .1 ,
23.0, 24.1, 26.2, 26.3, 32.3, 35.0, 35.7, 40.8, 47.5, 48.1, 70.2, 72.9, 82.7, 165.0; m/z 
(El) 260 (M+-Me, 1%), 232 (M+-C3H7, 10%), 138 (C8H ,2NO+, 100%), 122 (C8H i2N \  
15%), 120 (C8H ioN+, 6%).
(!R,2S,5.R)-2-isopropyI-5-methylcycIohexyl 5-aminopentanoate 293
To a solution of 288 (0.0247 g, 0.10 mmol) in CHCI3 (0.5 ml) was added 0.1M  HC1 
(1.6 ml, 0.16 mmol) and the reaction mixture stirred vigorously for 16 hours. The 
reaction was quenched using sodium carbonate (0.016 g, 0.15 mmol). The reaction was 
concentrated in vacuo and extracted with CHCI3 to yield then title compound 293 as an 
oil (0.0241 g, 0.09 mmol) in 94% yield; Vmax/cm' 1 1747 (C =0); 6h(300MHz, CDCI3, 
M e4Si) 0.69-0.1.07 (12H, bm), 1.29 (1H, m), 1.34-1.47 (3H, bm), 1.52-1.66 (4H, bm), 
1.78 (1H, app heptd, 7 7.0 2.5 Hz, 1 x H 7’), 1.90 (1H, dm, 7 12.0 Hz), 2.24 (2H, t, 7  7.0 
Hz, 2 x H2), 2.62 (2H, t, 7 7.0 Hz, 2 x H5), 4.61 (1H, td, 7  10.9, 4.5 Hz, 1 x H I ’); 
6c(75MHz, CDCI3, M e4Si) 14.2, 18.6, 19.9, 20.3, 21.2, 24.1, 29.2, 31.0, 32.1, 33.3, 




1" \  
295 y. 296
NH,
To a solution of 291c/292c (0.1014 g, 0.365 mmol) in THF (5 ml) was added 0.1M  HC1 
(5.5 ml, 0.55 mmol) and the reaction mixture stirred vigorously for 16 hours. The
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reaction was quenched using sodium carbonate (0.12 g, 0.83 mmol). The reaction was 
concentrated in vacuo and extracted with CHCI3 to yield the title compounds 295/296 
as an oil, (0.1127 g, 0.332 mmol), in 91% yield; Vmax/cnT1 1735 (C =0); 8h(300MHz, 
CDCI3, M e4Si) 0.68-1.66 (19H, bm), 1.75-1.93 (3H, m), 2.14-2.43 (3H, bm), 2.97-3.10 
(2H, m, 2 x H5), 4.60 (1H, td, J  11.0 and 4.3 Hz, 1 x H I ’), 4.95 (1H, dm, /  9.0 Hz, 1 x 
H 3” cis), 4.99 (1H, dm, J  16.0 Hz, 1 x H 3 ,,trans), 5.65 (1H, ddt, /  17.0, 10.0, 6.8 Hz, 1 x 
H 2’); 6c(75MHz, CDCI3, Me4Si) 18.1, 18.6, 19.2, 21.1, 22.3, 23.6, 27.0, 27.2, 30.7,




To a solution of 291c/292c (0.1127 g, 0.332 mmol) in MeCN (5 ml) was BOC 
anhydride (0.9614 g, 0.432 mmol) and triethylamine (0.68 g, 0.665 mmol) and the 
reaction mixture stirred vigorously for 16 hours. Alkaline water (pH >8 via K2 CO3 ) was 
added and the reaction extracted with Et20 (3 x 25 ml). The combined organic extracts 
were dried (M gS04) and concentrated in vacuo to afford a crude product. The crude 
product was purified by silica gel chromatography (5% EtO Ac/petrol) to afford the title 
compound 297c/298c (0.1195 g, 0.302 mmol) in 91% yield as a clear oil; Vmax/cm' 1 
1742 (C =0), 1690 (C =0); 5h(300MHz, CDC13, M e4Si) 0.66 (2H, app dd, J  7.2 and 3.2 
Hz), 0.82 (2H, app d, J  1.7 Hz), 0.84 (4H, app d, J  1.2 Hz), 0.86-1.27 (4H, bm), 1.32 
(9H, s, *Bu), 1.35-1.66 (7H, bm) 1.75-1.93 (3H, m), 2.06-2.39 (3H, bm), 2.97-3.10 (2H, 
m, 2 x H5), 4.50 (1H, bs, NH), 4.60 (1H, td, J  11.0 and 4.3 Hz, 1 x H I ’), 4.95 (1H, dm, 
J  9.0 Hz, 1 x H 3” cis), 4.99 (1H, dm, J  16.0 Hz, 1 x H 3’,trans), 5.65 (1H, ddt, J  17.0,
10.0, 6.8 Hz, 1 x H 2’); 8c(75MHz, CDC13, Me4Si) 16.4, 21.2, 22.4, 23.5, 26.3, 27.8,
28.8, 29.1, 29.5, 31.8, 34.6, 37.0, 40.7, 41.3, 45.6, 47.3, 74.6, 117.3, 135.7, 156.3,
175.3.





A solution of valerolactim ether 15 (2.1125 g, 18.56 mmol) and (lS,2S)-2- 
methoxycyclohexanol (3.1417 g, 24.13 mmol) in toluene (50 ml) was allowed to stand 
in the presence of 5A molecular sieves (2.51 g) for 30 minutes. Trifluoroacetic acid (1.9 
ml, 24.87 mmol) was added to the solution and allowed to stir for 18 hours. 1M K2CO3 
solution (4.01 g, 31.3 mmol) was added to the reaction mixture and the reaction was 
extracted with Et20 (3 x 20 ml). The combined organic extracts were dried (MgS04) 
and concentrated in vacuo to afford a crude product which was purified by Kiigelrohr 
distillation to afford the title compound 302 as a clear oil (2.0800 g, 9.83 mmol) in 53% 
yield; [a]D25 -86.1 (c 0.71 EtO Ac); v ^ / c m ' 1 1681 (C=N); 6h(300MHz, CDC13, Me4Si)
1.04-1.36 (4H, bm, 2 x H 4’ and 2 x H 5’), 1.43-1.70 (6H, bm, 2 x H4, 2 x H5 and 2 x 
H 3’), 1.89-2.20 (4H, bm, 2 x H3 and 2 x H6 ’), 3.11 (1H, ddd, 7 9.6, 8.5 and 4.1 Hz, 1 x 
H 2’), 3.33 (3H, s, OMe), 3.39 (2H, tt, J  5.6 and 1.2 Hz, 2 x H6), 4.71 (1H, ddd, J  9.6,
8.5 and 4.9 Hz, 1 x H I ’); 6c(75MHz, CDC13, Me4Si) 20.9, 22.9, 23.7, 23.9, 26.9, 29.9,





A 2.2M solution of “BuLi in hexanes (1.4 ml, 2.94 mmol) was added dropwise to a 
stirred solution of (-)-sparteine (0.70 g, 2.94 mmol) at -78 °C and allowed to stir under 
a nitrogen atmosphere. After 30 minutes a precooled solution of valerolactim ether 15 
(0.2578 g, 2.27 mmol) in THF (2 ml) was added, the reaction mixture was then allowed 
to warm to room temperature and to stir for 60 minutes before being cooled to -78 °C.
Chapter 6 233 Experimental
The methyl iodide (0.55 ml, 8.79 mmol) was then added dropwise to the stirred 
solution and allowed to warm to room temperature over 16 hours. Alkaline water (pH 
>8 via K2CO3) was added and the reaction extracted with Et20 (x 3). The combined 
organic extracts were dried (MgSCU) and concentrated in vacuo to afford a crude oil. 
The product was purified via Kiigelrohr distillation to afford the title product 224 
(0.2107 g, 1.65 mmol) as a clear oil in 73% yield. Spectroscopic data matched that of 






Caesium carbonate (0.0394 g, 121 mmol), (S)-BINOL (0.0355 g, 122 mmol) and 2- 
formyl boronic acid (0.0185 g, 121 mmol) were added to a solution of 253 (0.0159 g, 
0.110 mmol) in CDCI3 (2 ml) containing 3 A molecular sieves (0.10 g) and the reaction 
mixture was allowed to stir for 20 minutes. The reaction mixture was then filtered and 
used for NMR analysis directly. 8h(300MHz, CDCI3, Me4Si) 0.85 (3H, d, J  7.0 Hz, 3 x 
H I ’), 0.87 (3H, d, 7 7 .0  Hz, 3 x H I ’), 0.96-1.72 (8H, bm, 4 x H3 and 4 x H4), 2.08-2.24 
(2H, m, 2 x H2), 3.33-3.59 (4H, bm, 4 x H5), 3.50 (3H, s, OMe), 3.51 (3H, s, OMe), 
6.62-7.91 (32H, bm, 32 x HAr), 8.27 (1H, s, 1 x HC=N), 8.28 (1H, s, 1 x HC=N).
(S)-4-isopropyloxazolidine-2,5-dione 287130
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Phosgene (200 ml, 20% solution by weight in toluene, 0.39 mol) was added to a stirred 
suspension of L-valine (41.12 g, 0.35 mol) in TH F (350 ml) and the reaction mixture 
slowly heated to 55 °C. After 4 hours the reaction mixture was cooled and the excess 
phosgene removed by bubbling nitrogen gas through the solution. The exhaust gases 
were passed through a solution of excess aqueous sodium hydroxide. The solvent was 
removed in vacuo to afford a 287 as a white crystalline solid (50.81 g, 0.35 mol) in 
91% yield. [a ]D25 -44.0 (c 1.0 in THF) [lit.130 -44.2 (c 1.0 in THF)]; 6H(300 MHz, D20 )
1.03 (3H, d, 7 7 .0  Hz, 3 x H 2’), 1.11 (3H, d, 7 7 .0  Hz, 3 x H 2’), 2.28 (1H, m, 1 x H I ’),
4.25 (1H, d, 7 4 .0  and 6.8 Hz, 1 x H4), 7.01 (1H, bs, NH).
(S')-3-isopropylpiperazine-2,5-dione 23'30
23
Triethylamine (75 g, 0.75 mol) was added to a mechanically stirred suspension of 
glycine methyl ester hydrochloride (47.34 g, 0.37 mol) in chloroform (300 ml) under 
nitrogen and the reaction mixture cooled to -78 °C. A solution of (S)-4- 
isopropyloxazolidine-2,5-dione 287 (50.80 g, 0.35 mol) in THF (200 ml) was added 
dropwise over a period of two and a half hours, the reaction mixture was then stirred for 
a further hour at -78 °C. The crude reaction mixture was then filtered through Celite® 
and the filtrate concentrated in vacuo to afford a crude oil which was redissolved in 
THF (200 ml). Further filtration through Celite® and concentration in vacuo afforded a 
colourless oil, which was dissolved in toluene (200 ml) and heated to reflux. After 24 
hours the residual solvent was removed via decantation and the remaining toluene 
removed in vacuo the resulting solid was powdered and dried for 24 hours at 110 °C 
under vacuum to afford the title compound 23 as a white powder (39.36 g, 0.25 mol) in 
72% yield. [a]D25 +23.1 (c 1.0 in H20 ) , [lit.130 [a]D25 +23.7 (c 1.0 in H20 )]; JH NMR 
5h(300 MHz, D 20 )  0.90 (3H, d, J  7.0 Hz, 3 x H I ’), 1.00 (3H, d, J  7.0 Hz, 3 x H I ’),
2.25 (1H, m, 1 x H 2’), 3.80 (1H, d, J  3.8 Hz, 1 x H3), 3.95 (1H, d, J  18.2 Hz, 1 x H6), 
4.12 (1H, dd, J  19.2 and 1.2 Hz, 1 x H6); 8C(75 MHz, D 20 )  16.6, 18.8, 33.7, 44.6, 60.7,
169.7, 171.1.
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(S)-2,5-dihydro-5-isopropyl-3,6-dimethoxypyrazine 203130
203
Trimethyloxonium tetrafluoroboronate 221 (13.5 g, 91.5 mmol) was added to a 
vigorously stirred suspension of diketopiperazine 23 (5.0 g, 32.0 mmol) in DCM  (30 
ml) under an atmosphere of nitrogen and allowed to stir for 24 hours. Saturated K2CO3 
(19.2 g, 150 mmol) was then added to the reaction mixture as a slurry in water (20 ml) 
which was allowed to slowly stir for a further hour. The reaction mixture was then 
diluted with water (100 ml) and DCM  (100 ml) and the organic layer extracted with 
DCM  (3 x 50 ml). The combined organic extracts filtered through Celite®, dried 
(MgSC>4) and concentrated in vacuo to afford the title compound 321 as a light yellow 
oil (12.1413 g, 65.9 mmol) in 72% yield. [a]D23 +105.1 (c 1.0 in EtOH) [lit.130 [a]D23 
+108.9 (c 1.0 in EtOH)]; v ^ / c m ' 1 1694 (C=N), 6h(300MHz, CDC13, Me4Si) 0.68 (3H, 
d, J  6.8 Hz, 3 x H I ’), 0.96 (3H, d, J  6.8 Hz, 3 x H I ’), 2.16 (1H, app ddq, J  14.0, 6 .8 ,
3.5 Hz, 1 x H 2’), 3.61 (3H, s, OMe C6), 3.65 (3H, s, OMe C3), 3.89-3.97 (3H, m, 1 x 
H5 and 2 x H2); 8c(75MHz, CDC13, Me4Si) 16.8, 18.9, 32.3, 46.4, 52.3, 52.4, 60.8, 
162.2,164.7; m/z (Cl) 185.1285 (M-H+ requires 185.1284) 185 (100%)
(S)-6-isopropyl-5-methoxy-l,6-dihydropyrazin-2(3H)-one 335
335
di-acetic acid (5 g, 81.9 mmol) was added to 203 (0.2537 g, 1.38 mmol) and allowed to 
stir for 16 hours. 1M K2CO3 solution (13.15 g, 102.8 mmol) was added to the reaction 
mixture and the reaction was extracted with Et20 (3 x 10 ml). The combined organic 
extracts were dried (MgSCU) and concentrated in vacuo to afford the title compound 
335 as clear solid (0.1891 g, 1.11 mmol) in 81% yield, mp = 45 °C; [cx] d 23 +8.8 (c 1.0 in
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H 20 )  [lit.130 [a]D23 +9.1 (c 1.0 in H20 )]; v „ ,/c m '' 3240 (NH), 1702 (C=N), 1676 
(C = 0); 8h(300MHz, M eOD) 0.92 (3H, d, 7 7 .0  Hz, 3 x H I ’), 1.00 (3H, d, 7 7 .0  Hz, 3 x 
H I ’), 2.20 (1H, m, 1 x H 2’), 3.75 (3H, s, OMe), 3.95 (1H, m, 1 x H5), 4.07 (2H, m, 2 x 
H2); 8c(75MHz, CDC13, Me4Si) 16.9, 18.6, 34.2, 50.5, 53.6, 59.5, 162.7, 171.7; m/z 
(Cl) 171.1134 (M-H+ requires 174.1139) 174 (100%)
(S)-6-(benzyloxy)-2,5-dihydro-2-isopropyl-3-methoxypyrazine 328
328
A solution of 203 (1.1589 g, 6.23 mmol) and benzyl alcohol (0.8748 g, 8.10 mmol) in 
toluene (20 ml) was allowed to stand in the presence of 5A molecular sieves (1.1 g) for 
30 minutes. Trifluoroacetic acid (0.62 ml, 8.10 mmol) was added to the solution and 
allowed to stir for 18 hours. 1M potassium carbonate solution (1.54 g, 12.1 mmol) was 
added to the reaction mixture and the reaction was extracted with Et20 (3 x 25 ml). The 
combined organic extracts were dried (M gS04) and concentrated in vacuo to afford a 
crude oil, which was purified by Kiigelrohr distillation to afford the title compound as a 
clear oil (0.8612 g, 3.32 mmol) in 53% yield. [a]o23 175.1 (c 1.0 in EtOH); Vmax/cm' 1 
1699 (C=N), 6h(300MHz, CDC13, M e4Si) 0.63 (3H, d, J  6.9 Hz, 3 x H I ’), 0.94 (3H, d, 
J  6.9 Hz, 3 x H I ’), 2.17 (1H, ddq, J  20.6, 6.9 and 3.4 Hz, 1 x H 2’), 3.61 (3H, s, OMe), 
3.89-4.11 (3H, m, 2 x H2 and 1 x H5), 4.98 (1H, d, J  12.3 Hz, 1 x H I” ), 5.18 (1H, d, J
12.3 Hz, 1 x H I” ), 7.18-7.34 (5H, bm, 5 x Hat); 8c(75MHz, CDC13, Me4Si) 17.3, 19.5,
32.7, 47.2, 53.0, 61.5, 67.2, 128.2, 128.4, 128.8, 137.5, 161.9, 165.1; m/z (Cl) 261.1595 
(M-KT requires 261.1598) 261 (91%), 171 (-Bn, 100), 108 (OBn, 46).
(2/£,5S)-2-benzyl-3-(benzyloxy)-2,5-dihydro-5-isopropyl-6- 
methoxypyrazine 337
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MeO'
337
Reaction of 321 (0.0101 g, 0.039 mmol) in THF (10 ml) with 2.36M  nBuLi in hexanes 
(0.5 ml, 1.18 mmol) and benzyl bromide (0.16 ml, 1.40 mmol) in THF (2 ml) according 
to general procedure G afforded the title compound 347 as a crude product in >95% 
d.e. The crude product was purified by silica gel chromatography (5% EtOAc/petrol) to 
afford the title compound as a clear oil (0.0109 g, 0.031 mmol) in a 80% yield and 
>90% d.e.; [a]D25 111.2 (c 1.3 in EtOH); v ^ / c m 1 1691 (C=N), 6h(300MHz, CDC13, 
M e4Si) 0.47 (3H, d, J  6.9 Hz, 3 x H I ’), 0.86 (3H, d, J  6.9 Hz, 3 x H I ’), 2.05 (1H, m, 1 
x H 2’), 3.05 (2H, dd, J  8.3 and 3.4 Hz, 2 x H I ” ), 3.13 (1H, app t, J  3.4 Hz, 1 x H5),
3.61 (3H, s, OMe), 4.33 (1H, dd, J  4.7 and 3.8 Hz, 1 x H2), 5.10 (1H, d, J  12.4 Hz, 1 x 
O C//H ), 5.04 (1H, d, J  12.4 Hz, 1 x OCHtf), 6.95-6.99 (2H, m, 2 x Hat), 7.07-7.13 
(3H, m, 3 x Hat), 7.22-7.38 (5H, m, 5 x H ^); 5c (75MHz, MeOD, M e4Si) 15.3, 18.1,




A solution of 203 (12.54 g, 67.4 mmol) in di-methanol (25 ml) was allowed to stand in 
the presence of 4A molecular sieves (9.6 g) for 30 minutes. Trifluoroacetic acid (6.85 
ml, 87.65 mmol) was added to the solution and allowed to stir for 18 hours. 1M K 2CO3 
solution (14.38 g, 112.4 mmol) was added to the reaction mixture and the reaction was 
extracted with Et20 (3 x 50 ml). The combined organic extracts were dried (M gS04) 
and concentrated in vacuo to afford the title com pound 321 (11.53 g, 62.0 mmol) in 
92% yield. [a]D23 72.0 (c 1.0 in EtOH) [lit.173 [a]D23 65.6 (c 1.38 in EtOH)]; v „ / c m '‘
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1694 (C=N), 5h(300MHz, CDC13, Me4Si) 0.68 (3H, d, J  6.8 Hz, 3 x H I ’), 0.96 (3H, d, 
J  6.8 Hz, 3 x H I ’), 2.16 (1H, m, 1 x H 2’), 3.61 (3H, s, OMe), 3.65 (3H, s, OMe), 3.92 
(1H, d, J  3.5 Hz, 1 x H5); 8D(60MHz, CHC13) 3.99 (ID , d, J  3.1 Hz, 1 x D); 8c(75MHz, 
CDC13, Me4Si) 16.8, 18.9, 32.3, 52.3, 52.4, 60.8, 162.2, 164.7; m/z (Cl) 187.1409 (M- 




Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M nBuLi in hexanes 
(0.5 ml, 1.18 mmol) and benzyl bromide (0.16 ml, 1.40 mmol) in THF (2 ml) according 
to general procedure H afforded the title compound 347 as a crude product in >90% 
d.e. The crude product was purified by silica gel chromatography (5% EtOAc/petrol) to 
afford the title compound as a clear oil (0.2379 g, 0.864 mmol) in a 80% yield and 
>95% d.e.; [<x]D25 41.2 (c 1.3 in CH2C12) [lit.173 40.4 (c 1.55 CH2C12)] ; vm„ /c irr ' 1681 
(C=N), 8h(300MHz, CDCIs, Me4Si) 0.53 (3H, d, J  6.8 Hz, 3 x H I ’), 0.87 (3H, d, J  6.8 
Hz, 3 x H I ’), 2.07 ( lH ,m , 1 x H 2 ’), 3.01 (2H, app s, 2 x H I ” ), 3.18 (1H, d, J 3.2 Hz, 1 
x H5), 3.61 (3H, s, OMe), 3.65 (3H, s, OMe), 6.99-7.20 (5H, bm, 5 x H Ar); 8c(75MHz, 
MeOD, M e4Si) 16.8, 19.4, 31.5, 40.3, 52.5, 52.8, 60.6, 126.7, 128.2, 130.4, 137.7, 
162.8,164.4; m/z (Cl) 276.1814 (M-H* requires 276.1817) 276 (100%).
(2/?,5S)-2-(4-fluorobenzyl)-2-deutero-2,5-dihydro-5-isopropyl-3,6- 
dimethoxypy razine 348
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Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M  “BuLi in hexanes 
(0.5 ml, 1.18 mmol) and p-fluoro-benzyl bromide (0.17 ml, 1.40 mmol) in THF (2 ml) 
according to general procedure H afforded the title compound 348 as a crude product in 
>90% d.e. The crude product was purified by silica gel chromatography (5% 
EtOAc/petrol) to afford the title compound as a clear oil (0.2249 g, 0.767 mmol) in a 
71% yield and >95% d.e.; [a]D27 +62.4 (c 1.0 in EtOAc); v ^ / c m ' 1 1694 (C=N), 
5h(300MHz, CDC13, Me4Si) 0.53 (3H, d, J  6.8 Hz, 3 x H I ’), 0.88 (3H, d, J  6.8 Hz, 3 x 
H I ’), 2.08 (H I, m, 1 x H 2’), 2.98 (2H, app t, /  14 Hz, 2 x H I ” ), 3.25 (1H, d, J  3.0 Hz, 
1 x H5), 3.59 (3H, s, OMe), 3.63 (3H, s, OMe), 6.82 (2H, app t, J  8.1 Hz, 2 x H 4” ), 
6.97 (2H, dd, J  7.7, 5.8 Hz, 2 x H 3” ); 5c(75MHz, MeOD, Me4Si) 16.8, 19.4, 31.6,
39.4, 52.5, 52.7, 60.7, 115.0 (d, J  10.5 Hz), 131.7 (d, J  3.8 Hz), 133.4, 162.6, 164.4X; 
m/z (Cl) 294.1721 (M-H+ requires 294.1723) 294 (32%), 278 (100, -Me), 250 (84, -‘Pr), 






Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M  nBuLi in hexanes 
(05 ml, 1.18 mmol) and o-bromo-benzyl bromide (0.3581 g, 1.41 mmol) in TH F (2 ml) 
according to general procedure H afforded the title compound 349 as a crude product in 
>90% d.e. The crude product (0.2 g) was purified by silica gel chromatography (5% 
EtOAc/petrol) to afford the title compound as a clear oil (0.2793 g, 0.79 mmol) in a 
73% yield and >95% d.e.; [a]D25 -7.5 (c 1.0 in EtOAc); v ^ / c m '1 1694 (C=N); 
8h(300MHz, CDC13, Me4Si) 0.58 (3H, d, J  6.8 Hz, 3 x H I ’), 0.94 (3H, d, J  6.8 Hz, 3 x 
H I ’), 2.14 (1H, m, 1 x H 2’), 2.86 (1H, d, J  14.0 Hz, 1 x H I ” ), 3.39 (1H, d, J  14.0 Hz, 1 
x H I ” ), 3.57 (3H, s, OMe), 3.66 (3H, s, OMe), 3.59 (1H, d, J  3.6 Hz, 1 x H5), 6.99 
(1H, app ddd, J  9.0, 5.8 and 3.2 Hz, 1 x Ha,), 7.06-7.26 (2H, bm, 2 x Ha,), 131-1.51  
(1H, m, 1 x Ha,); 8c(75MHz, MeOD, Me4Si) 16.9, 19.5, 31.8, 40.6, 52.9, 56.3, 60.8,
* Quaternary para centre not observed.
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125.8, 127.2, 128.3, 132.3, 133.0, 138.2, 163.5, 164.2; m/z (Cl) 354.0922 (M^Br-H* 






Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M “BuLi in hexanes 
(05 ml, 1.18 mmol) and p-bromo-benzyl bromide (0.3539 g, 1.40 mmol) in THF (2 ml) 
according to general procedure H afforded the title compound 350 as a crude product in 
>90% d.e. The crude product was purified by silica gel chromatography (5% 
EtOAc/petrol) to afford the title compound as a clear oil (0.2870 g, 0.81 mmol) in a 
75% yield and >95% d.e.; mp = 58-64 °C; [a]o25 -5.2 (c 1.0 in EtOAc); Vmax/cnT1 1694 
(C=N), §h(300MHz, CDCIs, Me4Si) 0.54 (3H, d, J  6.8 Hz, 3 x H I ’), 0.88 (3H, d, J  6.8 
Hz, 3 x H I ’), 2.08 (1H, m, 1 x H 2’), 2.96 (2H, app s, 2 x H I ” ), 3.32 (1H, d, J 3.0 Hz, 1 
x H5), 3.59 (3H, s, OMe), 3.63 (3H, s, OMe), 6.89 (2H, d, J  7.9 Hz, 2 x H 4” ), 7.25 
(2H, d, J  7.9 Hz, 2 x H 3” ), 8c(75MHz, CDC13, M e4Si) 16.8, 19.4, 31.7, 39.6, 52.6,
56.7, 60.7, 120.7, 131.3, 132.0, 136.8, 162.5, 164.4; m/z (Cl) 354.0922 (M79Br-Kr 
requires 354.0921) 356 (M ^B r-lT , 33%), 354 (M79B r-H \ 36), 340 (98), 338 (100), 






Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M “BuLi in hexanes 
(05 ml, 1.18 mmol) and oiodo-benzyl bromide (0.4140 g, 1.40 mmol) in THF (2 ml)
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according to general procedure H afforded the title compound 351 as a crude product in 
>90% d.e. The crude product (0.2 g) was purified by silica gel chromatography (5% 
EtOAc/petrol) to afford the title compound as a clear oil (0.2947 g, 0.73 mmol) in a 
68% yield and >95% d.e.; [ (x ] d 2 5  +15.5 (c 1.0 in EtOAc); V m a x /c m ' 1 1692 (C=N), 
5h(300MHz, CDC13, Me4Si) 0.58 (3H, d, J  7.0 Hz, 3 x H I ’), 0.94 (3H, d, J  7.0 Hz, 3 x 
H I ’), 2.15 (1H, m, 1 x H 2’), 2.86 (1H, d, J  13.6 Hz, 1 x H I” ), 3.35 (1H, d, J  13.6 Hz, 1 
x H I ” ), 3.57 (3H, s, OMe), 3.64 (1H, d, J  3.4 Hz, 1 x H5), 3.66 (3H, s, OMe), 6.80 
(1H, ddd, J  2.6, 6.4 and 7.9 Hz, 1 x H ^), 7.10-7.19 (2H, bm, 2 x Hat), 7.73 (1H, d, J
7.9, 1 x Hat), 6c(75MHz , CHC13, Me4Si) 15.5, 18.1, 30.4, 43.7, 51.5, 51.6, 59.5, 100.8,
126.7, 127.0, 130.0, 138.3, 140.2, 162.0, 162.8; m/z (Cl) 402.0783 (M -lT  requires 
402.0783) 403 (17%), 358 (-iPr, 100), 274 (-1, 14), 217 (CyHeBr, 34), 184 






Reaction of 321 (0.2000 g, 1.08 mmol) in THF (10 ml) with 2.36M nBuLi in hexanes 
(05 ml, 1.18 mmol) and p-trifluoromethyl-benzyl bromide (0.3301 g, 1.40 mmol) in 
THF (2 ml) according to general procedure H  afforded the title compound 352 as a 
crude product in >90% d.e. The crude product was purified by silica gel 
chromatography (5% EtOAc/petrol) to afford the title compound as a clear oil (0.3078 
g, 0.90 mmol) in a 83% yield and >95% d.e.; mp = 57-58 °C; [a]o25 -20.7 (c 1.0 in 
EtOAc); Vmax/cm' 1 1694 (C=N), 5h(300MHz, CDC13, M e4Si) 0.54 (3H, d, J  7.2 Hz, 3 x 
H 2’), 0.87 (3H, d, J  7.2 Hz, 3 x H I ’), 2.08 (1H, m, 1 x H I ’), 2.99 (1H, d, J  13.2 Hz, 1 x 
H I ” ), 3.11 (1H, d, J  13.2 Hz, 1 x H I ” ), 3.33 (1H, d, J  3.2 Hz, 1 x H5), 3.58 (3H, s, 
OMe), 3.63 (3H, s, OMe), 7.14 (2H, d, J  8.0 Hz, 2 x H 3” ), 7.39 (2H, d, J  8.0 Hz, 1 x 
H 4” ), 5c(75MHz, MeOD, Me4Si); 16.7, 19.3, 31.9, 40.2, 52.5, 52.7, 60.8, 124.8 (q, J  
270 Hz), 125.0 (q, J  3.8 Hz), 130.6, 131.0 (q, J  32.3 Hz), 142.2, 162.5, 164.5; m/z (Cl) 
344.1692 (M-FT requires 344.1691) 344 (15%) 300 (-‘Pr, 100), 329 (-Me, 33), 300 (-
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‘Pr, 100), 271 (-‘Pr, -OMe, 50), 184 (C9H 14D N 2O2, 9) 159 (C8H6F3, 10), 142 




H2N ''D  \[  J
353
Reaction of 347 (0.0217 g, 0.12 mmol) in acetonitrile (1.2 ml) was treated with 0.3M  
HC1 (1.2 ml, 0.36 mmol) according to general procedure I afforded the title compound 
353 (0.0186 g, 0.086 mmol) as a clear oil in 72% yield; [a]D25 4.3 (c 1.0 in H20 )  [lit.187 
[a]D23 4.4 (c 1.02 in H20 )]; v ^ / c m ’1 3412 (NH), 1740 (C =0); 5h(300MHz, D 20 )  3.24 
(1H, d, J  14.5 Hz, 1 x H2), 3.35 (1H, d, J  14.5 Hz, 1 x H2), 3.85 (3H, s, OMe), 7.26- 
7.49 (5H, bm, 5 x H a r ); 5d(60MHz, EtOH) 4.22 (ID , s, 1 x D); 8c(75MHz, CDC13, 
M e4Si) 35.7, 53.8, 128.3, 129.5, 129.7, 134.0, 170.3; m/z (Cl) 181.1080 (M-H+ requires 
181.1082) 181 (100%).
(K)-methyl 2-amino-2-deutero-3-(4-fluorophenyl)propanoate 354188
Reaction of 348 (0.0291 g, 0.10 mmol) in acetonitrile (1.2 ml) was treated with 0.3M  
HC1 (1.0 ml, 0.30 mmol) according to general procedure I afforded the title compound 
354 (0.0279 g, 0.119 mmol) as a clear oil in 81% yield; [a]o25 -34.3 (c 1.0 in EtOH) 
[lit.188 [a]D23 -32.2 (c 1.0 in EtOH)]; v ^ / c r a ' 1 3389 (NH), 1740 (C =0); 8h(300MHz, 
CDC13, M e4Si) 3.22 (1H, d, J  14.0 Hz, 1 x H2), 3.32 (1H, d, J  14.0 Hz, 1 x H2), 3.86 
(3H, s, OMe), 7.13 (2H, app t, J  8.1 Hz, 2 x H5), 7.31 (2H, dd, J  7.7, 5.8 Hz, 2 x H4); 
5d(60MHz, EtOH) 4.14 (ID , s, 1 x D); 5c(75MHz, CDCI3, M e4Si)xi 35.0, 53.9,116.3 (J
Xl Quaternary aromatic centre resonances too weak.
Chapter 6 243 Experimental
21.8 Hz), 131.5 ( /  6.8 Hz), 164.2; m/z (Cl) 199.0987 (M-H+ requires 199.0988) 199 
(100%).
(K)-methyl 2-amino-2-deutero-3-(2-bromophenyl)propanoate 355
Reaction of 349 (0.0213 g, 0.06 mmol) in acetonitrile (1.2 ml) was treated with 0.3M  
HC1 (0.6 ml, 0.18 mmol) according to general procedure I afforded the title compound 
355 (0.0134 g, 0.45 mmol) as a clear oil in 75% yield; [a]o25 -3.1 (c 1.0 in EtOH); 
Vmax/cm1 3435 (NH), 1740 (C =0); 5h(300MHz, CDC13, Me4Si) 3.21 (1H, d, J  14.7 Hz, 
1 x H2), 3.53 (1H, d, J  14.7 Hz, 1 x H2), 3.81 (3H, s, OMe), 7.25-7.44 (3H, bm, 3 x 
H a r ) ,  7.70 (1H, dd, J  7.9 and 1.0 Hz, 1 x H a r ); 5d(60MHz, H20 )  4.35 (ID , s, 1 x D); 
§c(75MHz, CDC13, Me4Si) 34.6, 52.1, 122.7, 126.8, 128.5, 130.3, 131.8, 131.9, 168.3; 
m/z (Cl) 259.0184 (M79B r-lT  requires 259.0187) 261 (M ^B r-lT , 98) 259 (M79Br- 
H M 00), 181 (-Br, 43).
(/?)-methyl 2-amino-3-(4-bromophenyl)-2-deutero-propanoate 356
Reaction of 350 (0.0210 g, 0.06 mmol) in acetonitrile (1.2 ml) was treated with 0.3M 
HC1 (0.6 ml, 0.18 mmol) according to general procedure I afforded the title compound 
356 (0.0147 g, 0.05 mmol) as a clear oil in 83% yield; [a]o25 18.5 (c 1.0 in EtOH); 
Vmax/cm' 1 3420 (NH), 1740 (C =0); 8h(300MHz, CDCI3, Me4Si) 3.21 (1H, d, J  14.7 Hz, 
1 x H2), 3.31 (1H, d, J  14.7 Hz, 1 x H2), 3.84 (3H, s, OMe), 7.20 (2H, d, J  8.5 Hz, 2 x 
H5), 7.58 (2H, d, J  8.5 Hz, 2 x H4); 6D(60MHz, EtOH) 4.35 (ID , s, 1 x D); 5c(75MHz, 
CDCI3, Me4Si) 35.2, 53.9, 121.8, 131.5, 132.5, 133.2, 170.2; m/z (Cl) 259.0184 
(M79Br-H+ requires 259.0187) 261 (M81Br-Kr, 97) 259 (M^Br-HTjOO), 181 (-Br, 43).





Reaction of 351 (0.0256 g, 0.06 mmol) in acetonitrile (1.2 ml) was treated with 0.3M 
HC1 (0.7 ml, 0.21 mmol) according to general procedure I afforded the title compound 
357 (0.0167 g, 0.05 mmol) as a clear oil in 76% yield; [a]o25 -13.3 (c 1.0 in EtOH); 
Vmax/cm1 3420 (NH), 1740 (C=0); 6h(300MHz, CDC13, M e4Si) 2.84 (1H, d, 7  13.6 Hz, 
1 x H2), 3.16 (1H, d, 7 13.6 Hz, 1 x H2), 3.70 (3H, s, OMe), 6.87 (1H, td, 7 7.5 and 1.5 
Hz, 1 x H a r ) ,  7.14 (1H, dd, 77 .5  and 1.9 Hz, lx  H a r ) ,  7.22 (1H, td, 77 .5  and 1.1 Hz, 1 
x H a r ) , 7.78 (1H, dd, 7 7.5 and 1.1 Hz, 1 x H a r ); 6d(60MHz, EtOH) 4.32 (ID , s, 1 x 
D); 5c(75MHz, CDC13, Me4Si) 40.8, 54.0, 130.2, 131.2, 131.3, 132.1, 137.0, 140.5, 
170.0; m/z (Cl) 307.0049 (M-H+ requires 349.0048) 307 (65%), 181 (-1, 100).
(R)-methyl 2-amino-2-deutero-3-(4-(trifluoromethyl)phenyl) 
propanoate 358
Reaction of 352 (0.0310 g, 0.09 mmol) in acetonitrile (1.2 ml) was treated with 0.3M 
HC1 (0.9 ml, 0.27 mmol) according to general procedure I afforded the title compound 
358 (0.0219 g, 0.08 mmol) as a clear oil in 85% yield; [a]o25 -24.8 (c 1.0 in EtOH) 
[lit.188 [a]D25 24 (for ent 358) (c 1.0 in EtOH)]; v ^ / c m ' 1 3402 (NH), 1742 (C =0); 
8h(300MHz, CDC13j M e4Si) 3.33 (1H, d, J  14.5 Hz, 1 x H2), 3.43 (1H, d, J  14.5 Hz, 1 x 
H2), 3.83 (3H, s, OMe), 7.46 (2H, d, J  7.9 Hz, 2 x H4), 7.74 (2H, d, J  7.9 Hz, 2 x H5); 
8d(60MHz, EtOH) 4.23 (ID , s, l  x D); 8c(75MHz, CDCI3, Me4Si)xii 35.6, 53.9, 126.4, 
130.2; m/z (Cl) 249.0955 (M-H* requires 249.0956) 249 (100%).
x" Quaternary centres too weak.
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(S,E)-methyl 2-((2-(naphtho[2,l>6,7-def][l,3,2]dioxaborepin-4- 
yl)phenyl)methyleneamino)-2-deutero-3-phenylpropanoate
Caesium carbonate (0.0394 g, 121 mmol), (S)-BINOL (0.0355 g, 122 mmol) and 2- 
formyl boronic acid (0.0185 g, 121 mmol) were added to a solution of 353 (0.0159 g, 
0.110 mmol) in CDCI3 (2 ml) containing 3A molecular sieves (0.10 g) and the reaction 
mixture was allowed to stir for 20 minutes. The reaction mixture was then filtered and 
used for NMR analysis directly; [a]o25 -576 (c 1.0 in CDCI3); 8h(300MHz, CDCI3, 
Me4Si) 3.07 (1H, d, J  13.6 Hz, 1 x H2), 3.36 (1H, d, J  13.6 Hz, 1 x H2), 3.77 (3H, s, 
OMe), 7.01-7.41 (13H, bm, 13 x Hat), 7.48 (1H, d, J  8.4 Hz, 1 x Hat), 7.80 (1H, d, J  8.7 
Hz, 1 x Hat), 7.87-7.93 (4H, m, 4 x Hat), 8.03 (1H, s, HC=N); 5C(75 MHz, CDC13),
39.4, 53.1, 118.2, 122.7, 123.4, 123.8, 127.5, 127.9, 128.3, 128.9, 129.0, 129.3, 129.5,
130.3, 130.4, 130.8, 133.7, 133.8, 135.3, 137.3, 154.4, 154.9, 170.4, 172.0; m/z (El) 
562.2178 (M-H+ requires 562.2176) 562 (100%).
(K,E)-methyl 2-((2-(naphtho[2,l,6,7-def][l,3,2]dioxaborepin-4-
yl)phenyl)methyleneamino)-3-phenylpropanoate
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Caesium carbonate (0.0220 g, 0.66 mmol), (S)-BINOL (0.0181 g, 0.6 mmol) and 2- 
formyl boronic acid (0.0087 g, 0.6 mmol) were added to a solution of (R)- 
phenylalanine methyl ester hydrochloride (0.0131 g, 0.6 mmol) in CDCI3 (4 ml) 
containing 3 A molecular sieves (0.10 g) and the reaction mixture was allowed to stir for 
20 minutes. The reaction mixture was then filtered and used for NMR analysis directly; 
[a]D25 -581 (c 1.0 in CDCI3); 5h(300MHz, CDCI3, Me4Si) 3.07 (1H, dd, J  13.6 and 7.6 
Hz, 1 x H2), 3.36 (1H, dd, J  13.6 and 3.3 Hz, 1 x H2), 3.77 (3H, s, OMe), 4.60 (1H, dd, 
J  7.6 and 4.8 Hz, 1 x H I), 7.01-7.41 (13H, bm, 13 x Ha,), 7.48 (1H, d, J  8.4 Hz, 1 x 
H Ar), 7.80 (1H, d, J  8.7 Hz, 1 x Ha,), 7.87-7.93 (4H, m, 4 x Ha,), 8.03 (1H, s, HC=N); 
Sc(75 MHz, CDCI3) 39.4, 53.1, 118.2, 122.7, 123.4, 123.8, 127.5, 127.9, 128.3, 128.9,
129.0, 129.3, 129.5, 130.3, 130.4, 130.8, 133.7, 133.8, 135.3, 137.3, 154.4, 154.9, 
170.4,172.0; m/z (El) 561.2108 (M-H+ requires 561.2106) 561 (100%).
(77,/:)-methyl 2-((2-(naphtho[7,6,l,2-def][l,3,2]dioxaborepin-4-
yl)phenyl)methyleneamino)-3-phenylpropaiioate
Caesium carbonate (0.0215 g, 0.66 mmol), (R)-BINOL (0.0172 g, 0.6 mmol) and 2- 
formyl boronic acid (0.0090 g, 0.6 mmol) were added to a solution of (R)- 
phenylalanine methyl ester hydrochloride (0.0129 g, 0.6 mmol) in CDCI3 (4 ml) 
containing 3 A molecular sieves (0.10 g) and the reaction mixture was allowed to stir for 
20 minutes. The reaction mixture was then filtered and used for NMR analysis directly; 
[a]D25 336 (c 1.0 in CDC13); 5h(300MHz, CDC13, Me4Si) 3.25 (1H, dd, /  13.6 and 8.6 
Hz, 1 x H2), 3.41 (3H, s, OMe), 3.47 (1H, dd, J  13.6 and 4.8 Hz, 1 x H2), 4.61 (1H, dd, 
J  8.4 and 4.8 Hz, 1 x H I), 6.95 (1H, d, J  7.0 Hz, 1 x H ^), 7.00-7.04 (2H, m, 2 x Hat), 
7.09-7.43 (12H, bm, 12 x Hat), 7.48 (1H, d, J 1A  Hz, 1 x Hat), 7.80-7.92 (5H, m, 5 x 
HAr), 8.40 (1H, s, HC=N); 8C(75 MHz, CDC13) 39.7, 53.0, 60.4, 118.2, 122.4, 123.4,
Chapter 6 247 Experimental
123.8, 127.7, 128.8, 128.2, 128.4, 128.8, 129.3, 129.4, 129.5, 130.0, 130.3, 133.6,
134.0, 134.8, 137.3, 154.4, 154.4, 154.8, 170.6, 172.5, 172.5; m/z (El) 561.2099 (M-H+ 
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Completeness to theta = 27.50° 
Absorption correction 
Max. and min. transmission
Refinement method
Data /  restraints / parameters
Goodness-of-fit on F^
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter 
Extinction coefficient
h03sdb01 






a =8.1550(2) A D =90°.
b = 6.15500(10) A □=
c = 14.8540(4) A □ = 90°.
729.79(3) A3 
2
1.080 M g/m 3 
0.066 m m 'l 
264
0.25 x 0.20 x 0.17 mm3 
4.24 to 27.50°.
-10<=h<=10, -7<=k<=7, -19<=1<=19 
15378




Full-matrix least-squares on F^
3 2 3 0 / 1 /  158
1.045
R1 = 0.0327, wR2 = 0.0830 
R1 = 0.0355, wR2 = 0.0849 
-0.3(10)
0.060(16)
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Largest diff. peak and hole 0.162 and -0.122 e.A~3
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Table 2. Atomic coordinates ( x 10^) and equivalent isotropic displacement parameters 
(A2x io3)
for h03sdb01. U(eq) is defined as one third of the trace of the orthogonalized U!J tensor.
x y z U(eq)
0 (1 ) 7905(1) -918(1) 1889(1) 27(1)
N (l) 7203(1) 1175(2) 592(1) 28(1)
C (l) 7805(1) 1005(2) 2443(1) 23(1)
C(2) 9442(1) 2250(2) 2570(1) 28(1)
C(3) 9427(1) 4247(2) 3176(1) 28(1)
C(4) 9027(2) 3555(2) 4094(1) 34(1)
C(5) 7396(2) 2256(2) 3964(1) 31(1)
C(6) 7429(1) 240(2) 3358(1) 24(1)
C(7) 11068(2) 5495(2) 3301(1) 42(1)
C(8) 5838(1) -1174(2) 3246(1) 27(1)
C(9) 5550(2) -1996(2) 4170(1) 38(1)
C(10) 4264(2) -61(3) 2709(1) 44(1)
C ( l l ) 7643(1) -633(2) 958(1) 25(1)
0(12) 7971(2) -2733(2) 505(1) 32(1)
C(13) 8097(2) -2332(2) -494(1) 35(1)
C(14) 6715(2) -779(2) -931(1) 37(1)
C(15) 6930(2) 1360(2) -415(1) 32(1)
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Table 3. Bond lengths [A] and angles [°] for h03sdb01.
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0(1)-C(11) 1.3673(13)
0(1)-C(1) 1.4528(13)
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C (ll) -0 (1 )-C (l)





C (2)-C (l)-H (l)
























































































H( 10 A)-C( 10)-H( IOC) 109.5
H(10B)-C(10)-H(10C) 109.5
N (l) -C ( ll) -0 (1 ) 121.48(10)
N (l)-C (ll)-C (1 2 ) 128.84(10)
0(1)-C(11)-C(12) 109.68(10)
C (ll)-C (12)-C (13) 110.40(10)
C(11)-C(12)-H(12A) 109.6
C(13)-C(12)-H(12A) 109.6












C( 13)-C( 14)-H( 14A) 109.8
C(15)-C(14)-H(14B) 109.8
C(13)-C(14)-H(14B) 109.8
H( 14A)-C( 14)-H( 14B) 108.3
N (l)-C(15)-C(14) 115.14(10)
N(1)-C(15)-H(15A) 108.5
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Table 4. Anisotropic displacement parameters (A^x 103)for h03sdb01. The anisotropic 
displacement factor exponent takes the form: -2C|2[ h2a*2l j l l  + ... + 2 h k a* b* U ^2 ]
•
U H u22 U33 U 23 U 13 U 12
0(1) 37(1) 22(1) 24(1) -2(1) 10(1) 1(1)
N (l) 32(1) 29(1) 25(1) -1(1) 8(1) -KD
C (l) 27(1) 21(1) 23(1) -1(1) 8(1) 0(1)
C(2) 26(1) 28(1) 31(1) 0(1) 10(1) -3(1)
C(3) 27(1) 25(1) 32(1) 1(1) 5(1) -2(1)
C(4) 40(1) 32(1) 29(1) -6(1) 5(1) -8(1)
C(5) 37(1) 33(1) 27(1) -5(1) 13(1) -5(1)
C(6) 26(1) 23(1) 23(1) 1(1) 6(1) 0(1)
0(7) 35(1) 38(1) 52(1) -4(1) 9(1) -11(1)
0(8) 28(1) 26(1) 28(1) 2(1) 9(1) -2(1)
0(9) 43(1) 40(1) 35(1) 4(1) 15(1) -10(1)
0(10) 28(1) 43(1) 59(1) 15(1) 2(1) -5(1)
0(11) 25(1) 28(1) 24(1) -4(1) 9(1) -4(1)
0(12) 40(1) 27(1) 34(1) -5(1) 14(1) -KD
0(13) 42(1) 35(1) 31(1) -9(1) 14(1) -4(1)
0(14) 41(1) 41(1) 28(1) -6(1) 7(1) -8(1)
0(15) 36(1) 34(1) 25(1) 0(1) 6(1) -2(1)
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P2i 2! 2, 
a = 6.2600(3) A 
b = 6.3070(11) A 















Completeness to theta = 27.48° 
Absorption correction 
Max. and min. transmission
Refinement method
Data /  restraints / parameters
Goodness-of-fit on
Final R indices [I>2sigma(I)]
R indices (all data)
Absolute structure parameter 
Extinction coefficient
Largest diff. peak and hole
0.087 m m 'l 
368
0 .1 7 x 0 .1 3 x 0 .1 0  mm3 
3.67 to 27.48°.
-8<=h<=5, -7<=k<=8, -23<=1<=30 
5090




Full-matrix least-squares on F^ 
2 0 3 0 /0 /1 1 7
1.023
R1 =0.0483, wR2 = 0.1061 
R1 =0.0919, wR2 = 0.1197 
- 1(2)
0.054(16)
0.300 and -0.332 e .A '3
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters
(A2x io3)
for h04sdb01. U(eq) is defined as one third of the trace of the orthogonalized U0 tensor.
X y z U(eq)
0 (1 ) -5239(3) -5276(2) -2960(1) 47(1)
0 (2 ) -4280(3) 887(2) -4466(1) 41(1)
N (l) -4326(3) -1873(3) -3154(1) 30(1)
N(2) -4785(3) -2638(2) -4311(1) 32(1)
C (l) -4788(4) -3863(3) -3299(1) 32(1)
0(2) -4794(4) -4386(3) -3913(1) 37(1)
C(3) -4319(3) -840(3) -4127(1) 28(1)
C(4) -3715(3) -195(3) -3540(1) 27(1)
C(5) -1315(4) 350(4) -3516(1) 46(1)
0(6) -699(4) 1243(4) -2956(1) 57(1)
0(7) 70(4) -1532(4) -3677(1) 75(1)
0(8) -4703(5) 480(4) -5049(1) 55(1)
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C (l)-N (l)-C (4)
C (l)-N (l)-H (l)
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Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2x 103)for h04sdb01. The anisotropic 
displacement factor exponent takes the form: -2D^[ h2a*2U l l  + ... + 2 h k a* b* U ^2 ]
U H u 2 2 U 3 3 U 2 3 U 13 u 1 2
0 (1 ) 77(1) 34(1) 29(1) 8(1) 8(1) 3(1)
0 (2 ) 67(1) 27(1) 29(1) 3(1) 0(1) -1(1)
N (l) 41(1) 31(1) 19(1) -2(1) -1(1) 4(1)
N(2) 47(1) 23(1) 25(1) 1(1) 0(1) -2(1)
C (l) 40(1) 30(1) 27(1) 0(1) 2(1) 8(1)
C(2) 57(1) 28(1) 25(1) 0(1) 2(1) -1(1)
C(3) 34(1) 28(1) 22(1) 3(1) 3(1) 4(1)
C(4) 31(1) 24(1) 27(1) -2(1) K D 2(1)
C(5) 36(1) 56(2) 45(1) -12(1) 2(1) -7(1)
0(6) 43(1) 64(2) 63(2) -10(1) -14(1) -6(1)
C(7) 29(1) 104(2) 90(2) -44(2) 0(1) 15(2)
C(8) 98(2) 43(1) 23(1) 8(1) -6(1) -2(1)
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Table 5. Hydrogen bonds for h04sdb01 [A and °].
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
N (l)-H (l) ...0(1#) 0.89(3) 1.975(3) 2.859(2) 173.42(15)
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